m+Medelevator.RU
← Поиск публикаций
BMC palliative care · 2026

Implementing patient-centred outcome measures in palliative care clinical practice. An updated systematic review of facilitators and barriers.

Название и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Antunes B, Barclay S, Kuhn I, Eagar K, Bausewein C, Murtagh F, Etkind S, Bowers B, Dixon S, Lovick R, Harding R, Higginson I, Shokraneh F

Аннотация

BackgroundPatient-centred outcome measures (PCOMs), when well implemented, are powerful tools facilitating patient, family and clinical communication to better respond to patient needs. Their routine use in palliative care practice still faces challenges.ObjectiveTo update a systematic review of PCOMs implementation, reviewing and synthesising new evidence on facilitators, barriers, lessons learned, measures used, models of implementation, costs, implementation outcomes, and consequences in clinical practice.MethodsWe searched eight information sources supplemented by hand-searching and citations of the original review and studies identified by the expert advisory committee. This prospectively registered review included studies using a PCOM during clinical care of adult patients with advanced disease in all settings and extracted data on: PCOMs used, models of implementation, facilitators, barriers, lessons learned, costs, and implementation outcomes. We employed narrative synthesis and tabulated findings, following all PRISMA reporting guidelines.ResultsWe included 114 studies. A major new facilitator was the integration of electronic/digital PCOMs into Information Technology systems. Main barriers remain largely unchanged and relate to healthcare professionals' beliefs. Implementation was highlighted as a complex intervention, needing planning, assessment and fine tuning throughout. Sixty-two included studies mentioned at least one implementation outcome. Eighteen models, frameworks and theories were identified in 25 included studies. No studies reported on costs of implementation.ConclusionThis work reveals the complexity of implementing PCOMs in palliative care practice. The main clinical and research implications of our findings highlight the central importance of staff engagement and training staff in PCOM tools, communication strategies, and cultural competence.

Перевод полного текста: Перевод в очереди

Читать найденный полный текст

https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ .

Key Statements

What is already known about the topic

The importance of using patient-centred outcome measures (PCOMs) to understand the effect and effectiveness of health interventions has been established: they are an essential component of evidence-based clinical practice. Data collected at individual patient-level can be used immediately by healthcare professionals to act on any identified distressing symptoms or palliative needs. Despite the development of PCOMs in the past three decades, their routine use in clinical practice remains challenging in most countries.

What this paper adds

Having a coordinator onsite and training clinicians are key to the initial implementation of PCOMs in clinical practice. Embedding PCOMs at point of care is critical to their ongoing implementation in practice. The integration of electronic/digital PCOMs into Information Technology systems is a new development that is still emerging Evidence is scarce on the models of PCOMs implementation used in clinical practice and their associated financial costs.

Implication for practice, theory or policy

Successful implementation requires embedding outcome measures at the point of care and tailoring the implementation process to local circumstances and contexts. Constant feedback of patient-level outcomes to clinicians is vital. Implementing PCOMs in palliative care clinical practice is a complex intervention and guidelines and statements on complex interventions should be followed.

Background

The importance of patient-centred outcome measures (PCOMs) in palliative care clinical practice is well established: they include patient-reported outcome measures (PROMs), which capture patients’ own perspectives on their health and wellbeing, and together they allow for clinical care to respond to real-time need, and longitudinal comprehensive measurement of patient and family outcomes across physical, psychological, existential, emotional, and practical domains [ 1 – 5 ].

When used properly, PCOMs become powerful communication tools, keeping all involved in patient care at the same level of knowledge regarding patient and family outcomes [ 6 – 8 ]. Additionally, PCOMs data, collected at patient level, can be aggregated for audit, research, quality improvement, and benchmarking. Ultimately those data can be used by policy makers to improve patient and family care [ 9 – 11 ].

Regardless of the recognition and importance PCOMs have in patient and family care, their implementation in clinical practice remains challenging [ 12 , 13 ]. Time pressures in busy clinical settings, limited clinician training and confidence in using and interpreting PCOM data, and concerns about increasing workload are some of the issues. Additionally, organisational and system-level factors—such as inadequate leadership support and poor integration into existing clinical processes—continue to impede sustainable implementation [ 1 ].

We have updated and expanded a 2013 systematic review on implementation of PCOMs in palliative care [ 1 ]. The original review objectives were to (a) identify barriers and facilitators to the systematic implementation of PROMs in palliative care clinical practice, (b) identify needs and other comments of clinical teams regarding the routine use of PROMs and (c) identify lessons learned on the process of implementation of PROMs in clinical practice. Twenty-six studies were included within 31 articles. We updated the original review objectives and recommendations and added four more objectives, with review questions as follows:

What are the PCOMs implemented in palliative care clinical practice? What are the facilitators to PCOMs implementation in palliative care clinical practice? What are the barriers to PCOMs implementation in palliative care clinical practice? What are the lessons learned on implementing PCOMs in PC clinical practice? What are the implementation models used in PCOMs implementation in palliative care clinical practice? What implementation outcomes were measured and how, when implementing PCOMs in palliative care clinical practice? What are the financial costs of implementing PCOMs in palliative care clinical practice? Are there new recommendations since the previous literature review to inform the implementation process in palliative care clinical practice for all stakeholders?

Methods

We conducted a systematic literature review and narrative synthesis. PRISMA reporting guidelines were followed, including PRISMA, PRISMA-Abstracts [ 14 ] and PRISMA-Search [ 15 ]. The review protocol has been published elsewhere in open access [ 16 ]; we briefly describe the methods below.

On 14 November 2022, we searched MEDLINE, Embase, Emcare, CINAHL, PsycINFO, BNI, Web of Science Core Collections (SSCI, SCI, ESCI), and Scopus with no date, language, publication type, or publication status limitations [ 17 ], supplemented by a list of studies recommended by the expert advisory committee and hand-searching references of included studies. Appendix 1 provides the full search strategy for MEDLINE. We included primary empirical studies using PCOMs in clinical care for adult patients with advanced disease in all palliative care settings. We included studies using a PCOM during clinical care of adult patients with advanced disease in all settings and extracted data on: PCOMs used, models of implementation, facilitators, barriers, lessons learned, costs, and implementation outcomes. Narrative reviews, editorials, commentaries, and case reports were excluded.

The search results were imported into EndNote and de-duplicated. Following the removal of duplicates, approximately 20,000 records were screened. The de-duplicated results were then exported from EndNote and imported into Rayyan (Ouzzani et al., 2016) for screening. Two reviewers (B.A., F.S.) independently screened 20% of the records using the blinding mode. When inter-reviewer agreement exceeded 90%, the remaining records were screened by a single reviewer. Any discrepancies between reviewers were resolved through discussion. All full-text reports were independently assessed by two reviewers, and any unresolved disagreements were adjudicated by a senior topic expert, who made the final decision regarding study eligibility.

We used Gough’s Weight of Evidence Framework [ 18 ] to appraise each included study’s internal validity, appropriateness, and contribution to addressing the review questions. The framework applies to quantitative, qualitative, and mixed-methods research at the study level. The weight of evidence refers to the preponderance of evidence used to inform decision-making. It involves judgements on general methodological quality (Weight of Evidence A), the appropriateness of the research design for the review question (Weight of Evidence B), and the relevance or focus of the evidence to the review (Weight of Evidence C). Each of these dimensions was rated as low, medium, or high. These three judgements were then combined to generate an overall assessment (Weight of Evidence D), also categorised as low, medium, or high, reflecting the strength and relevance of each study’s contribution to the synthesis. Studies were weighted independently by two reviewers (B.B., S.E.), with a third reviewer (S.B.) consulted when necessary to reach consensus.

The narrative synthesis was undertaken in the same way, following the Guidance on the Conduct of Narrative Synthesis in Systematic Reviews [ 19 ]. Finally, we mapped the updated recommendations, and reiterated those from our previous review, on the updated Medical Research Council (MRC) Framework for Developing and Evaluating Complex Interventions [ 20 ]. The Framework has four phases, each with six core elements.

We updated the original 2022 search by a scoping search using our main keywords on 9 February 2025 to identify any new relevant studies.

Results

We included 114 studies (117 reports) [ 2 , 7 , 8 , 13 , 21 – 133 ] which are shown in Table 1 .

Table 1 Characteristics and quality assessment of included studies Study Name Research Date Country Design Setting Participants (Patient, Carer, HCP) Age (Mean (SD)) Sex/Gender; N (%) Size Conditions WoE Appleyard et al. 2021 2016–2017 UK Single-Arm Interventional Study (Mixed-Method) Uro-Oncology Clinics (Outpatient Department) of 1 Teaching & 2 District General Hospitals; Home (Optional) Patients (Computer-Familiar) M (R): 74 (58–89 M 40 Advanced Prostate Cancer on Palliative Systemic Treatment HHH-H Bausewein et al. 2011a 2009–2010 Africa, EU, Malaysia, Taiwan, Australia, Brazil, US, Canada, Japan, Thailand Survey (Mixed Methods) NA HCP 46 (9) F: 420; M: 243 663 NA HHH-H Bausewein et al. 2016 2011–2013 EU Concensus (EAPC White/Position Paper) NA HCP NA NA 28 NA LLL-L Bausewein et al. 2018 2014 Germany Case Study 1 university palliative care unit (10-bedded) Patients NA F/M 574 Advanced cancer; advanced lung and heart disease; neurological disease LMM-M Beddard-Huber et al. 2015 2013 Canada Single-Arm Interventional Study; Survey 1 Tertiary Palliative Care Unit (15-bed palliative care unit at Vancouver General Hospital); Acute Patients, HCP: Nurses, Physicians Median: 68.6 (Patients) F/M 92 Patients, 23 Nurses, 7 Physicians Cancer (84%); Cardiac disease (4%); End-stage liver disease (3%); Other chronic diseases (8%); Brain injury (1%) LLL-L Bennett et al. 2012 NA UK, US Survey Oncology (Hospice, Hospital, Home) NA NA F/M NA Oncology (Treatment and survivorship, Adults and adolescents receiving chemotherapy and palliative care, Postsurgery for radical prostatectomy, In hospice) LMH-M Bookbinder et al. 1996 1992–1994 US Pre-Post Interventional Study; Focus Groups; Chart Reviews Major Urban Cancer Center: 12 inpatient units Patients; HCP: Nurse NA NA 398 Patients; Nurses (NA) Cancer Pain (acute and chronic) MMM-M Bourbonnais et al. 2004 NA Canada Retrospective Chart Reivew; Focus group 12 settings Patients; HCP: Nurses NA NA 55 Patients; 25 Nurses Cancer Pain HHH-H Bouvette et al. 2002 2000 Canada Exploratory study; Focus groups; Chart audits 12: Community agencies (5); Tertiary Hospital (2); Community Hospital (2); Hospices (2); ORPCU (1) HCP: Nurses NA NA 180 Lung cancer; Breast cancer; Prostate cancer; Stomach and peritoneal cancer; Lower back pain; Oesophagus, larynx, parotid cancer; Brain cancer; CHF, MI, angina, COPD, emphysema; Liver or pancreas cancer; Cervix cancer; Diabetes; Lymphoma; Myeloma HHH-H Bradshaw et al. 2021b 2019 UK Qualitative Study (Exploratory (Interpretive Paradigm) 11 services delivering specialist palliative care in Yorkshire, England (inpatient, outpatient/day therapy, home-based/community) HCP: Nurse (29); Doctor/consultant (16); AHP (8); Healthcare assistant (4); Chief executive (2); IT (2); Other (2) 25–55+ F (59); M (4) 63 NA HHH-H Bush et al. 2018 NA NA Systematic Review NA NA NA NA 30 primary studies NA LHM-M Campbell et al. 2022 NA US Prospective Observational Study; Interviews 2 outpatient gynecologic oncology clinics at a large urban academic medical center Patients 60.6 (10.7) F 30 Gynecologic cancer receiving chemotherapy: Ovarian/fallopian; Primary peritoneal, uterine, endometrial, or cervical; Other/unknown MLL-L Carli Buttenschoen et al. 2014 2010 Canada Survey Palliative Community Consult Team (1 20-bed Tertiary Palliative Care Unit, 3 Hospice Palliative Care Units, 1 Community Consultation Team, and 3 Acute Care Hospital Palliative Consultation Teams) and University Hospital Chronic Pain Clinic; Inpatient (hospital, hospice); outpatient clinics; home consultations HCP: Staff physician: 11; Fellows, residents, students: 11; Nurses: 51; Other (dieticians, occupational therapists, pharmacists, physiotherapists, respiratory therapists, and spiritual care): 10 NA NA 193 Palliative care; Chronic pain MMM-M Coast et al. 2018 2012–2014 UK Qualitative Study; Interviews; Constant Comparative Analysis; Feasibility 1 UK Adult Hospice (patients recruited via community service, day hospice and in-patient unit) 33 hospice patients, 22 close persons and 17; HCP: 8 doctors, 7 nurses and 2 AHP 50+ (13 aged 50–69, 10 aged 70–79, 10 aged ≥ 80 years) F: 12 72 Life-threatening illness and approaching EoL: Cancer-related diagnoses; motor neurone disease MML-M Collins et al. 2015 2010–2014 NA Systematic Review Palliative Care NA NA NA 43 studies (POS n = 35, STAS n = 8) Cancer, HIV/AIDS, Dementia, Parkinson’s Disease, Chronic Kidney Disease, Chronic Heart Failure, COPD, Renal Transplant Patients, End-Stage Renal Disease, Parkinson Syndromes (Idiopathic Parkinson’s Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy) HHM-H Collins et al. 2015 NA NA Systematic Review Palliative Cancer Care NA NA NA 13 primary studies NA HHH-H Currow et al. 2014 2008 Australia Prospective Database Analysis (Symptom Control Performance Data) 30 Services (Metropolitan; Regional/rural): Inpatient, Ambulatory/community, Both Patients NA F: NA (46) 19,747 Cancer: 85% HHH-H Daveson et al. 2012 NA Europe and Africa Survey (Web-Based) NA HCP: Palliative care professionals working in clinical care, audit and research Doctors: 46.9 (8.74); Nurses: 45.1 (8.42) Doctors: F: 92 (47); Nurses: F: 87 (84) 196 Doctors; 104 Nurses NA MMM-M Diffin et al. 2018 2013–2014 UK Pre-Post Single-Arm Interventional Study; Survey 36 UK palliative care services: Day services, Community clinical nurse specialist teams, day hospices, social work teams, and an outpatient clinic HCP: Clinical Nurse Specialist (CNS) (73); Registered Nurse (other than CNS) (37); Social Worker (7); Medical Practitioner (3); Other (34) NA NA 462 NA HHH-H Diplock et al. 2019 2011–2013 Canada Prospective Cohort Study 1 Ambulatory Clinics in a Regional Cancer Center Patients Control: 58.33 (16.06); Case 61.19 (12.99) M: Control − 94 (58.75); Case − 28 (25.93); F: Control − 66 (41.25); Case − 80 (74.07) 268: Control ( n = 160) and Case ( n = 108) Breast, Gastro-intestinal, Genitourinary, Gynecology, Hematology oncology, Head and neck, Lung, Melanoma MMM-M Dobrina et al. 2018 2012–2014 Italy Mixed-Method; Single-Arm Interventional Study; Action Research 1 Italian hospice (19 beds) Patients; HCP NA NA 16 patients; 2 Physicians (1 Chief), 1 Chief Nurse, 10 RNs, 10 NAs, 1 Psychologist (Patient and Family Support), 1 Psychologist (Staff Support) advanced cancer MML-M Donaldson et al. 2004 NA NA Literature Review; Interviews Oncology Practice; hospice, home-care, and long-term care settings NA NA NA NA Cancer HHH-H Downing et al. 2012 2010 Africa Survey (Web-Based) NA HCP: 69 (Physician: 27; Nurse: 29; Other: 13); Researcher: 27 (Pure Researcher: 9; Researcher-Clinician: 18) 47 (9) F: 55; M: 33 301 NA MHH-H Dunckley et al. 2005 NA UK Pre-Post Interventional Study; Action Research; Interviews; Case Studies; Staff Diaries 1 specialist hospice inpatient unit and a nursing home providing care for people with neurological illness HCP NA NA 28 permanent nursing home staff and to 23 clinical hospice staff NA HMM-M Eijsink et al. 2023 NA NA Scoping Review NA NA NA NA 20 studies Bariatric surgery; Pain interference in carpal tunnel release; Ischemic stroke; Minor stroke and transient ischemic attack; Total knee and hip replacement; Aortic valve disease; Hernia care; Hepatatis C; Orthopedic surgery; Coronary artery disease; Breast cancer; Breast cancer; Inflammatory arthritis; Turner syndrome; IBD; Lynch syndrome; Burn injury; Cancer care; Hemodialysis; Advanced non-small-cell lung cancer HMM-M Ellis-Smith et al. 2018 2014–2016 UK Mixed-Method; Feasibility 3 residential care homes registered to provide care for people aged 65 and over (26–33 beds) 6 family members and 20 professionals care home staff ( n = 15), GPs ( n = 3) and DNs ( n = 2) 87.2 (8.3) F: 24 (75); M: 8 (25) 32 Residents (Dementia with comorbidities) Dementia HHH-H Etkind et al. 2015 1985–2013 NA Systematic Review Outpatient oncology (Mainly); Community oncology; Home hospice patients; Hospice inpatient unit; Long-term care units; Outpatient oncology; Palliative home care NA NA NA 16 papers corresponding to 13 studies NA HHH-H Evans et al. 2020 2017–2018 Canada Mixed-Methods; Pre-Post Study; Survey; Interviews; Chart Audit; Pilot; Longitudinal Study 8 in-facility hemodialysis programs Patients, Carers, HCP (48 providers and staff: nephrologists ( n = 5), nurse practitioners ( n = 3), nurse managers ( n = 5), registered nurses and registered practical nurses ( n = 7), pharmacists ( n = 3), dietitians ( n = 9), social workers ( n = 4), clerical staff ( n = 3), and project leads ( n = 9)) M: 68 (1459 patients) NA 9 patients/caregivers and 48 HCPs; 1207 charts (1459 patients) Hemodialysis MHH-H Fabian et al. 2021 NA NA Systematic Review Palliative Radiotherapy NA NA NA 4 studies (primary objective); 3 studies (secondary objective) Head and Neck Cancer Patients HMM-M Fetz et al. 2018 2011–2015 Germany Observational Cohort study; Retrospective Analysis of Longitudinal Data Specialised Palliative Care Unit of a University Medical Centre HCP: Nurses M (R; SD): 67 (17–114; 14) F: 420; M: 400 820 Cancer; Non-cancer; Previous cancer MMM-M Friedman et al. 2022 2013–2019 US Prospective Single-Arm Interventional Study Hematology-oncology clinics in Veteran Administration (VA) medical centers in the Southeast Patients M (R): 67 (21–97) M: 8,106 (89); F: 952 (11) 9,058 Ambulatory patients: No retrievable cancer diagnosis; Prostate cancer; Lung cancer; Leukemias and lymphomas; Colorectal cancer; Head and neck cancer; Multiple myeloma; Hepatocellular carcinoma; Renal cell carcinoma; Breast cancer; Pancreatic cancer; Other cancers MML-M Friis et al. 2021 2014–2018 Denmark Prospective Single-Arm Cohort 1 oncology outpatient Patients Median (IQR): 70 (64–74) F: 35 (37.2); M: 59 (62.8) 94 Advanced Lung Cancer: SCLC, NSCLC HML-M Gabbard et al. 2021 2017–2018 US Feasibility 1 outpatient dialysis unit affiliated with a large academic tertiary medical center Patients 69.4 (6.6) F: 14 (63.6); M: 8 (36.4) 22 End-Stage Renal on Hemodialysis Disease; Charlson Comorbidity Index was 8.45 (2.28) HHH-H Garcia et al. 2019 2015–2017 US Prospective Database Analysis 1 comprehensive cancer center Patients 57.15 (13.39) F: 2398 (68.11) 6825 (3521 Responders) Oncology outpatients; Hematologic malignancies (lymphoma and leukemia), Breast, Gynecologic malignancies, Gastrointestinal malignancies, Sarcoma (soft tissue and bone), Lung and other thoracic malignancies, Other or unspecified malignancies, Prostate, Skin, Other genitourinary, Central nervous system, Head and neck, Thyroid and other endocrine glands, Missing HMM-M Goyal et al. 2020 2013–2014 US Prospective Pre-Post Study 1 radiotherapy outpatient setting Patients 64.3 (12.2) F: 106 (42); M: 149 (58) 255 Tumor Primary disease site: Breast, Head and neck, Lung, Prostate, GI, Lymphoma, Sarcoma, CNS, Gynecology, Other HMM-M Graf et al. 2022 2015–2016 Germany Prospective Trial 2 centers in major university hospitals Patients Adjuvant Therapy ( n = 76, AGE: 49.39 (10.28)); Metastatic Situation ( n = 30, AGE: 53.93 (13.94)) F 106 Adjuvant or advanced breast cancer; Adjuvant Therapy ( n = 76, AGE: 49.39 (10.28)); Metastatic Situation ( n = 30, AGE: 53.93 (13.94)) MHL-M Greenhalgh et al. 2017 NA NA Realist Synthesis NA NA NA NA NA NA HMM-M Gressel et al. 2019 2016–2017 US Prospective Cross-Sectional Study; Pilot 1 Gynecologic oncology outpatient clinic Patients 65 (12) NA 336 Uterine cancer, Ovarian/fallopian/PPC, Cervical/vaginal/vulvar cancer HMM-M Guo et al. 2018 2017 Asia Workshop Report NA HCP: doctors, nurses, AHP; Managers, policy makers, and academics NA NA 350 NA LLM-L Hall et al. 2020 2018 UK Qualitative Study; Longitudinal Study 1 NHS Trust HCP NA NA 12 hospital practitioners, 1 hospital administrator and 4 community practitioners (= 17 (then 15): 4 Nurses Community; 8 Nurses; 3 Consultants, Matron, Project Officer Hospital) NA HMM-M Harding et al. 2007 2005 South Africa Workshop Report NA HCP NA NA 32: doctor ( n = 11), service manager/developer ( n = 6), nurse ( n = 6), social/support worker ( n = 5), trainer/educator ( n = 2), technical advisor ( n = 1), and medical student ( n = 1) NA MHH-H Harding et al. 2011 2009 EU Survey (Online) Palliative and Advanced Disease Care HCP: Physicians, nurses, other allied professionals, and academics 45.8 (8.93) F: 187 (63.6) 311 NA HMM-M Hardy et al. 1999 NA UK Pre-Post Single-Arm Interventional Study 1 palliative care unit Patients Median (R): 66 (36–83) NA 52 Advanced disease MMM-M Hawley et al. 2011 NA Canada Pre-Post Controlled Interventional Study; Retrospective Chart Review 3 outpatient oncology pain and symptom management/palliative care clinics, 4 palliative care units (general hospitals), 4 residential hospices, 1 control palliative care unit HCP: 15 members of clinical staff: 9 registered nurses, 4 licensed practical nurses, 1 physician, and 1 other. NA NA 180 charts Constipation in patients receiving palliative care: Mostly cancer patients (Breast, lung, gastrointestinal, and prostate primaries) MMM-M Hill et al. 2002 NA New Zealand Qualitative Study; Theme of Revelation (De Santis and Ugarriza) Hospice setting HCP; Patients NA NA NA NA MLL-L Hogberg et al. 2019 2016–2017 Sweden Qualitative Study: Interpretive Descriptive Design; Interviews (Telephone) 3 Specialized palliative home-care Patients M (R): 72 (46–85) F: 3; M: 7 10 Incurable cancer; Advanced cancer (9), stroke (1) HHH-H Howell et al. 2020 2014–2016 Canada Observational Pre-Post Controlled Population Cohort Study 8 disease site clinics at 3 regional cancer centers (RCCs) Patients M, Median (IQR): 62.69, 64 (19) F: 35,122; M: 35,732 70,854 Brain cancer, Breast cancer, Lung cancer, Gynecological cancer, Colorectal cancer, Prostate cancer, Other cancer HHH-H Hughes et al. 2003* NA UK Qualitative Study; Interviews (Telephone); Exploratory NA HCP NA NA 26 NA HHM-H Hughes et al. 2004* NA UK Qualitative Study; Exploratory Scoping Exercise 10 settings: 4 oncology wards, 4 nursing homes, 1 general medical ward, 1 specialist hospital palliative care team HCP NA NA NA NA MML-M Hui et al. 2017a NA US Narrative Review NA NA NA NA NA NA MLL-L Hui et al. 2017b 2015 US Pre-Post Interventional Study 1 Community Cancer Center (General Medical Oncology Outpatient Clinic) Patients Average (R) 55 (19–87) F: 265 (57) 465 Breast, Gastrointestinal, Genitourinary, Head and neck, Hematological, Other, Respiratory Cancers HMM-M Ihler et al. 2019 2017 Norway Qualitative Study; Interviews (Interpretive) 2 Oncology Wards in a Hospital; Inpatients HCP: 6 RN (5 Oncology Nurse) Average (R): 37.2 (28–49) F 6 Cancer MMM-M Jordhoy et al. 2007 2005 Norway Systematic Review NA NA NA NA 40 references NA MMM-M Kamal et al. 2016 2014–2015 US Prospective Cross-Sectional Study Palliative care (Diverse Clinical Settings) 5 organizations within the Palliative Care Research Cooperative Group: 4 academic sites and 1 community-based site; across 6 common clinical settings of palliative care: hospital general floor, hospital intensive care unit (ICU), emergency department, outpatient, long-term care, and home; (general floor, ICU, and emergency department) as acute care; outpatient palliative care clinics, home-based palliative care consultations, and long-term care facility palliative care visits were aggregated into nonacute care Patients NA F: 1228 (55); M: 961 (43); Left blank: 53 (2) 2242 Cancer, Neurologic, Cardiovascular, Pulmonary, Infectious, Other diagnosis, Gastrointestinal, Renal, Unknown HHH-H Kane et al. 2017* 2014–2015 Ireland Mixed Method; Pre-Post Study; Qualitative Study; Interviews CHF disease management clinics in 2 national tertiary referral centres in Dublin, Ireland; urban teaching hospital sites Patients (18), HCP (4 Nurses) NA NA 25 Chronic Heart Failure MMM-M Kane et al. 2018* NA Ireland Mixed-Method; Qualitative Study; Feasibility; Interviews (Framework Analysis) Nurse-led chronic heart failure disease management clinics in two tertiary referral centres Patients (18), HCP (4 Nurses) 75 (8.5) M: 11 (61) 22 Advanced heart failure: chronic heart failure: New York Heart Association functional class II-IV HMM-M Karamanidou et al. 2020 2019 Greece Systematic and Mapping Review NA NA NA NA 24 primary studies Cancer HHH-H Kilonzo et al. 2015 2012–2013 Ireland Prospective Single-Arm Interventional Study 1 30-bed specialist palliative care daycare unit Patients M (R): 69 (47–89) F: 19 (56) 34 Malignancy (Lung cancer, Other cancer), Noncancer (Progressive neurological diagnosis; Chronic lung diagnosis) MLL-L Kotronoulas et al. 2017 2014–2015 Scotland, UK Mixed-Method; Prospective; Focus Group; Systematic Review 1 NHS board Patients; HCP:1 gynecology CNS and 2 consultant oncologists NA F: 30 (100) 30 Cervical Cancer LLM-L Krawczyk et al. 2019a 2016 Canada Qualitative Study (Exploratory collaborative research; participatory, focus groups, observation, interviews) Hospital palliative consult care; acute care; large tertiary acute care hospital; large urban tertiary care centre with more than 500 beds and a dedicated 12-bed palliative unit 2 palliative nurse specialists within a larger palliative outreach consult team (POCT) Average 66 (older adult patients (age 55+)) M: 15 (75) 20 Cancer, chronic obstructive pulmonary disease, heart failure, renal failure, cirrhosis HMH-H Krawczyk et al. 2019b 2014–2015 Canada Mixed-Method; Qualitative Study; Focus Group 1 10-bed palliative unit is part of a larger 300-bed suburban acute care hospital HCP: Nurses ( n = 19), 1 patient care coordinator, 1 unit clerk, 1 social worker, 1 pharmacist, and 2 palliative care physicians HCP: Median 43 F: 80% 25 Chronic life-limiting illnesses and their family members HMM-M Krulewitch et al. 2000 1998 US Prospective Cohort Study; Chart Reviews In-home assessments of community-dwelling patients and family members, adult foster care providers, or aides in residential care facilities Patient-Caregiver Dyads M (R): 83 (65–98) F: 83% 156 Cognitively Impaired Older Adults: Alzheimer’s disease, vascular dementia, other dementia (e.g., MRDD/dementia or Huntington’s disease, dementia not otherwise specified MLL-L Krumm et al. 2014 NA Germany Qualitative Study; Interviews 3 Nursing homes HCP NA NA 13 Dementia HMM-M Lee et al. 2016 2014–2015 Singapore Pre-Post Observational Study; Retrospective Case-Notes Review Audits Residential Hospice HCP: Nurses NA NA NA NA HHM-H Lind 2018 2010–2016 Sweden Mixed Methods; Single-Arm Interventional Study; Quantitative Descriptive Study; Explorative Design 3 Acute Care Settings in 2 Urban Hospitals in Central Sweden; 1 Palliative Care Unit in a Smaller Hospital in Central Sweden HCP: RNs, ANs, Physicians, Healthcare Managers, Politicians R: 65–75+ NA Interview 1: Regional Politicians (6), Managers, HCP (5); Interview 2: HCP (37: 5 Physicians, 20 RNs, 9 ANs); Implementation: Nurse Managers (10), Internal Facilitators (15) RNs/ANs (23), Physicians (1) = 49 Pulmonary, Neurological, Gastro-Surgery MLL-L Lind et al. 2004 2002–2003 Sweden Survey Hospital-based home care clinic; advanced palliative home healthcare Patients NA NA 12 Terminal cancer MHM-M Lind et al. 2008 2002–2003 Sweden Qualitative Study (Cross-Case Content Analysis); Interviews; Survey; Medical Records; System Log Analysis; Qualitative Study (Descriptive and Explorative); Case Study 1 Advanced palliative home healthcare Patients M, Median (R): 67, 65.5 (58–79) F: 4; M: 8 12 Palliative patients MMM-M Lucey et al. 2013 2007 Ireland Mixed-Method; Survey; Focus Group 1 specialist palliative care unit; 30 bedded tertiary palliative care unit HCP NA NA 20 Advanced cancer (> 90%) and where 10% have non-malignant disease LML-L Mahmoudi et al. 2022 NA France Systematic Review NA NA NA NA 66 studies (60 primary, 6 reviews) Heart transplant recipient registry MHH-H Mai et al. 2018 NA Germany Prospective Cohort Study Palliative care unit (PCU) Patients 70 (12.9); R: 20–95 F: 99 (45%); M: 120 (55%) 60 End of Life: Cancer as main diagnosis (Gastrointestinal; Pulmonary; Hematological neoplasia; Urology; Gynecological; Other cancers; Dermatological cancers; Neurological diseases; Liver diseases; Cardiovascular diseases; Other noncancer diseases) MLL-L Martins Pereira et al. 2018 2018 NA Umbrella Review NA NA NA NA 2 reviews NA HML-M Mayahara et al. 2019 NA US Single-Arm Pre-Post Study; Pilot Home Hospice (1 hospice agency) Patient-Caregiver Dyads M (R): Patients: 67.8 (35–96); Caregivers: 53.7 (37–69) Patient: F: 7 (58.3); Caregiver: F: 11 (91.7) 12 dyads Cancer, Dementia, Congestive heart failure, Other MLL-L Mills et al. 2008 NA Northern Ireland, UK Pre-Post Single-Arm Interventional Study(within an RCT); Mixed-Method (Qualitative Content analysis) Home (Outpatient clinics at the Cancer Centre and 2 of the 4 cancer units in the country) Patients < 50 to 80+ M: 34; F: 23 57 Non-operable Lung Cancer (NSCLC; SCLS; Mesothelioma Unknown Primary) MML-M Muir et al. 2018 2007–2015 US Prospective Single-Arm Interventional Study Home Hospice (community-based hospice organizations) NA NA NA 13,000 < NA MMM-M Nair et al. 2019 NA US Narrative Review NA NA NA NA NA Kidney Disease HHH-H Oldenburger et al. 2020 2008–2020 NA Topical Review Palliative radiotherapy NA NA NA 94 studies NA MML-M O’Reilly et al. 2016 NA Ireland Pre-Post Single-Arm Interventional Study; Systematic Review 1 Specialist Palliative Care Inpatient Unit Patients, HCP: Pre 40: medical (4), nursing (27), and therapy and social care staff (9); Post 37: medical (5), nursing (23), and therapy and social care staff (9) 68.3 (14.7) M: 24; F: 18 42 (12 Months); 46 (6 Months); 35 (Baseline) Malignant, Nonmalignant MHM-M Parker et al. 2010 NA NA Systematic Review Residential Aged Care Facilities NA NA NA 10 studies NA HHH-H Patel et al. 2022 2019 US Pre-Post Single-Arm Interventional Study 3 Outpatient Oncology Palliative Care Clinics: Hematology-oncology, Interprofessional, Surgical oncology Patients NA NA 372 appointments Primarily metastatic diseases MMM-M Pearson et al. 2007 2006 Australia Systematic Review NA HCP: Occupational therapists NA NA 78 studies (18 reviews, 59 primary) NA MLL-L Pezold et al. 2019 2017–2018 US Pre-Post Single-Arm Interventional Study; Retrospective Chart Audits Outpatient palliative care practice (serving patients living in their private homes or long-term care facilities) HCP: Nurses 65 or 65+ F/M 4 NA MHM-M Pinto et al. 2018 2014–2015 UK Qualitative Study; Mixed-Method; Interviews; Non-Participant Observation 9 specialist palliative care services (1 in-patient hospice, 5 hospital and 3 community teams) 38 interviewed: 7 patients, 4 family caregivers, 27 HCP: 11 doctors, 8 nurses, and 8 allied health professionals NA NA 38 NA MHH-H Potts et al. 2018 NA NA Systematic Review Low-Resource Setting: homes, regional hospitals and clinics, a hospital with daycare hospice center, HIV clinics, and hospices NA NA NA 18 papers Advanced cancer, HIV/AIDs, other end-stage chronic diseases MMM-M Radionova et al. 2020 NA Germany Qualitative Study; Interviews PC settings HCP: 10 physicians and 9 nurses NA F: 14; M: 5 19 HCP NA HMH-H Rauenzahn et al. 2017 2015–2016 US Pre-Post Single-Arm Interventional Study 5 Ambulatory Oncology Clinics Patients; HCP NA NA 607 Ambulatory Oncology (Breast, GI, Lung, and Head and Neck Cancers) MLL-L Rawlings et al. 2011 NA Australia Literature Review NA NA NA NA NA NA LLM-L Reynolds et al. 2019 NA UK Action Research; Participatory; Qualitative Study 1 Hospice HCP: occupational therapists and physiotherapists will be referred to as AHP NA NA NA NA MMM-M Ruder et al. 2010 NA NA Literature Review Hospice and Home Care NA NA NA NA NA LLL-L Rugno et al. 2016 1999–2014 NA Integrative Review NA NA NA NA 11 papers NA MML-M Sandham et al. 2022 2017–2019 New Zealand Mixed-Method; Interviews 1 community outpatient palliative care service 7 clinical staff members 70.9 (13.7); Median (IQR, R): 73 (20, 23–101) 404 (50.2); M: 398 (49.5); Unreported gender: 2 (0.3) 804 Oncological cancer with organ failure (heart, lung, liver, kidney), Haematological cancer, Dementia, Other neurological disease (motor neurone, multisystem atrophy, supranuclear palsy), Acute event (stroke, sepsis, abdominal aortic aneurysm) MML-M Sawatzky et al. 2018 NA Canada Qualitative Study; Focus Groups; Interviews 1 palliative home care setting and an inpatient palliative care unit 46 clinician participants: RN; medical doctors, social workers, spiritual care workers, AHPs, and licensed practical nurses, 18 patients, and 17 family caregivers HCP: R = 23–63; Patients: R = 46–95; Family caregivers: R = 51–89 NA 46 clinician participants, 18 patients, and 17 family caregivers NA HHH-H Schick-Makaroff et al. 2020 NA Canada Qualitative Study; Focus Group; Iinterviews 1 tertiary inpatient palliative care unit (10 beds) and a palliative home care setting HCP NA NA 46 NA MMM-M Schlichter et al. 2020 2015–2017 US Prospective Single-Arm Interventional Study Neuroscience Intensive Care Unit Patients 59.5 (17.6) M: 724 (54.7) 1324 Ischemic stroke, Seizures or status epilepticus, Traumatic brain injury, Intracerebral hemorrhage, Subarachnoid hemorrhage MML-M Schuler et al. 2021 2018–2019 Australia Prospective Single-Arm Intervntional Study Palliative Radiation Therapy Patients Median (R): 71.5 (21–98) F: 97 (61); M: 63 (39) 160 Lung, Prostate, Colorectal, Breast, Other HHH-H Schulman-Green et al. 2008 NA US Interviews (Telephone) NAHC QAPI Collaborative: 9 volunteer hospice organizations: Participating hospices programs had varied characteristics in terms of size (average census 36 − 2,550); type (6 non-profit/3 for-profit; 3 HHA-based, 1 hospital-based, 1 hospital affiliated, 3 free-standing; 1 in corporate chain); experience (1 new hospice, the others established 1974–2000); and location (2 primarily rural, 3 primarily urban, 4 serving both rural and urban areas) 24 individuals representing the 9 hospices were interviewed: 6 administrators, 6 Quality Assessment (QA) directors or QA nurses, 3 performance improvement (PI) coordinators, 4 team leaders or program supervisors, 2 staff nurses, 2 hospice presidents or chief executives, and 1 chaplain NA NA 24 NA MMM-M Schulman-Green et al. 2010 2006–2007 US Qualitative Study; Interviews (Telephone) Hospice characteristics: Ownership type (Nonprofit, For-profit); Structure (Home health agency-based; Free-standing; Hospital-based; Hospital affiliated; Corporate chain); Location (Primarily rural area; Primarily urban area; Serve urban and rural areas) 24 individuals representing 8 hospices: 6 administrators, 6 quality assessment directors/nurses, 3 performance improvement coordinators, 4 team leaders/program supervisors, 2 staff nurses, 2 hospice presidents/chief executives, and 1 chaplain. P: 348 patients NA NA 24 NA HHH-H Schwartz et al. 2005 NA US Mixed-Method; Psychometric Study; Feasibility; Interviews 12: dialysis clinics (5), hospices (5), and long-term care facilities (2) in US; Implementation: 3 settings: hospice, home health, and palliative care Patients NA F: 67 (40.6); M: 98 (59.4) 175 End-stage renal patients on dialysis, hospice, or long-term care patients MML-L Seipp et al. 2022 2018–2019 Germany Mixed-Method; Qualitative Study; Focus Group; Field Notes Specialised outpatient palliative care HCP: SOPC nurse; SOPC coordinator; SOPC physician; SOPC social worker M (R): 44.3 (37–61) F: 10 (71.4); M: 4 (28.6) 14 NA HHH-H Slater et al. 2004* NA UK Qualitative Study; Focus Group; Interpretive Phenomenological Approach 1 palliative day care Patients R: 39–81 F: 6; M: 3 9 Malignant and non-malignant disease HMH-H Slater et al. 2005* NA UK Qualitative Study; Focus Group: Interpretive Phenomenological Approach 1 day hospice unit 4 RNs; 1 AHP; and 3 support staff NA NA 8 NA MLL-L Smith et al. 2017 NA Australia Mixed-Method; Retrospective Audit; Focus Group Haemodialysis HCP: Nurses (11) 60 or 60+ (74%) M: 39 (69) 54 Haemodialysis; 18% dual diagnosis of malignant carcinoma including multiple myeloma, lymphoma, colon, liver carcinoma, metastatic prostate carcinoma HMM-M Sommerbakk et al. 2016 2012 Norway Qualitative Study; Focus Group; Interviews; Thematic Analysis (Inductive and Theoretical) Health care services: 2 hospitals (3 hospital services: 1 specialist PC unit, 1 geriatric/dementia unit (H-GU) in a regional university hospital, and 1 PC consult team (PCT) in a local hospital), 1 nursing home (ordinary nursing home with 1 ward specializing in dementia), 2 local medical centers (primary care service with short term in-patient care) HCP M (R): 51 (25–65) F: 19; M: 1 20 HCP NA MLL-L Spaner et al. 2017 2014–2016 Canada Pre-Post Observational Study; Survey 1 palliative care unit (PCU) HCP: RNs, registered practical nurses (RPNs), social worker, chaplain, physicians, and the patient care manager NA NA 20 NA MMM-M Stevens et al. 2005 NA UK Feasibility; Pilot 1 specialist cancer centre (two palliative care wards) Patients Median (R): 65 (25–91) F: 23 (77); M: 7 (23) 30 Breast, Gynae, GU, Lung, Other LML-L Stewart et al. 2022 2020–2021 UK Prospective Single-Arm Interventional Study 6 Different Hospital Sites (Cancer Centre (Tertiary Cancer Services)) Patients living with treatable but not curable cancer Median (IQR): 69 (59–75) M: 165; F: 161 326 Mixed Oncology Population: Secondary Breast, Prostate and Other MLL-L Stiel et al. 2012 2009 NA Systematic Review PC and hospice care NA NA NA 725 papers NA MLL-L Suri et al. 2022 2019 Canada Implementation Research; Cross-Sectional Study 1 busy, academic, urban Canadian urban HIV clinic Patients NA F: 149 (25.1); M: 445 (74.9) 600 People living with HIV (PLWH) HHM-H Swart et al. 2022 2017–2018 Botswana Survey 1 hospital’s oncology Ward Patients; HCP Patients: 48.5 (13.9), R: 20–85; Nurses 36.5 (6.4), R: 27–55 Patients: F: 84; Nurses: F:14 124 patients; 20 nurses Tissue-confirmed diagnosis of cancer MHM-M Tavares et al. 2017 2012–2014 Brazil Observational Prospective Study; Content Analysis 1 specialist palliative care inpatient hospital unit (17 individual rooms) Patients, Carers, HCP: 5 palliative doctors, 1 specialised palliative nurse, 1 extra nurse/shift, 1 nursing assistant for every 3–4 beds, 1 social worker, 1 psychologist, 1 chaplain NA F: 214; M: 186 84/317 = 401 (Pilot/Main) Malignancy: 208; Dementia: 60; Frailty: 29; Stroke: 34; Organ failure: 40; Other: 30 MMH-M Van Cutsem et al. 2017 2016 EU Narrative Review; Workshop Report NA NA NA NA NA Colorectal Cancer MLM-M van den Hurk et al. 2022 NA NA Literature Review Cancer Survivorship Care NA NA NA NA Cancer LLM-L Viecelli et al. 2022 2019–2020 Australia Qualitative Study; Interviews; Focus Group 4 Australian HD care units 41 participants (12 patients; 13 nephrologists, 16 dialysis nurses) 69.5 (13.41), R (39–88) 12 patients = F: 5/12 (42); M: 7/12 (58) 41 Patients receiving HD HHM-H Voorend et al. 2021 2017–2018 Netherlands Qualitative Study; Focus Group 3 Dutch hospital-based study- and routine care initiatives Patients, Caregivers, HCP: Nephrologist: 7 (28%); Geriatrician: 4 (16%); Nephrologist/geriatrician: 2 (8%); Nurse (nephrology): 3 (12%); Nurse (other): 2 (8%); Social worker: 4 (16%); Dietician: 1 (4%) M (R): Patients: 79 (67–88); Caregivers: 60 (51–76); HCP: 48 (29–61) Patients: M: 9 (50); Caregivers: M: 0 (0); HCP: M: 4 (16) 47 Chronic kidney disease (Geriatric) HHH-H Wu et al. 2022 2020–2021 Canada Pre-Post Single-Arm Interventional Study Home; Oncology (Radiation Therapy) Patients (T1: 92 ± 5; T2: 100 ± 11), HCP: 2 Radiation Therapists NA NA NA Patients Receiving Radiation Therapy LML-L NA Not Available, Not Applicable, or Not Reported, HCP Healthcare Professionals, M Male, F Female, M Mean, R Range, SD Standard Deviation, IQR Interquartile Range; RN: Registered Nurse, AN Assistant Nurse, PC Palliative Care, AHP Allied Healthcare Professional, SOPC Specialised Outpatient Palliative Care, HD Hemodialysis. WoE column: H High, M Medium, L Low * indicates same study from different reports

Table 1
Characteristics and quality assessment of included studies
NA Not Available, Not Applicable, or Not Reported, HCP Healthcare Professionals, M Male, F Female, M Mean, R Range, SD Standard Deviation, IQR Interquartile Range; RN: Registered Nurse, AN Assistant Nurse, PC Palliative Care, AHP Allied Healthcare Professional, SOPC Specialised Outpatient Palliative Care, HD Hemodialysis. WoE column: H High, M Medium, L Low * indicates same study from different reports

Study NameResearch DateCountryDesignSettingParticipants (Patient, Carer, HCP)Age (Mean (SD))Sex/Gender; N (%)SizeConditionsWoE
Appleyard et al. 20212016–2017UKSingle-Arm Interventional Study (Mixed-Method)Uro-Oncology Clinics (Outpatient Department) of 1 Teaching & 2 District General Hospitals; Home (Optional)Patients (Computer-Familiar)M (R): 74 (58–89M40Advanced Prostate Cancer on Palliative Systemic TreatmentHHH-H
Bausewein et al. 2011a2009–2010Africa, EU, Malaysia, Taiwan, Australia, Brazil, US, Canada, Japan, ThailandSurvey (Mixed Methods)NAHCP46 (9)F: 420; M: 243663NAHHH-H
Bausewein et al. 20162011–2013EUConcensus (EAPC White/Position Paper)NAHCPNANA28NALLL-L
Bausewein et al. 20182014GermanyCase Study1 university palliative care unit (10-bedded)PatientsNAF/M574Advanced cancer; advanced lung and heart disease; neurological diseaseLMM-M
Beddard-Huber et al. 20152013CanadaSingle-Arm Interventional Study; Survey1 Tertiary Palliative Care Unit (15-bed palliative care unit at Vancouver General Hospital); AcutePatients, HCP: Nurses, PhysiciansMedian: 68.6 (Patients)F/M92 Patients, 23 Nurses, 7 PhysiciansCancer (84%); Cardiac disease (4%); End-stage liver disease (3%); Other chronic diseases (8%); Brain injury (1%)LLL-L
Bennett et al. 2012NAUK, USSurveyOncology (Hospice, Hospital, Home)NANAF/MNAOncology (Treatment and survivorship, Adults and adolescents receiving chemotherapy and palliative care, Postsurgery for radical prostatectomy, In hospice)LMH-M
Bookbinder et al. 19961992–1994USPre-Post Interventional Study; Focus Groups; Chart ReviewsMajor Urban Cancer Center: 12 inpatient unitsPatients; HCP: NurseNANA398 Patients; Nurses (NA)Cancer Pain (acute and chronic)MMM-M
Bourbonnais et al. 2004NACanadaRetrospective Chart Reivew; Focus group12 settingsPatients; HCP: NursesNANA55 Patients; 25 NursesCancer PainHHH-H
Bouvette et al. 20022000CanadaExploratory study; Focus groups; Chart audits12: Community agencies (5); Tertiary Hospital (2); Community Hospital (2); Hospices (2); ORPCU (1)HCP: NursesNANA180Lung cancer; Breast cancer; Prostate cancer; Stomach and peritoneal cancer; Lower back pain; Oesophagus, larynx, parotid cancer; Brain cancer; CHF, MI, angina, COPD, emphysema; Liver or pancreas cancer; Cervix cancer; Diabetes; Lymphoma; MyelomaHHH-H
Bradshaw et al. 2021b2019UKQualitative Study (Exploratory (Interpretive Paradigm)11 services delivering specialist palliative care in Yorkshire, England (inpatient, outpatient/day therapy, home-based/community)HCP: Nurse (29); Doctor/consultant (16); AHP (8); Healthcare assistant (4); Chief executive (2); IT (2); Other (2)25–55+F (59); M (4)63NAHHH-H
Bush et al. 2018NANASystematic ReviewNANANANA30 primary studiesNALHM-M
Campbell et al. 2022NAUSProspective Observational Study; Interviews2 outpatient gynecologic oncology clinics at a large urban academic medical centerPatients60.6 (10.7)F30Gynecologic cancer receiving chemotherapy: Ovarian/fallopian; Primary peritoneal, uterine, endometrial, or cervical; Other/unknownMLL-L
Carli Buttenschoen et al. 20142010CanadaSurveyPalliative Community Consult Team (1 20-bed Tertiary Palliative Care Unit, 3 Hospice Palliative Care Units, 1 Community Consultation Team, and 3 Acute Care Hospital Palliative Consultation Teams) and University Hospital Chronic Pain Clinic; Inpatient (hospital, hospice); outpatient clinics; home consultationsHCP: Staff physician: 11; Fellows, residents, students: 11; Nurses: 51; Other (dieticians, occupational therapists, pharmacists, physiotherapists, respiratory therapists, and spiritual care): 10NANA193Palliative care; Chronic painMMM-M
Coast et al. 20182012–2014UKQualitative Study; Interviews; Constant Comparative Analysis; Feasibility1 UK Adult Hospice (patients recruited via community service, day hospice and in-patient unit)33 hospice patients, 22 close persons and 17; HCP: 8 doctors, 7 nurses and 2 AHP50+ (13 aged 50–69, 10 aged 70–79, 10 aged ≥ 80 years)F: 1272Life-threatening illness and approaching EoL: Cancer-related diagnoses; motor neurone diseaseMML-M
Collins et al. 20152010–2014NASystematic ReviewPalliative CareNANANA43 studies (POS n = 35, STAS n = 8)Cancer, HIV/AIDS, Dementia, Parkinson’s Disease, Chronic Kidney Disease, Chronic Heart Failure, COPD, Renal Transplant Patients, End-Stage Renal Disease, Parkinson Syndromes (Idiopathic Parkinson’s Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy)HHM-H
Collins et al. 2015NANASystematic ReviewPalliative Cancer CareNANANA13 primary studiesNAHHH-H
Currow et al. 20142008AustraliaProspective Database Analysis (Symptom Control Performance Data)30 Services (Metropolitan; Regional/rural): Inpatient, Ambulatory/community, BothPatientsNAF: NA (46)19,747Cancer: 85%HHH-H
Daveson et al. 2012NAEurope and AfricaSurvey (Web-Based)NAHCP: Palliative care professionals working in clinical care, audit and researchDoctors: 46.9 (8.74); Nurses: 45.1 (8.42)Doctors: F: 92 (47); Nurses: F: 87 (84)196 Doctors; 104 NursesNAMMM-M
Diffin et al. 20182013–2014UKPre-Post Single-Arm Interventional Study; Survey36 UK palliative care services: Day services, Community clinical nurse specialist teams, day hospices, social work teams, and an outpatient clinicHCP: Clinical Nurse Specialist (CNS) (73); Registered Nurse (other than CNS) (37); Social Worker (7); Medical Practitioner (3); Other (34)NANA462NAHHH-H
Diplock et al. 20192011–2013CanadaProspective Cohort Study1 Ambulatory Clinics in a Regional Cancer CenterPatientsControl: 58.33 (16.06); Case 61.19 (12.99)M: Control − 94 (58.75); Case − 28 (25.93); F: Control − 66 (41.25); Case − 80 (74.07)268: Control ( n = 160) and Case ( n = 108)Breast, Gastro-intestinal, Genitourinary, Gynecology, Hematology oncology, Head and neck, Lung, MelanomaMMM-M
Dobrina et al. 20182012–2014ItalyMixed-Method; Single-Arm Interventional Study; Action Research1 Italian hospice (19 beds)Patients; HCPNANA16 patients; 2 Physicians (1 Chief), 1 Chief Nurse, 10 RNs, 10 NAs, 1 Psychologist (Patient and Family Support), 1 Psychologist (Staff Support)advanced cancerMML-M
Donaldson et al. 2004NANALiterature Review; InterviewsOncology Practice; hospice, home-care, and long-term care settingsNANANANACancerHHH-H
Downing et al. 20122010AfricaSurvey (Web-Based)NAHCP: 69 (Physician: 27; Nurse: 29; Other: 13); Researcher: 27 (Pure Researcher: 9; Researcher-Clinician: 18)47 (9)F: 55; M: 33301NAMHH-H
Dunckley et al. 2005NAUKPre-Post Interventional Study; Action Research; Interviews; Case Studies; Staff Diaries1 specialist hospice inpatient unit and a nursing home providing care for people with neurological illnessHCPNANA28 permanent nursing home staff and to 23 clinical hospice staffNAHMM-M
Eijsink et al. 2023NANAScoping ReviewNANANANA20 studiesBariatric surgery; Pain interference in carpal tunnel release; Ischemic stroke; Minor stroke and transient ischemic attack; Total knee and hip replacement; Aortic valve disease; Hernia care; Hepatatis C; Orthopedic surgery; Coronary artery disease; Breast cancer; Breast cancer; Inflammatory arthritis; Turner syndrome; IBD; Lynch syndrome; Burn injury; Cancer care; Hemodialysis; Advanced non-small-cell lung cancerHMM-M
Ellis-Smith et al. 20182014–2016UKMixed-Method; Feasibility3 residential care homes registered to provide care for people aged 65 and over (26–33 beds)6 family members and 20 professionals care home staff ( n = 15), GPs ( n = 3) and DNs ( n = 2)87.2 (8.3)F: 24 (75); M: 8 (25)32 Residents (Dementia with comorbidities)DementiaHHH-H
Etkind et al. 20151985–2013NASystematic ReviewOutpatient oncology (Mainly); Community oncology; Home hospice patients; Hospice inpatient unit; Long-term care units; Outpatient oncology; Palliative home careNANANA16 papers corresponding to 13 studiesNAHHH-H
Evans et al. 20202017–2018CanadaMixed-Methods; Pre-Post Study; Survey; Interviews; Chart Audit; Pilot; Longitudinal Study8 in-facility hemodialysis programsPatients, Carers, HCP (48 providers and staff: nephrologists ( n = 5), nurse practitioners ( n = 3), nurse managers ( n = 5), registered nurses and registered practical nurses ( n = 7), pharmacists ( n = 3), dietitians ( n = 9), social workers ( n = 4), clerical staff ( n = 3), and project leads ( n = 9))M: 68 (1459 patients)NA9 patients/caregivers and 48 HCPs; 1207 charts (1459 patients)HemodialysisMHH-H
Fabian et al. 2021NANASystematic ReviewPalliative RadiotherapyNANANA4 studies (primary objective); 3 studies (secondary objective)Head and Neck Cancer PatientsHMM-M
Fetz et al. 20182011–2015GermanyObservational Cohort study; Retrospective Analysis of Longitudinal DataSpecialised Palliative Care Unit of a University Medical CentreHCP: NursesM (R; SD): 67 (17–114; 14)F: 420; M: 400820Cancer; Non-cancer; Previous cancerMMM-M
Friedman et al. 20222013–2019USProspective Single-Arm Interventional StudyHematology-oncology clinics in Veteran Administration (VA) medical centers in the SoutheastPatientsM (R): 67 (21–97)M: 8,106 (89); F: 952 (11)9,058Ambulatory patients: No retrievable cancer diagnosis; Prostate cancer; Lung cancer; Leukemias and lymphomas; Colorectal cancer; Head and neck cancer; Multiple myeloma; Hepatocellular carcinoma; Renal cell carcinoma; Breast cancer; Pancreatic cancer; Other cancersMML-M
Friis et al. 20212014–2018DenmarkProspective Single-Arm Cohort1 oncology outpatientPatientsMedian (IQR): 70 (64–74)F: 35 (37.2); M: 59 (62.8)94Advanced Lung Cancer: SCLC, NSCLCHML-M
Gabbard et al. 20212017–2018USFeasibility1 outpatient dialysis unit affiliated with a large academic tertiary medical centerPatients69.4 (6.6)F: 14 (63.6); M: 8 (36.4)22End-Stage Renal on Hemodialysis Disease; Charlson Comorbidity Index was 8.45 (2.28)HHH-H
Garcia et al. 20192015–2017USProspective Database Analysis1 comprehensive cancer centerPatients57.15 (13.39)F: 2398 (68.11)6825 (3521 Responders)Oncology outpatients; Hematologic malignancies (lymphoma and leukemia), Breast, Gynecologic malignancies, Gastrointestinal malignancies, Sarcoma (soft tissue and bone), Lung and other thoracic malignancies, Other or unspecified malignancies, Prostate, Skin, Other genitourinary, Central nervous system, Head and neck, Thyroid and other endocrine glands, MissingHMM-M
Goyal et al. 20202013–2014USProspective Pre-Post Study1 radiotherapy outpatient settingPatients64.3 (12.2)F: 106 (42); M: 149 (58)255Tumor Primary disease site: Breast, Head and neck, Lung, Prostate, GI, Lymphoma, Sarcoma, CNS, Gynecology, OtherHMM-M
Graf et al. 20222015–2016GermanyProspective Trial2 centers in major university hospitalsPatientsAdjuvant Therapy ( n = 76, AGE: 49.39 (10.28)); Metastatic Situation ( n = 30, AGE: 53.93 (13.94))F106Adjuvant or advanced breast cancer; Adjuvant Therapy ( n = 76, AGE: 49.39 (10.28)); Metastatic Situation ( n = 30, AGE: 53.93 (13.94))MHL-M
Greenhalgh et al. 2017NANARealist SynthesisNANANANANANAHMM-M
Gressel et al. 20192016–2017USProspective Cross-Sectional Study; Pilot1 Gynecologic oncology outpatient clinicPatients65 (12)NA336Uterine cancer, Ovarian/fallopian/PPC, Cervical/vaginal/vulvar cancerHMM-M
Guo et al. 20182017AsiaWorkshop ReportNAHCP: doctors, nurses, AHP; Managers, policy makers, and academicsNANA350NALLM-L
Hall et al. 20202018UKQualitative Study; Longitudinal Study1 NHS TrustHCPNANA12 hospital practitioners, 1 hospital administrator and 4 community practitioners (= 17 (then 15): 4 Nurses Community; 8 Nurses; 3 Consultants, Matron, Project Officer Hospital)NAHMM-M
Harding et al. 20072005South AfricaWorkshop ReportNAHCPNANA32: doctor ( n = 11), service manager/developer ( n = 6), nurse ( n = 6), social/support worker ( n = 5), trainer/educator ( n = 2), technical advisor ( n = 1), and medical student ( n = 1)NAMHH-H
Harding et al. 20112009EUSurvey (Online)Palliative and Advanced Disease CareHCP: Physicians, nurses, other allied professionals, and academics45.8 (8.93)F: 187 (63.6)311NAHMM-M
Hardy et al. 1999NAUKPre-Post Single-Arm Interventional Study1 palliative care unitPatientsMedian (R): 66 (36–83)NA52Advanced diseaseMMM-M
Hawley et al. 2011NACanadaPre-Post Controlled Interventional Study; Retrospective Chart Review3 outpatient oncology pain and symptom management/palliative care clinics, 4 palliative care units (general hospitals), 4 residential hospices, 1 control palliative care unitHCP: 15 members of clinical staff: 9 registered nurses, 4 licensed practical nurses, 1 physician, and 1 other.NANA180 chartsConstipation in patients receiving palliative care: Mostly cancer patients (Breast, lung, gastrointestinal, and prostate primaries)MMM-M
Hill et al. 2002NANew ZealandQualitative Study; Theme of Revelation (De Santis and Ugarriza)Hospice settingHCP; PatientsNANANANAMLL-L
Hogberg et al. 20192016–2017SwedenQualitative Study: Interpretive Descriptive Design; Interviews (Telephone)3 Specialized palliative home-carePatientsM (R): 72 (46–85)F: 3; M: 710Incurable cancer; Advanced cancer (9), stroke (1)HHH-H
Howell et al. 20202014–2016CanadaObservational Pre-Post Controlled Population Cohort Study8 disease site clinics at 3 regional cancer centers (RCCs)PatientsM, Median (IQR): 62.69, 64 (19)F: 35,122; M: 35,73270,854Brain cancer, Breast cancer, Lung cancer, Gynecological cancer, Colorectal cancer, Prostate cancer, Other cancerHHH-H
Hughes et al. 2003*NAUKQualitative Study; Interviews (Telephone); ExploratoryNAHCPNANA26NAHHM-H
Hughes et al. 2004*NAUKQualitative Study; Exploratory Scoping Exercise10 settings: 4 oncology wards, 4 nursing homes, 1 general medical ward, 1 specialist hospital palliative care teamHCPNANANANAMML-M
Hui et al. 2017aNAUSNarrative ReviewNANANANANANAMLL-L
Hui et al. 2017b2015USPre-Post Interventional Study1 Community Cancer Center (General Medical Oncology Outpatient Clinic)PatientsAverage (R) 55 (19–87)F: 265 (57)465Breast, Gastrointestinal, Genitourinary, Head and neck, Hematological, Other, Respiratory CancersHMM-M
Ihler et al. 20192017NorwayQualitative Study; Interviews (Interpretive)2 Oncology Wards in a Hospital; InpatientsHCP: 6 RN (5 Oncology Nurse)Average (R): 37.2 (28–49)F6CancerMMM-M
Jordhoy et al. 20072005NorwaySystematic ReviewNANANANA40 referencesNAMMM-M
Kamal et al. 20162014–2015USProspective Cross-Sectional StudyPalliative care (Diverse Clinical Settings) 5 organizations within the Palliative Care Research Cooperative Group: 4 academic sites and 1 community-based site; across 6 common clinical settings of palliative care: hospital general floor, hospital intensive care unit (ICU), emergency department, outpatient, long-term care, and home; (general floor, ICU, and emergency department) as acute care; outpatient palliative care clinics, home-based palliative care consultations, and long-term care facility palliative care visits were aggregated into nonacute carePatientsNAF: 1228 (55); M: 961 (43); Left blank: 53 (2)2242Cancer, Neurologic, Cardiovascular, Pulmonary, Infectious, Other diagnosis, Gastrointestinal, Renal, UnknownHHH-H
Kane et al. 2017*2014–2015IrelandMixed Method; Pre-Post Study; Qualitative Study; InterviewsCHF disease management clinics in 2 national tertiary referral centres in Dublin, Ireland; urban teaching hospital sitesPatients (18), HCP (4 Nurses)NANA25Chronic Heart FailureMMM-M
Kane et al. 2018*NAIrelandMixed-Method; Qualitative Study; Feasibility; Interviews (Framework Analysis)Nurse-led chronic heart failure disease management clinics in two tertiary referral centresPatients (18), HCP (4 Nurses)75 (8.5)M: 11 (61)22Advanced heart failure: chronic heart failure: New York Heart Association functional class II-IVHMM-M
Karamanidou et al. 20202019GreeceSystematic and Mapping ReviewNANANANA24 primary studiesCancerHHH-H
Kilonzo et al. 20152012–2013IrelandProspective Single-Arm Interventional Study1 30-bed specialist palliative care daycare unitPatientsM (R): 69 (47–89)F: 19 (56)34Malignancy (Lung cancer, Other cancer), Noncancer (Progressive neurological diagnosis; Chronic lung diagnosis)MLL-L
Kotronoulas et al. 20172014–2015Scotland, UKMixed-Method; Prospective; Focus Group; Systematic Review1 NHS boardPatients; HCP:1 gynecology CNS and 2 consultant oncologistsNAF: 30 (100)30Cervical CancerLLM-L
Krawczyk et al. 2019a2016CanadaQualitative Study (Exploratory collaborative research; participatory, focus groups, observation, interviews)Hospital palliative consult care; acute care; large tertiary acute care hospital; large urban tertiary care centre with more than 500 beds and a dedicated 12-bed palliative unit2 palliative nurse specialists within a larger palliative outreach consult team (POCT)Average 66 (older adult patients (age 55+))M: 15 (75)20Cancer, chronic obstructive pulmonary disease, heart failure, renal failure, cirrhosisHMH-H
Krawczyk et al. 2019b2014–2015CanadaMixed-Method; Qualitative Study; Focus Group1 10-bed palliative unit is part of a larger 300-bed suburban acute care hospitalHCP: Nurses ( n = 19), 1 patient care coordinator, 1 unit clerk, 1 social worker, 1 pharmacist, and 2 palliative care physiciansHCP: Median 43F: 80%25Chronic life-limiting illnesses and their family membersHMM-M
Krulewitch et al. 20001998USProspective Cohort Study; Chart ReviewsIn-home assessments of community-dwelling patients and family members, adult foster care providers, or aides in residential care facilitiesPatient-Caregiver DyadsM (R): 83 (65–98)F: 83%156Cognitively Impaired Older Adults: Alzheimer’s disease, vascular dementia, other dementia (e.g., MRDD/dementia or Huntington’s disease, dementia not otherwise specifiedMLL-L
Krumm et al. 2014NAGermanyQualitative Study; Interviews3 Nursing homesHCPNANA13DementiaHMM-M
Lee et al. 20162014–2015SingaporePre-Post Observational Study; Retrospective Case-Notes Review AuditsResidential HospiceHCP: NursesNANANANAHHM-H
Lind 20182010–2016SwedenMixed Methods; Single-Arm Interventional Study; Quantitative Descriptive Study; Explorative Design3 Acute Care Settings in 2 Urban Hospitals in Central Sweden; 1 Palliative Care Unit in a Smaller Hospital in Central SwedenHCP: RNs, ANs, Physicians, Healthcare Managers, PoliticiansR: 65–75+NAInterview 1: Regional Politicians (6), Managers, HCP (5); Interview 2: HCP (37: 5 Physicians, 20 RNs, 9 ANs); Implementation: Nurse Managers (10), Internal Facilitators (15) RNs/ANs (23), Physicians (1) = 49Pulmonary, Neurological, Gastro-SurgeryMLL-L
Lind et al. 20042002–2003SwedenSurveyHospital-based home care clinic; advanced palliative home healthcarePatientsNANA12Terminal cancerMHM-M
Lind et al. 20082002–2003SwedenQualitative Study (Cross-Case Content Analysis); Interviews; Survey; Medical Records; System Log Analysis; Qualitative Study (Descriptive and Explorative); Case Study1 Advanced palliative home healthcarePatientsM, Median (R): 67, 65.5 (58–79)F: 4; M: 812Palliative patientsMMM-M
Lucey et al. 20132007IrelandMixed-Method; Survey; Focus Group1 specialist palliative care unit; 30 bedded tertiary palliative care unitHCPNANA20Advanced cancer (> 90%) and where 10% have non-malignant diseaseLML-L
Mahmoudi et al. 2022NAFranceSystematic ReviewNANANANA66 studies (60 primary, 6 reviews)Heart transplant recipient registryMHH-H
Mai et al. 2018NAGermanyProspective Cohort StudyPalliative care unit (PCU)Patients70 (12.9); R: 20–95F: 99 (45%); M: 120 (55%)60End of Life: Cancer as main diagnosis (Gastrointestinal; Pulmonary; Hematological neoplasia; Urology; Gynecological; Other cancers; Dermatological cancers; Neurological diseases; Liver diseases; Cardiovascular diseases; Other noncancer diseases)MLL-L
Martins Pereira et al. 20182018NAUmbrella ReviewNANANANA2 reviewsNAHML-M
Mayahara et al. 2019NAUSSingle-Arm Pre-Post Study; PilotHome Hospice (1 hospice agency)Patient-Caregiver DyadsM (R): Patients: 67.8 (35–96); Caregivers: 53.7 (37–69)Patient: F: 7 (58.3); Caregiver: F: 11 (91.7)12 dyadsCancer, Dementia, Congestive heart failure, OtherMLL-L
Mills et al. 2008NANorthern Ireland, UKPre-Post Single-Arm Interventional Study(within an RCT); Mixed-Method (Qualitative Content analysis)Home (Outpatient clinics at the Cancer Centre and 2 of the 4 cancer units in the country)Patients< 50 to 80+M: 34; F: 2357Non-operable Lung Cancer (NSCLC; SCLS; Mesothelioma Unknown Primary)MML-M
Muir et al. 20182007–2015USProspective Single-Arm Interventional StudyHome Hospice (community-based hospice organizations)NANANA13,000 <NAMMM-M
Nair et al. 2019NAUSNarrative ReviewNANANANANAKidney DiseaseHHH-H
Oldenburger et al. 20202008–2020NATopical ReviewPalliative radiotherapyNANANA94 studiesNAMML-M
O’Reilly et al. 2016NAIrelandPre-Post Single-Arm Interventional Study; Systematic Review1 Specialist Palliative Care Inpatient UnitPatients, HCP: Pre 40: medical (4), nursing (27), and therapy and social care staff (9); Post 37: medical (5), nursing (23), and therapy and social care staff (9)68.3 (14.7)M: 24; F: 1842 (12 Months); 46 (6 Months); 35 (Baseline)Malignant, NonmalignantMHM-M
Parker et al. 2010NANASystematic ReviewResidential Aged Care FacilitiesNANANA10 studiesNAHHH-H
Patel et al. 20222019USPre-Post Single-Arm Interventional Study3 Outpatient Oncology Palliative Care Clinics: Hematology-oncology, Interprofessional, Surgical oncologyPatientsNANA372 appointmentsPrimarily metastatic diseasesMMM-M
Pearson et al. 20072006AustraliaSystematic ReviewNAHCP: Occupational therapistsNANA78 studies (18 reviews, 59 primary)NAMLL-L
Pezold et al. 20192017–2018USPre-Post Single-Arm Interventional Study; Retrospective Chart AuditsOutpatient palliative care practice (serving patients living in their private homes or long-term care facilities)HCP: Nurses65 or 65+F/M4NAMHM-M
Pinto et al. 20182014–2015UKQualitative Study; Mixed-Method; Interviews; Non-Participant Observation9 specialist palliative care services (1 in-patient hospice, 5 hospital and 3 community teams)38 interviewed: 7 patients, 4 family caregivers, 27 HCP: 11 doctors, 8 nurses, and 8 allied health professionalsNANA38NAMHH-H
Potts et al. 2018NANASystematic ReviewLow-Resource Setting: homes, regional hospitals and clinics, a hospital with daycare hospice center, HIV clinics, and hospicesNANANA18 papersAdvanced cancer, HIV/AIDs, other end-stage chronic diseasesMMM-M
Radionova et al. 2020NAGermanyQualitative Study; InterviewsPC settingsHCP: 10 physicians and 9 nursesNAF: 14; M: 519 HCPNAHMH-H
Rauenzahn et al. 20172015–2016USPre-Post Single-Arm Interventional Study5 Ambulatory Oncology ClinicsPatients; HCPNANA607Ambulatory Oncology (Breast, GI, Lung, and Head and Neck Cancers)MLL-L
Rawlings et al. 2011NAAustraliaLiterature ReviewNANANANANANALLM-L
Reynolds et al. 2019NAUKAction Research; Participatory; Qualitative Study1 HospiceHCP: occupational therapists and physiotherapists will be referred to as AHPNANANANAMMM-M
Ruder et al. 2010NANALiterature ReviewHospice and Home CareNANANANANALLL-L
Rugno et al. 20161999–2014NAIntegrative ReviewNANANANA11 papersNAMML-M
Sandham et al. 20222017–2019New ZealandMixed-Method; Interviews1 community outpatient palliative care service7 clinical staff members70.9 (13.7); Median (IQR, R): 73 (20, 23–101)404 (50.2); M: 398 (49.5); Unreported gender: 2 (0.3)804Oncological cancer with organ failure (heart, lung, liver, kidney), Haematological cancer, Dementia, Other neurological disease (motor neurone, multisystem atrophy, supranuclear palsy), Acute event (stroke, sepsis, abdominal aortic aneurysm)MML-M
Sawatzky et al. 2018NACanadaQualitative Study; Focus Groups; Interviews1 palliative home care setting and an inpatient palliative care unit46 clinician participants: RN; medical doctors, social workers, spiritual care workers, AHPs, and licensed practical nurses, 18 patients, and 17 family caregiversHCP: R = 23–63; Patients: R = 46–95; Family caregivers: R = 51–89NA46 clinician participants, 18 patients, and 17 family caregiversNAHHH-H
Schick-Makaroff et al. 2020NACanadaQualitative Study; Focus Group; Iinterviews1 tertiary inpatient palliative care unit (10 beds) and a palliative home care settingHCPNANA46NAMMM-M
Schlichter et al. 20202015–2017USProspective Single-Arm Interventional StudyNeuroscience Intensive Care UnitPatients59.5 (17.6)M: 724 (54.7)1324Ischemic stroke, Seizures or status epilepticus, Traumatic brain injury, Intracerebral hemorrhage, Subarachnoid hemorrhageMML-M
Schuler et al. 20212018–2019AustraliaProspective Single-Arm Intervntional StudyPalliative Radiation TherapyPatientsMedian (R): 71.5 (21–98)F: 97 (61); M: 63 (39)160Lung, Prostate, Colorectal, Breast, OtherHHH-H
Schulman-Green et al. 2008NAUSInterviews (Telephone)NAHC QAPI Collaborative: 9 volunteer hospice organizations: Participating hospices programs had varied characteristics in terms of size (average census 36 − 2,550); type (6 non-profit/3 for-profit; 3 HHA-based, 1 hospital-based, 1 hospital affiliated, 3 free-standing; 1 in corporate chain); experience (1 new hospice, the others established 1974–2000); and location (2 primarily rural, 3 primarily urban, 4 serving both rural and urban areas)24 individuals representing the 9 hospices were interviewed: 6 administrators, 6 Quality Assessment (QA) directors or QA nurses, 3 performance improvement (PI) coordinators, 4 team leaders or program supervisors, 2 staff nurses, 2 hospice presidents or chief executives, and 1 chaplainNANA24NAMMM-M
Schulman-Green et al. 20102006–2007USQualitative Study; Interviews (Telephone)Hospice characteristics: Ownership type (Nonprofit, For-profit); Structure (Home health agency-based; Free-standing; Hospital-based; Hospital affiliated; Corporate chain); Location (Primarily rural area; Primarily urban area; Serve urban and rural areas)24 individuals representing 8 hospices: 6 administrators, 6 quality assessment directors/nurses, 3 performance improvement coordinators, 4 team leaders/program supervisors, 2 staff nurses, 2 hospice presidents/chief executives, and 1 chaplain. P: 348 patientsNANA24NAHHH-H
Schwartz et al. 2005NAUSMixed-Method; Psychometric Study; Feasibility; Interviews12: dialysis clinics (5), hospices (5), and long-term care facilities (2) in US; Implementation: 3 settings: hospice, home health, and palliative carePatientsNAF: 67 (40.6); M: 98 (59.4)175End-stage renal patients on dialysis, hospice, or long-term care patientsMML-L
Seipp et al. 20222018–2019GermanyMixed-Method; Qualitative Study; Focus Group; Field NotesSpecialised outpatient palliative careHCP: SOPC nurse; SOPC coordinator; SOPC physician; SOPC social workerM (R): 44.3 (37–61)F: 10 (71.4); M: 4 (28.6)14NAHHH-H
Slater et al. 2004*NAUKQualitative Study; Focus Group; Interpretive Phenomenological Approach1 palliative day carePatientsR: 39–81F: 6; M: 39Malignant and non-malignant diseaseHMH-H
Slater et al. 2005*NAUKQualitative Study; Focus Group: Interpretive Phenomenological Approach1 day hospice unit4 RNs; 1 AHP; and 3 support staffNANA8NAMLL-L
Smith et al. 2017NAAustraliaMixed-Method; Retrospective Audit; Focus GroupHaemodialysisHCP: Nurses (11)60 or 60+ (74%)M: 39 (69)54Haemodialysis; 18% dual diagnosis of malignant carcinoma including multiple myeloma, lymphoma, colon, liver carcinoma, metastatic prostate carcinomaHMM-M
Sommerbakk et al. 20162012NorwayQualitative Study; Focus Group; Interviews; Thematic Analysis (Inductive and Theoretical)Health care services: 2 hospitals (3 hospital services: 1 specialist PC unit, 1 geriatric/dementia unit (H-GU) in a regional university hospital, and 1 PC consult team (PCT) in a local hospital), 1 nursing home (ordinary nursing home with 1 ward specializing in dementia), 2 local medical centers (primary care service with short term in-patient care)HCPM (R): 51 (25–65)F: 19; M: 120 HCPNAMLL-L
Spaner et al. 20172014–2016CanadaPre-Post Observational Study; Survey1 palliative care unit (PCU)HCP: RNs, registered practical nurses (RPNs), social worker, chaplain, physicians, and the patient care managerNANA20NAMMM-M
Stevens et al. 2005NAUKFeasibility; Pilot1 specialist cancer centre (two palliative care wards)PatientsMedian (R): 65 (25–91)F: 23 (77); M: 7 (23)30Breast, Gynae, GU, Lung, OtherLML-L
Stewart et al. 20222020–2021UKProspective Single-Arm Interventional Study6 Different Hospital Sites (Cancer Centre (Tertiary Cancer Services))Patients living with treatable but not curable cancerMedian (IQR): 69 (59–75)M: 165; F: 161326Mixed Oncology Population: Secondary Breast, Prostate and OtherMLL-L
Stiel et al. 20122009NASystematic ReviewPC and hospice careNANANA725 papersNAMLL-L
Suri et al. 20222019CanadaImplementation Research; Cross-Sectional Study1 busy, academic, urban Canadian urban HIV clinicPatientsNAF: 149 (25.1); M: 445 (74.9)600People living with HIV (PLWH)HHM-H
Swart et al. 20222017–2018BotswanaSurvey1 hospital’s oncology WardPatients; HCPPatients: 48.5 (13.9), R: 20–85; Nurses 36.5 (6.4), R: 27–55Patients: F: 84; Nurses: F:14124 patients; 20 nursesTissue-confirmed diagnosis of cancerMHM-M
Tavares et al. 20172012–2014BrazilObservational Prospective Study; Content Analysis1 specialist palliative care inpatient hospital unit (17 individual rooms)Patients, Carers, HCP: 5 palliative doctors, 1 specialised palliative nurse, 1 extra nurse/shift, 1 nursing assistant for every 3–4 beds, 1 social worker, 1 psychologist, 1 chaplainNAF: 214; M: 18684/317 = 401 (Pilot/Main)Malignancy: 208; Dementia: 60; Frailty: 29; Stroke: 34; Organ failure: 40; Other: 30MMH-M
Van Cutsem et al. 20172016EUNarrative Review; Workshop ReportNANANANANAColorectal CancerMLM-M
van den Hurk et al. 2022NANALiterature ReviewCancer Survivorship CareNANANANACancerLLM-L
Viecelli et al. 20222019–2020AustraliaQualitative Study; Interviews; Focus Group4 Australian HD care units41 participants (12 patients; 13 nephrologists, 16 dialysis nurses)69.5 (13.41), R (39–88)12 patients = F: 5/12 (42); M: 7/12 (58)41Patients receiving HDHHM-H
Voorend et al. 20212017–2018NetherlandsQualitative Study; Focus Group3 Dutch hospital-based study- and routine care initiativesPatients, Caregivers, HCP: Nephrologist: 7 (28%); Geriatrician: 4 (16%); Nephrologist/geriatrician: 2 (8%); Nurse (nephrology): 3 (12%); Nurse (other): 2 (8%); Social worker: 4 (16%); Dietician: 1 (4%)M (R): Patients: 79 (67–88); Caregivers: 60 (51–76); HCP: 48 (29–61)Patients: M: 9 (50); Caregivers: M: 0 (0); HCP: M: 4 (16)47Chronic kidney disease (Geriatric)HHH-H
Wu et al. 20222020–2021CanadaPre-Post Single-Arm Interventional StudyHome; Oncology (Radiation Therapy)Patients (T1: 92 ± 5; T2: 100 ± 11), HCP: 2 Radiation TherapistsNANANAPatients Receiving Radiation TherapyLML-L

The update scoping search identified ten relevant studies [ 10 , 134 – 142 ], which confirmed the existing findings rather than adding any new information.

Figure 1 depicts the PRISMA flow chart reporting the literature search and selection of articles. A total of 31,796 records were identified through database searches, with no additional records retrieved from other sources. After the removal of 16,010 duplicate records, 15,786 records remained for title and abstract screening. Of these, 15,553 records were excluded as they did not meet the inclusion criteria. The remaining 233 full-text articles were assessed for eligibility. Following full-text review, 116 articles were excluded for the following reasons: not an implementation study ( n = 86), inappropriate study design ( n = 8), not focused on PCOMs ( n = 8), protocol only ( n = 6), not related to palliative care ( n = 5), palliative care comprising less than 50% of the study sample ( n = 2), or duplicate publication ( n = 1). A total of 114 studies, reported across 117 articles, were included in the qualitative synthesis. Fig. 1 PRISMA flow chart reporting the literature search and selection of articles.

Fig. 1 PRISMA flow chart reporting the literature search and selection of articles.
Fig. 1 PRISMA flow chart reporting the literature search and selection of articles.

Figure 1 illustrates the geographical distribution of the included studies. Compared with the original review, which identified studies from nine countries, the updated search revealed a markedly broader international representation. The largest number of studies originated from the United States ( n = 23), Canada ( n = 16), and Australia ( n = 7). Additional studies were conducted across Europe, Africa, Asia, and Oceania, reflecting the growing global engagement with PCOM implementation in palliative care. As noted in the figure legend, the appearance of several countries with a single study on the map results from a multi-country web-based survey of healthcare professionals. Fig. 2 Countries of included studies.The appearance of most countries with one study on the map is because of an online multi-country web-based survey from healthcare professionals from these counties; for more details, see Table 1 of Included Studies. Data that cannot be displayed on the map are as follows: United Kingdom (21), Republic of Ireland (6), Italy (4), Netherlands (3), Belgium (2), New Zealand (2), Portugal (2), Denmark (1), Eswatini (1), Greece (1), Japan (1), Lesotho (1), Rwanda (1), Sierra Leone (1), Singapore (1), Taiwan (1), and Thailand (1)

Fig. 2 Countries of included studies.The appearance of most countries with one study on the map is because of an online multi-country web-based survey from healthcare professional…
Fig. 2 Countries of included studies.The appearance of most countries with one study on the map is because of an online multi-country web-based survey from healthcare professionals from these counties; for more details, see Table 1 of Included Studies. Data that cannot be displayed on the map are as follows: United Kingdom (21), Republic of Ireland (6), Italy (4), Netherlands (3), Belgium (2), New Zealand (2), Portugal (2), Denmark (1), Eswatini (1), Greece (1), Japan (1), Lesotho (1), Rwanda (1), Sierra Leone (1), Singapore (1), Taiwan (1), and Thailand (1)

In this updated review we present results using a two-part structure: first results are shown by objective, second, recommendations are reported using the updated Medical Research Council Framework for Developing and Evaluating Complex Interventions [ 20 ]. We use their definition of complex intervention: “ An intervention might be considered complex because of properties of the intervention itself , such as the number of components involved; the range of behaviours targeted; expertise and skills required by those delivering and receiving the intervention; the number of groups , settings , or levels targeted; or the permitted level of flexibility of the intervention or its components .”

PCOMs implemented in clinical practice

Just over 70 different PCOMs were reported to be implemented in palliative care clinical practice; half of these were only used once, therefore appearing in only one study each. The Palliative Care Outcome Scale (POS) and its family of measures were the most used family of measures with 30 mentions, followed by the Edmonton Symptom Assessment Scale (ESAS) original, revised and renal with 26 mentions. Australia is the only country that has adopted one measure, the Symptom Assessment Score (SAS) as the national standard, which is used by all specialist palliative care services in the country and the IPOS is the recommended measure for use in UK. See Appendix 3 for the full list of measures by primary studies and reviews.

Facilitators of implementing PCOMs in clinical practice

The most notable facilitator was the integration of electronic/digital PCOMs into Information Technology (IT) systems [ 140 – 142 ] and routine care structures, including user experiences and user interface.

Across the included studies, several categories of facilitators for PCOM implementation were identified. Planning-related facilitators included the development of tailored implementation strategies and clear logistical preparation. At the system level, consistency with national guidelines supported adoption. Facilitators related to training and knowledge involved the provision of education to enhance clinicians’ competence in administering and using PCOM data. Organisational culture and structure facilitated implementation when teams engaged in discussions about the value of measurement and demonstrated commitment to routine use. Team-level facilitators included the presence of formally appointed implementation leads, involvement of staff in the process, and active participation from senior managers. Personal characteristics such as clinicians’ beliefs and prior experience also influenced engagement. Patient-related facilitators included coping styles that supported engagement and access to remote communication options for safety. Additional facilitators concerned effective team communication, use of PCOM data for continuous service improvement, and allocation of sufficient time for implementation activities. Resource-related facilitators included supportive infrastructure, readiness for change, adequate staffing, shorter completion times—particularly for electronic formats—and potential cost efficiencies associated with digital integration. Factors related to the PCOMs themselves, such as their ability to support patient expression, as well as flexible timing of administration, user-friendly equipment, and appropriate data security and equity measures, also supported successful implementation.

See Appendix 4 for the full list of categories and sub-categories of facilitators.

Barriers to implementing patient-centred outcome measures in clinical practice

The main barriers are mainly related to healthcare professionals, including: resistance to change, negative attitudes towards changing routine, scepticism regarding the necessity and usability of data collected, concerns regarding privacy and confidentiality, and belief that data collection is a burden to patients but also for themselves, given high workload:

Regarding resources, lack of training, time constraints, access to the tool and equipment to support electronic tools, were widely mentioned, as were unwell and complex patients who might not be able to fill the measures or have a rapidly changing condition that they felt the measure might not reflect:

Regarding the measures themselves, there were concerns relating to complexity, adaptability, interpretation, individualisation, comprehensibility, timing of use, numerical scoring, acceptability, and lack of consensus on what tool to use and their psychometric properties. See Appendix 5 for the full list of categories and sub-categories of barriers.

Lessons learned on implementing PCOMs in clinical practice

Implementing a PCOM in palliative care clinical practice is a complex intervention which needs planning, assessment and fine tuning throughout its course at different levels and with all involved [ 85 ]. We identified the following, mainly taken from the discussion section of included studies.

Guidance

Step by step guides specifically designed to implement PROMs in clinical practice [ 22 , 25 ].

Clinical Staff

Important to integrate nursing staff in the implementation process early with specific training and feedback. Consider individual attitudes and motivation to use new evidence-based practice. Changes that require clinicians to modify the interpersonal aspects of their care, or that are more complex, may be perceived as more difficult to implement [ 2 , 21 , 23 , 47 , 54 , 93 , 128 ].

Measure

Measures must be psychometrically sound and comparable [ 2 , 34 , 45 , 47 , 59 ].

Measurement frequency

When managing poorly controlled symptoms, measurement is needed multiple times a day [ 2 , 22 , 25 , 41 , 47 , 75 ].

Stability of measures

Once a measure is introduced, there needs to be a commitment for it to remain in place for a long period. Changing versions and measures should not be undertaken lightly as every change requires changes in IT and staff training and comes at a considerable cost [ 36 ].

Setting

The context in which measures are introduced and used is important. There are currently no palliative care measures for Intensive Care Unit (ICU) and paediatric palliative care settings. It has been suggested that the use of PCOMs in the palliative radiotherapy settings may not be possible, due to the large variety in pathologies, radiation schemes and treatment indications [ 25 , 34 , 45 , 46 , 56 , 61 , 65 , 93 , 106 , 115 ].

Implementation

Implementation is a time-consuming and long-term process and needs continuous attention and flexibility. Using the principles of change management, factors other than those relating to individual professionals are important, and greater use of theories of change may help to explain whether change is possible. Using PCOMs in palliative care clinical practice is a complex intervention; organisations’ aims must align with the effort to aid their clinical teams, with quality of care at the forefront as the rationale for implementing PCOMs [ 22 , 38 , 39 , 41 , 43 , 44 , 47 , 85 , 115 , 119 , 128 ].

Feedback

Across the studies reviewed, several forms of PCOMs feedback were identified as important for supporting care processes. These included individual patient-level feedback provided to clinicians, often in graphical or summary form to highlight symptom severity or change over time; feedback delivered directly to patients and family caregivers to support shared understanding; and aggregated feedback at team or service level used for monitoring quality and informing improvement activities. Timely and repeated feedback, particularly when integrated into electronic systems or displayed through dashboards, was also reported as facilitating clinical use. Together, these forms of objective, structured feedback were consistently valued by patients, family caregivers, and health professionals, even when patients’ health was deteriorating [ 7 , 13 , 30 , 36 , 39 , 47 , 54 ].

Patients

It is important to distinguish between patient burden and patients being too unwell to complete measures. PCOMs enable systematic symptom monitoring, and when ePROs trigger clinical alerts, they prompt timely clinician response to urgent patient needs. Patients who trigger electronic clinical alerts tend to be younger and more recently diagnosed, to have greater comorbidities, and to be from racial/ethnic minority groups. Clinicians and patients perceive that, when used in first assessments, individualised PCOMs supported relationship-building because they enable patients to ‘tell their story’: however, if the clinicians feel they cannot resolve an issue, there is a tendency to disregard and close the conversation [ 11 – 13 , 39 , 54 , 62 , 63 , 75 ].

Technology

Future digital health approaches in palliative care require understanding patients’ needs, and PCOMs help capture these systematically to guide timely, personalized clinical responses [ 21 , 23 , 30 , 34 , 93 , 95 ]. See Appendix 6 for full list.

Implementation models used when implementing PCOMs

A total of 18 models, frameworks and theories were identified as used in just 25 of included studies, most commonly Plan-Do-Study-Act (PDSA) [ 143 ], Promoting Action on Research Implementation in Health Services Framework (PARIHS) [ 144 , 145 ], and Consolidated Framework for Implementation Research (CFIR) [ 133 ] PDSA is an iterative, four-stage model that asks three questions: what are we trying to accomplish, how will we know that a change is an improvement and what changes can we make that will result in an improvement? PARIHS identifies three key components of the implementation process: evidence, context, and facilitation. Implementation is more likely to occur when evidence is scientifically robust, aligns with practitioner and patient beliefs and local experience, the context is receptive to change, and there is appropriate input from internal and external facilitators. CFIR, updated in 2022, has five domains to guide systematic assessment of potential barriers and facilitators, tailor implementation strategies and needed adaptations, and explain outcomes (individuals, inner setting, outer setting, implementation process and innovation/change to be implemented) [ 146 ].

See Appendix 7 for a complete list of the implementation models and frameworks identified.

Implementation outcomes measured, and how, when implementing PCOMs

Sixty-three included studies mentioned at least one implementation outcome and most studies reported only on feasibility of implementing a PCOM or e-PCOM in clinical practice and the acceptability to patients and healthcare professionals of the measure used.

Only two studies mentioned appropriateness: one considered three implementation outcomes [ 117 ]. It was concluded that by documenting evidence of pain assessment and screening for spiritual distress, the number of referrals improved and was maintained 12 months and more clinicians agreed that palliative care domains were comprehensively assessed post-intervention [ 117 ]; the other mapped to NPT constructs and the Context–Mechanism–Outcome framework. The study captured acceptability (professionals’ perceived benefits and burdens), appropriateness (fit with workflow and electronic systems), feasibility (practicality given staffing, routines, and IT capacity), adoption (extent and consistency of use), fidelity (variation in scoring and assessment practices), and initial indications of sustainability (whether teams continued after the study). These outcomes emerged entirely from thematic analysis of interview data rather than quantitative measurement [ 142 ].

Financial costs of implementing PCOMs

No included studies reported on the costs of implementation. Some provided suggestions in relation to costs, for example suggesting that the way to rationalise PCOMs implementation is for these to replace routine procedures [ 21 , 28 ] or as a complement to existing practices without requiring additional resources [ 73 ]. Others suggested that implementation would be costly in the short-term but cost-saving in the long term by reducing the workload [ 21 , 30 , 117 ]. One study observed that teams allocated work hours to using PCOMs and occasionally accepted overtime [ 142 ].

Studies suggested that the possible costs of implementation include: cost of the PCOMs [ 21 , 106 ]; cost of healthcare staff time and capacity [ 41 ]; cost of creating, maintaining and updating electronic systems and integration into existing IT systems [ 41 , 67 , 117 , 130 ]; costs to healthcare system of reimbursement and pay-for-performance incentives [ 30 , 41 , 92 , 121 ] setting-dependent costs including models of care, clinical competencies and resourcing [ 36 ]; unavailability of reimbursement/insurance plans to cover staff time in the US; [ 41 ] lack of funding in charitable organisations [ 106 ]; and costs associated with the outcomes of implementation including resources to respond to patients’ issues identified [ 8 , 41 ]. Some solutions were proposed to save costs [ 8 , 21 , 41 , 44 , 50 , 102 , 117 ]. See Appendix 8 for a full list of facilitators and barriers regarding financial costs.

Updated recommendations for PCOMs implementation

Based on the new evidence synthesis, we have updated recommendations, and reiterated those from our previous review, by mapping them on the updated MRC Framework for Developing and Evaluating Complex Interventions [ 20 ]. Table 2 presents a summarised description of the recommendations mapped on the MRC Framework in the form of actions. Below, we describe the main considerations arising from those actions.

Table 2 Recommendations per phases and respective core elements following the latest framework for developing and evaluating complex interventions by the medical research Council PHASES CORE ELEMENTS Identify the intervention: Implementing PCOM in palliative care clinical practice Feasibility testing Evaluation Implementation Context - Use “User’s Guide for Implementing Patient-Reported Outcomes Assessment in Clinical Practice” to help with discussions around the advantages and disadvantages of options for key design issues such as selecting questionnaires; determining the frequency with which the questionnaires are administered; determining when, where, how, and to whom the results will be presented; planning the response to patient needs identified by the PROs; and evaluating the use and benefit of PROs in a particular setting. 30 - There is an urgent need to develop a palliative care PROM for the ICU setting , as is a paediatric palliative care PROM. 61 - Consider the following implementation steps: (I) selection of outcomes of interest; (II) selection of outcome measure(s); (III) education about the measure and use of results; (IV) selection of one coordinator/facilitator; (V) who applies the measure and its periodicity. Implementation is time consuming and a long-lasting process needing continuous attention , never seems to be completed and touches on principles of change management. 27 - Be aware of issues for a speciality when selecting and implementing outcome measures in practice: different specialities have different challenges and concerns 111 - Challenges for using outcome measures are different in different settings 111 - Bespoke measures important to patients and their families must be collected prospectively and they cannot be derived from clinical records 41 - By controlling for patients’ overall physical status (which is the major predictor of resource utilisation at the end of life) in the comparisons made , residual variations are largely going to be due to variations between services: models of care , clinical competencies , resourcing or combinations of these factors. This has allowed a process of embedding quality systematically across a whole sector of the health system relatively quickly. Developing a culture of rapid evaluation and re-evaluation after adjusting local models of clinical care delivery is an exciting development within hospice/palliative care. 41 - Understand the health care organization context , including alignment with priorities and purposes regarding current and past use of QOL assessment instruments in the organization. 115 - To achieve significant and sustained improvements in patient care in response to the feedback of performance data , it is imperative to use system and organisation-wide strategies 59 - Use measures that are suited to the clinical task being delivered and suited to the aims of your clinical work and the population you work with. They differ in the domains and dimensions they measure , and in their length , measurement window , accessibility and cost 2 - Initial meeting to explore feasibility of implementation of the measure: planning and evaluating are essential; a coordinator is identified to undertake overall responsibility - Appraise characteristics and resources of the setting and the requirements of the proposed innovation: that is, it is necessary to attune the implementation protocol to the needs of the specific setting and think about good documentation: will allow staff to take ownership and understand the benefits of using the chosen measure, which needs to be adaptable to local circumstances - Education and training sessions: consider your setting and organisational needs, when planning, that is, timing of sessions - It is vital to assess organizational context when implementing an evidence-based complex intervention and having a plan in place to ensure practitioners remain motivated to use the new intervention 43 - Assess if collation of data generated using the measure allows continuous, accurate collection of information, which should reflect the activity of the palliative care team. It should also identify areas of potential future development - Assess if changes will be made in practice based on the results of implementing and using the measure - Maintain strategies of reminders to incorporate the use of the measures in clinical practice, for example, daily assessment easily fits with daily routine and does not take additional time, that is, if it is incorporated with moment of control of vital signs: better insight into patients’ situation - Need for better understanding of how institutions can join efforts to assist clinicians and services to implement PCOMs in PC clinical practice 133 - In kidney disease care , setting and time of electronic collection: clinic intake room before appointment (CKD/transplant); dialysis facility during dialysis treatment; home during home dialysis session; home between clinic appointments or dialysis sessions (via ecological momentary assessment) 98 - Storage: Integration into electronic medical record with password-protected access; Interpretation; Incorporation into risk prediction models; Comparison with national benchmarks 98 Programme Theory - Physical functioning needs to be clearly defined and conceptualized, and a consensus on terminology and which aspects that are relevant for palliative care is highly warranted. 76 - M ore systematic use of theories in planning and evaluating quality improvement interventions in clinical practice theories may help to explain whether change is possible 27 - C onsider theoretical aspects in the development of documentation systems or measurement instruments , to avoid different measurement levels for sub-items. 52 - Action research provides structure to involve healthcare professionals in introducing outcome measures within a practice setting. 111 - I ndividuals within an organization learn within the social context of other learners. People are “not passive recipients of innovations” but rather they seek to evaluate them and communicate about them. 43 - Implementation may be more successful for services that offer regular opportunities to use the intervention in practice , have sufficient levels of facilitators , stimulate more staff discussion , and encourage maintenance of positive motivation. 43 Stakeholders’ engagement - Meaningful outcomes can be routinely collected in hospice/palliative care and , that by providing a feedback loop and service to service benchmarking , patient-focused improvements can be delivered. 41 - Involve palliative patients in different settings in studies testing electronic PRO data assessments 39 - Establish clear boundaries at the outset to avoid unrealistic expectations from all actors involved - Visualisation of results should allow easy and quick interpretation by health-care providers, patients and their families - Consider investing in training of clinical key staff: improves data quality and demonstrates that data can be used (a) on a daily basis as part of clinical practice and (b) to manage and improve services, that is, data can be used in case conferencing and interdisciplinary team meetings and at staff handovers for patient care, discharge planning and discharge and transfer of patients as well as audit for quality assurance - Organisational support is needed to maximise the tool’s impact: mechanisms for sharing the information with caregivers need to be developed - Initiate implementation in stages to improve acceptability - Coordinator maintains good relationships with all involved by having both an awareness of the extra time and effort needed to implement new outcome measures and providing the appropriate resources and practical support to use the measures and carry out data analysis. Cascade management style is adopted - Integrating nursing staff into the implementation process at an early stage. This integration includes offering specific training in the use of the documentation interface in addition to the possibility of providing feedback and adapting the measurement system to foster its ease-of-use. 52 - Changing the practice is complex: provide enough time , continuing support , and quality in the methodologies of change enacted. 45 - Assess if practice improved initially as a result of just ‘planting the seed’ of the patient’s needs management. Continue to encourage its use, which will improve confidence with the tool - Assess if there is a benefit to both patient and practitioner in achieving better outcomes, improved concordance and potentially reducing the cost and effort of that management - Collected items are reviewed with the aim of being clinically relevant and not burdensome to collect - PCOMs reflect the excellence of the health service delivered and to use them in a continuous base for quality improvement and programme certification also allows for decision and policy makers to have more concrete evidence to support and make the best decisions 133 - Education and motivation of patients could improve compliance - Timely feedback of results is always done - Persistence and encouragement by the coordinator are necessary to ensure the implementation is successful and that communication among all actors involved is clear - Coordinator investigates all complaints/issues and addresses them immediately, at the time of the complaint/issue (negative views from both patients and professionals tend to be at the outset of implementation when they have not familiarised with the measure) - Every member of the team who should be using the outcome measures does so - I n kidney disease care , method and mode of collection: self-administered online surveys via tablet computer or smartphone; nurse-administered online surveys via tablet computer 98 - Regular sharing of results with patients , caregivers , and clinicians; Action; Targeted , individualized treatments based on results (referral to psychologist , change in dialysis prescription) 98 - Objective feedback from PCOMs is paramount: patients , family caregivers and health professionals value it , even in the face of deteriorating health 13 - When used in first assessments , individualised PROMs support relationship-building: they enable the patient to ‘tell their story’. 59 - PCOMs facilitate discussions between patients and nurses about care needs. Patients feel empowered. 68 Key uncertainties -From an ethical perspective , consider that by either excluding patients with dementia or cognitive impairment from their study samples or by performing a proxy-assessment of needs and outcomes , some vulnerable patients are at risk of developing further vulnerabilities 94 -Several factors may influence the success of the implementation of electronic PRO , such as cultural and socioeconomic , e-health literacy and care setting (inpatient vs. outpatient) , because patients’ goals and care needs often differ 39 -A clear guideline on the use of PROMs in the palliative radiotherapy setting may be impossible , due to the large variety in pathologies , radiation schemes and treatment indications. 100 - There is tension between PROMs as a QI strategy versus their use in the care of individual patients; some PROMs that clinicians find useful in assessing patients , such as individualised measures , are not useful as indicators of service quality. 59 -Potential risk of harm of using a measure in routine care. There are risks of inaccurate assessment either due to poor assessment or lack of measurement reliability 50 -Awareness of the potential of detracting from caring responsibilities in under-resourced care settings. 50 - Assess if there is a benefit to patient in achieving better outcomes - There is an important distinction between patient burden and patients being too unwell to complete outcome measures – these are often conflated. 13 - Recognise that patients , families and professionals may have differing views about the advantages and disadvantages of using outcome measures , particularly in relation to feelings of reassurance and burden. 13 - Whether PROMs support or constrain patients in sharing or raising issues with clinicians depends on the structure of the PROM , e.g.: standardised PROMs were useful for those patients who preferred not to talk about personal or sensitive issues , helping them to share information. 59 Intervention refinement - To maintain the possibility of evaluating a proxy-based measurement system with respect to its psychometric properties , it is highly recommended to add an empirically validated instrument for data collection. 52 - International developments can be unlocked by providing controlled access to ePRO data , algorithms , and models. The use of ePROs is instrumental in driving innovation in the eHealth era. For symptom management , it is shifting care from reactive to proactive and preventive by integrating predictive devices into the patient’s daily life. 135 - Discussions in this step should include assessment of current data collected, how data are collected, what new data items are to be extracted, how data can be extracted and provided to who will analyse it, and, which measure(s) to use, especially due to the high number of existing measures and the fact that many are used in research or were used in one study only. A measure broadly used will allow for comparisons. The aim should be to embed the collection of standardised clinical assessment and other clinically relevant data into daily clinical practice with a view to improving clinical care - Consider implementation strategies: consistency is paramount. Frequency of use of the measure; burden of completion on patient; measures that can be analysed using existing resources; a measure that is easy and quick to use; establish link with a research/audit group -ePRO survey can be used even in patients with a high burden of disease as well as in older patients 58 - Collected items are reviewed with the aim of being clinically relevant and not burdensome to collect - Assess if the measure generated valuable information, without an increase in paperwork, potentially freeing up some time to deliver more patient-centred care - Continue to refine the process to make it more understandable and acceptable to patients and caregivers - Assessing and improving documentation will potentially improve practice and quality of care by highlighting needs - Seek relevant patient and staff feedback on observing and implementing the measures considering lessons learned in the process 44 - Data that are more time consuming to collect but important for quality reporting are collected periodically, rather than, for example, daily - Space and time are created to discuss how implementation is going: problems and benefits of using outcome measures are easily and rapidly noticeable (what is working and what is not) - Interpretation of results is used in practice - Symptom burden is subject to frequent fluctuations in its intensity within a day: a high-frequency measurement approach of symptom burden data is highly recommended 52 - Initial decisions taken for implementation are not final and once the protocol is put in practice , several processes will need to change across time 133 - It is imperative to find strategies to widen participation using electronic measures across patient groups. On-site completion is achievable with limited staff support , but remote electronic completion requires further work to improve systems and acceptability for patients. 26 - Conceptualize and measure implementation outcomes to determine the effectiveness of implementation strategies. Need to measure implementation outcomes systematically. 13 Regarding dementia patients in care homes: improved observation and awareness of residents , collaborative assessment , comprehensive ‘picture of the person’ , systematic record keeping , improved review and monitoring , care planning and changes to care provision , and facilitated multi-agency communication. Potential benefit included improved symptom management , improved comprehensive care , and increased family empowerment and engagement. 50 - Standardisation and technologization of medicine cannot and must not replace a personal conversation between health care professionals and patients. 108 Specific to dementia Economic considerations - There is a disconnection between the development of PROMs (and PREMs) and the implementation of value-based health-care (VBHC) , a continuous implementation process still in its infancy 49 - Consider establishing a program evaluation system for the first month of each phase as well as every 6 months during the first year of implementation. Should include feedback from patients, staff members, physicians, nurses (and ITS team if applicable) as well as cost savings to the setting - Investment in computerised systems for quick data entry and analysis should be considered. Ways of visualising, storing, retrieving and backing up the data should be discussed - Use of PCOM in PC clinical practice , take into account individual needs , values and patient and families’ resources , which adds a much needed measure to help guide improvement of quality of care provided. 133 - Capability measures are appropriate for use in economic evaluations of interventions at end of life 38 New recommendations are in bold

Table 2
Recommendations per phases and respective core elements following the latest framework for developing and evaluating complex interventions by the medical research Council
New recommendations are in bold

PHASES CORE ELEMENTSIdentify the intervention: Implementing PCOM in palliative care clinical practiceFeasibility testingEvaluationImplementation
Context- Use “User’s Guide for Implementing Patient-Reported Outcomes Assessment in Clinical Practice” to help with discussions around the advantages and disadvantages of options for key design issues such as selecting questionnaires; determining the frequency with which the questionnaires are administered; determining when, where, how, and to whom the results will be presented; planning the response to patient needs identified by the PROs; and evaluating the use and benefit of PROs in a particular setting. 30 - There is an urgent need to develop a palliative care PROM for the ICU setting , as is a paediatric palliative care PROM. 61 - Consider the following implementation steps: (I) selection of outcomes of interest; (II) selection of outcome measure(s); (III) education about the measure and use of results; (IV) selection of one coordinator/facilitator; (V) who applies the measure and its periodicity. Implementation is time consuming and a long-lasting process needing continuous attention , never seems to be completed and touches on principles of change management. 27 - Be aware of issues for a speciality when selecting and implementing outcome measures in practice: different specialities have different challenges and concerns 111 - Challenges for using outcome measures are different in different settings 111 - Bespoke measures important to patients and their families must be collected prospectively and they cannot be derived from clinical records 41 - By controlling for patients’ overall physical status (which is the major predictor of resource utilisation at the end of life) in the comparisons made , residual variations are largely going to be due to variations between services: models of care , clinical competencies , resourcing or combinations of these factors. This has allowed a process of embedding quality systematically across a whole sector of the health system relatively quickly. Developing a culture of rapid evaluation and re-evaluation after adjusting local models of clinical care delivery is an exciting development within hospice/palliative care. 41 - Understand the health care organization context , including alignment with priorities and purposes regarding current and past use of QOL assessment instruments in the organization. 115 - To achieve significant and sustained improvements in patient care in response to the feedback of performance data , it is imperative to use system and organisation-wide strategies 59 - Use measures that are suited to the clinical task being delivered and suited to the aims of your clinical work and the population you work with. They differ in the domains and dimensions they measure , and in their length , measurement window , accessibility and cost 2- Initial meeting to explore feasibility of implementation of the measure: planning and evaluating are essential; a coordinator is identified to undertake overall responsibility - Appraise characteristics and resources of the setting and the requirements of the proposed innovation: that is, it is necessary to attune the implementation protocol to the needs of the specific setting and think about good documentation: will allow staff to take ownership and understand the benefits of using the chosen measure, which needs to be adaptable to local circumstances - Education and training sessions: consider your setting and organisational needs, when planning, that is, timing of sessions - It is vital to assess organizational context when implementing an evidence-based complex intervention and having a plan in place to ensure practitioners remain motivated to use the new intervention 43- Assess if collation of data generated using the measure allows continuous, accurate collection of information, which should reflect the activity of the palliative care team. It should also identify areas of potential future development - Assess if changes will be made in practice based on the results of implementing and using the measure- Maintain strategies of reminders to incorporate the use of the measures in clinical practice, for example, daily assessment easily fits with daily routine and does not take additional time, that is, if it is incorporated with moment of control of vital signs: better insight into patients’ situation - Need for better understanding of how institutions can join efforts to assist clinicians and services to implement PCOMs in PC clinical practice 133 - In kidney disease care , setting and time of electronic collection: clinic intake room before appointment (CKD/transplant); dialysis facility during dialysis treatment; home during home dialysis session; home between clinic appointments or dialysis sessions (via ecological momentary assessment) 98 - Storage: Integration into electronic medical record with password-protected access; Interpretation; Incorporation into risk prediction models; Comparison with national benchmarks 98
Programme Theory- Physical functioning needs to be clearly defined and conceptualized, and a consensus on terminology and which aspects that are relevant for palliative care is highly warranted. 76 - M ore systematic use of theories in planning and evaluating quality improvement interventions in clinical practice theories may help to explain whether change is possible 27- C onsider theoretical aspects in the development of documentation systems or measurement instruments , to avoid different measurement levels for sub-items. 52 - Action research provides structure to involve healthcare professionals in introducing outcome measures within a practice setting. 111- I ndividuals within an organization learn within the social context of other learners. People are “not passive recipients of innovations” but rather they seek to evaluate them and communicate about them. 43- Implementation may be more successful for services that offer regular opportunities to use the intervention in practice , have sufficient levels of facilitators , stimulate more staff discussion , and encourage maintenance of positive motivation. 43
Stakeholders’ engagement- Meaningful outcomes can be routinely collected in hospice/palliative care and , that by providing a feedback loop and service to service benchmarking , patient-focused improvements can be delivered. 41 - Involve palliative patients in different settings in studies testing electronic PRO data assessments 39- Establish clear boundaries at the outset to avoid unrealistic expectations from all actors involved - Visualisation of results should allow easy and quick interpretation by health-care providers, patients and their families - Consider investing in training of clinical key staff: improves data quality and demonstrates that data can be used (a) on a daily basis as part of clinical practice and (b) to manage and improve services, that is, data can be used in case conferencing and interdisciplinary team meetings and at staff handovers for patient care, discharge planning and discharge and transfer of patients as well as audit for quality assurance - Organisational support is needed to maximise the tool’s impact: mechanisms for sharing the information with caregivers need to be developed - Initiate implementation in stages to improve acceptability - Coordinator maintains good relationships with all involved by having both an awareness of the extra time and effort needed to implement new outcome measures and providing the appropriate resources and practical support to use the measures and carry out data analysis. Cascade management style is adopted - Integrating nursing staff into the implementation process at an early stage. This integration includes offering specific training in the use of the documentation interface in addition to the possibility of providing feedback and adapting the measurement system to foster its ease-of-use. 52 - Changing the practice is complex: provide enough time , continuing support , and quality in the methodologies of change enacted. 45- Assess if practice improved initially as a result of just ‘planting the seed’ of the patient’s needs management. Continue to encourage its use, which will improve confidence with the tool - Assess if there is a benefit to both patient and practitioner in achieving better outcomes, improved concordance and potentially reducing the cost and effort of that management - Collected items are reviewed with the aim of being clinically relevant and not burdensome to collect - PCOMs reflect the excellence of the health service delivered and to use them in a continuous base for quality improvement and programme certification also allows for decision and policy makers to have more concrete evidence to support and make the best decisions 133- Education and motivation of patients could improve compliance - Timely feedback of results is always done - Persistence and encouragement by the coordinator are necessary to ensure the implementation is successful and that communication among all actors involved is clear - Coordinator investigates all complaints/issues and addresses them immediately, at the time of the complaint/issue (negative views from both patients and professionals tend to be at the outset of implementation when they have not familiarised with the measure) - Every member of the team who should be using the outcome measures does so - I n kidney disease care , method and mode of collection: self-administered online surveys via tablet computer or smartphone; nurse-administered online surveys via tablet computer 98 - Regular sharing of results with patients , caregivers , and clinicians; Action; Targeted , individualized treatments based on results (referral to psychologist , change in dialysis prescription) 98 - Objective feedback from PCOMs is paramount: patients , family caregivers and health professionals value it , even in the face of deteriorating health 13 - When used in first assessments , individualised PROMs support relationship-building: they enable the patient to ‘tell their story’. 59 - PCOMs facilitate discussions between patients and nurses about care needs. Patients feel empowered. 68
Key uncertainties-From an ethical perspective , consider that by either excluding patients with dementia or cognitive impairment from their study samples or by performing a proxy-assessment of needs and outcomes , some vulnerable patients are at risk of developing further vulnerabilities 94 -Several factors may influence the success of the implementation of electronic PRO , such as cultural and socioeconomic , e-health literacy and care setting (inpatient vs. outpatient) , because patients’ goals and care needs often differ 39 -A clear guideline on the use of PROMs in the palliative radiotherapy setting may be impossible , due to the large variety in pathologies , radiation schemes and treatment indications. 100 - There is tension between PROMs as a QI strategy versus their use in the care of individual patients; some PROMs that clinicians find useful in assessing patients , such as individualised measures , are not useful as indicators of service quality. 59-Potential risk of harm of using a measure in routine care. There are risks of inaccurate assessment either due to poor assessment or lack of measurement reliability 50 -Awareness of the potential of detracting from caring responsibilities in under-resourced care settings. 50- Assess if there is a benefit to patient in achieving better outcomes- There is an important distinction between patient burden and patients being too unwell to complete outcome measures – these are often conflated. 13 - Recognise that patients , families and professionals may have differing views about the advantages and disadvantages of using outcome measures , particularly in relation to feelings of reassurance and burden. 13 - Whether PROMs support or constrain patients in sharing or raising issues with clinicians depends on the structure of the PROM , e.g.: standardised PROMs were useful for those patients who preferred not to talk about personal or sensitive issues , helping them to share information. 59
Intervention refinement- To maintain the possibility of evaluating a proxy-based measurement system with respect to its psychometric properties , it is highly recommended to add an empirically validated instrument for data collection. 52 - International developments can be unlocked by providing controlled access to ePRO data , algorithms , and models. The use of ePROs is instrumental in driving innovation in the eHealth era. For symptom management , it is shifting care from reactive to proactive and preventive by integrating predictive devices into the patient’s daily life. 135- Discussions in this step should include assessment of current data collected, how data are collected, what new data items are to be extracted, how data can be extracted and provided to who will analyse it, and, which measure(s) to use, especially due to the high number of existing measures and the fact that many are used in research or were used in one study only. A measure broadly used will allow for comparisons. The aim should be to embed the collection of standardised clinical assessment and other clinically relevant data into daily clinical practice with a view to improving clinical care - Consider implementation strategies: consistency is paramount. Frequency of use of the measure; burden of completion on patient; measures that can be analysed using existing resources; a measure that is easy and quick to use; establish link with a research/audit group -ePRO survey can be used even in patients with a high burden of disease as well as in older patients 58- Collected items are reviewed with the aim of being clinically relevant and not burdensome to collect - Assess if the measure generated valuable information, without an increase in paperwork, potentially freeing up some time to deliver more patient-centred care - Continue to refine the process to make it more understandable and acceptable to patients and caregivers - Assessing and improving documentation will potentially improve practice and quality of care by highlighting needs - Seek relevant patient and staff feedback on observing and implementing the measures considering lessons learned in the process 44- Data that are more time consuming to collect but important for quality reporting are collected periodically, rather than, for example, daily - Space and time are created to discuss how implementation is going: problems and benefits of using outcome measures are easily and rapidly noticeable (what is working and what is not) - Interpretation of results is used in practice - Symptom burden is subject to frequent fluctuations in its intensity within a day: a high-frequency measurement approach of symptom burden data is highly recommended 52 - Initial decisions taken for implementation are not final and once the protocol is put in practice , several processes will need to change across time 133 - It is imperative to find strategies to widen participation using electronic measures across patient groups. On-site completion is achievable with limited staff support , but remote electronic completion requires further work to improve systems and acceptability for patients. 26 - Conceptualize and measure implementation outcomes to determine the effectiveness of implementation strategies. Need to measure implementation outcomes systematically. 13 Regarding dementia patients in care homes: improved observation and awareness of residents , collaborative assessment , comprehensive ‘picture of the person’ , systematic record keeping , improved review and monitoring , care planning and changes to care provision , and facilitated multi-agency communication. Potential benefit included improved symptom management , improved comprehensive care , and increased family empowerment and engagement. 50 - Standardisation and technologization of medicine cannot and must not replace a personal conversation between health care professionals and patients. 108 Specific to dementia
Economic considerations- There is a disconnection between the development of PROMs (and PREMs) and the implementation of value-based health-care (VBHC) , a continuous implementation process still in its infancy 49- Consider establishing a program evaluation system for the first month of each phase as well as every 6 months during the first year of implementation. Should include feedback from patients, staff members, physicians, nurses (and ITS team if applicable) as well as cost savings to the setting - Investment in computerised systems for quick data entry and analysis should be considered. Ways of visualising, storing, retrieving and backing up the data should be discussed - Use of PCOM in PC clinical practice , take into account individual needs , values and patient and families’ resources , which adds a much needed measure to help guide improvement of quality of care provided. 133 - Capability measures are appropriate for use in economic evaluations of interventions at end of life 38

Intervention development/identification

Implementation of a PCOM in palliative care can occur in a range of clinical contexts including hospital, home, hospice, or care home. These contexts have different rules, different resources available, and different support from managers and different outcomes the team wish to measure [ 2 , 7 , 34 , 36 , 38 , 85 , 106 , 110 ]. Clinicians may not have experience or training in using PCOMs [ 21 , 22 , 38 , 47 , 61 , 128 ]. Patient populations will differ, being more or less complex and in a more or less advanced stage of illness [ 13 , 30 , 46 , 47 , 85 , 103 , 106 ]. Very ill patients may have missing data [ 2 , 46 , 54 , 85 ], in which case a PCOM which allows for proxy ratings may be appropriate [ 2 , 34 ]. These factors will all influence the measure(s) selected [ 2 , 46 , 54 , 75 , 85 ].

The use of theory to underpin implementation models is generally considered beneficial, as it provides a structured foundation for understanding and guiding the implementation process. From the theories available in the literature, it will be important to select one which is appropriate for the clinical context in which the implementation will be conducted [ 22 , 38 , 47 , 106 , 121 ].

Engaging stakeholders from the initial planning phase is vital, including: patients, families and other informal caregivers, healthcare professionals from all the teams involved, managers, policy makers, and decision makers [ 13 , 22 , 38 , 40 , 47 , 54 , 106 , 110 , 128 ].

Identification of key uncertainties, including the adjustments to be made during the different steps is key [ 2 , 21 , 25 , 38 , 47 , 54 , 85 , 128 ]. Consideration needs to be given to: when will patients be asked to complete the measure, who will ask the patient, will patients choose paper or electronic formats, whether a family or staff member will be able to act as a proxy if the patient is unable to complete the measure, will the institution provide IT resources for optimal use of the PCOM information, when will the feedback happen to healthcare professionals and patients, how will responses be used to support or improve patient care (and/or quality improvement), when will the team meet to discuss implementation [ 7 , 13 , 30 , 36 , 39 , 47 , 54 ]. Other uncertainties will arise as the implementation moves forward and clinicians become more familiar with the new routine [ 2 , 8 , 30 , 54 , 63 , 74 , 75 , 85 , 128 ].

Refining of the intervention can only take place after the team has met to review how the implementation is going and changes needed [ 40 , 85 , 128 ]. Consideration needs to be given in the planning phase to minimising missing data (this appears to improve with electronic data capture), how often will clinicians use the results and how will this be reported, how engaged are all members of the clinical team in the new routine, and other ways to improve the implementation [ 2 , 22 , 25 , 36 , 38 , 54 ].

Economic considerations must be contemplated from the outset [ 2 , 33 , 44 , 121 ]: for example, is there additional resource to support the implementation or will this be within current resources and workforce time available [ 8 , 30 , 36 , 41 , 64 , 67 , 73 , 117 ]; what IT and administrative support will be available initially and long term to store, synthesise and present data from the measure to clinicians [ 50 , 79 , 92 , 106 , 130 , 132 ].

Feasibility

Feasibility testing, against predefined progression criteria [ 2 , 34 , 45 ], assesses feasibility and acceptability of implementing the PCOM(s) in the clinical setting concerned [ 2 , 13 , 34 , 47 ]. This allows decisions to be made about progression to the next stage. Consideration of the optimal way to integrate the use of the measures and the use of their results in clinical practice [ 2 , 54 , 85 ] requires team leads to all be on board and meet periodically to discuss the six core elements as the phase progresses [ 2 , 8 , 13 , 45 , 54 , 75 , 128 ].

Context includes the setting where care is delivered, the institutional culture, the staff members involved, the physical setting in which patients will fill in the measure and when they will do so [ 9 , 38 , 54 , 109 , 110 , 128 ]. The theory employed needs review regarding how well it fits with the implementation setting [ 38 , 57 , 83 , 101 ]. Stakeholder engagement needs to involve patients and family members, clinicians, decision makers and policy makers [ 2 , 13 , 22 , 25 , 36 , 38 , 54 ], in order to understand if it is feasible to implement the selected PCOM, identify key uncertainties and how they will be explored and resolved [ 22 , 47 , 128 ]. One important issue raised in the included papers was the course of action when a patient reports a very high score for one or more items, when that indicates the worst possible state [ 2 , 13 , 22 , 25 , 34 , 36 , 39 , 47 , 54 , 63 , 69 , 74 , 93 , 106 , 107 , 109 , 128 ].

Regarding economic considerations, it is important to understand how much time the clinical, administrative and IT teams will spend on the implementation and whether that will be resourced [ 2 , 22 ].

Evaluation

The evaluation phase investigates whether and how the intervention works, the usefulness of the information gained, how it interacts with the clinical context and contributes to improved outcomes for patient and families and system change [ 22 , 39 – 41 , 45 , 54 , 75 , 85 , 93 , 121 , 128 ]. Strong networking relationships are likely to be established with formal and informal sectors outside of the organisation [ 38 , 40 , 41 , 54 , 85 ], including identification of outcomes which capture changes to the wider healthcare system [ 2 , 13 , 21 , 36 , 41 , 45 , 47 , 54 , 72 ]. When refining the theory, it is important to consider the interpretation of data and how it will have an impact on clinical processes and outcomes [ 38 , 57 , 83 , 101 ]. If the results of the PCOMs are being used, that should lead to improved levels and quality of care and improved patient and family outcomes [ 2 , 4 , 22 , 36 , 54 , 72 , 82 , 128 ]. When healthcare professionals are trained to interpret and act on PCOM feedback, care becomes more responsive to patients’ changing needs. Furthermore, using PCOMs systematically allows for benchmarking and continuous quality improvement at an organizational level, creating a feedback loop that fosters accountability and patient-centered service development. These mechanisms can ultimately contribute to better alignment of care with patient goals and improved experiences at the end of life. This underscores the importance of systematically assessing not only whether PCOMs are implemented, but also how they influence clinical practice and patient trajectories. Evaluation should explore the mechanisms through which PCOMs inform care—such as changes in clinical decision-making, timeliness of interventions, or communication with families—as well as measurable improvements in health outcomes and satisfaction. Additionally, the evaluation phase provides an opportunity to examine contextual factors, such as staff engagement or organizational readiness, that may mediate or moderate the impact of PCOM use. Evaluation should primarily focus on the performance and sustainability of measures within routine, long-term practice settings, rather than being limited to isolated or short-term studies [ 26 ]. The best example are the PCOC measures which have been collected in Australia continuously for 20 years.

Implementation

After developing and planning the implementation, piloting it, assessing how that first stage went and making changes, it is expected that there will be a “second try” that is better adapted to the reality of each clinical team, as an ongoing process. The six core elements will be unique to each clinical team and dependent on the previous work carried out. If the main issues which arose in the pilot phase were addressed in the evaluation phase, the implementation should run more smoothly with less issues to resolve, as illustrated in the Tavares AP et al. study describing all four steps of implementing a PCOM in an inpatient palliative care service [ 128 ].

By rigorously evaluating these components, we can determine whether and how PCOMs contribute to better patient-centred outcomes and generate transferable insights to guide future implementation and scale-up.

Discussion

Despite a decade of expansion in the literature (from 26 studies to 114), the core facilitators, barriers, and lessons learned in implementing PCOMs in palliative care clinical practice remain largely consistent. As in the original review, the updated synthesis confirms that successful implementation still depends heavily on organisational planning, the presence of a coordinator, staff training, perceived clinical relevance of the measures, and supportive team culture. Likewise, persistent barriers—time constraints, staff workload, lack of training, concerns about burden, and clinicians’ beliefs or reluctance—remain fundamentally unchanged. However, two important differences emerge. First, the updated review identifies digital integration of PCOMs into IT systems as a major new facilitator, reflecting technological developments absent from the earlier evidence base (e.g., user-friendly e-health interfaces and digital workflows). Second, the contemporary literature shows a broader international reach and introduces new domains—particularly implementation models, implementation outcomes, and cost considerations—which were not addressed in 2014. Despite these additions, the essential message of both reviews is consistent: implementing PCOMs remains a complex intervention requiring ongoing planning, adaptation, and engagement across all levels of palliative care practice..

PCOMs implemented in clinical practice

The PCOMs most widely used continue to be the POS and the ESAS families of measures. There are a plethora of outcome measures which appeared only once in this review.

Facilitators of implementing PCOMs in clinical practice

Despite a large increase in the volume of literature on PCOMs implementation since the original review (117 vs. 33 studies), in a lot more countries, illustrating how the field has expanded internationally since 2012, evidence on facilitators and barriers to implementation of PCOMs is largely unchanged since 2014. An exception to this is increased focus on the integration of electronic/digital PCOMs into IT systems and routine care structures, including user experiences and user interface as a facilitator to implementation. Recent studies conducted in specialist palliative home care similarly report that implementing ePROMs introduces new layers of complexity, particularly around digital workflows, data privacy, and professional workload [ 140 , 141 ].

Barriers to implementing patient-centred outcome measures in clinical practice

Organisational culture and privacy/confidentiality issues are more evident as barriers in this updated review, as healthcare professionals continue to raise significant concerns regarding the wider adoption of digital PCOM systems These concerns often relate to the security of electronic data, the potential for unauthorised access, and uncertainty about how sensitive patient information may be stored, shared, and protected within organisational systems. Addressing these issues through robust data-governance practices and clear communication about safeguards is essential to building clinicians’ trust and ensuring confident, sustained engagement with PCOMs in routine practice.

Lessons learned on implementing PCOMs in clinical practice

The implementation model presented in Fig. 1 of the 2014 review and the updated MRC Framework show clear conceptual alignment, with both depicting implementation as an iterative, phased process shaped by organisational context, stakeholder engagement, and continuous refinement. Each highlights the importance of early preparation, coordinated planning, staff involvement, and mechanisms for feedback and adaptation. Although developed a decade apart, both frameworks recognise implementation as dynamic rather than linear, influenced by interactions across individual, team, and system levels.

Important differences, however, reflect the broader evolution of implementation science. The 2014 model is practice-oriented and tailored to the specific realities of introducing PROMs/PCOMs into palliative care, emphasising operational steps, behaviour change processes, and the practical barriers and facilitators encountered in clinical settings. In contrast, the updated MRC Framework provides a more comprehensive and theoretically grounded guide for developing, evaluating, and implementing any complex intervention. It extends beyond workflow considerations to include programme theory, feasibility, uncertainties, and economic dimensions. Thus, while the earlier model offers a pragmatic roadmap rooted in clinical experience, the MRC Framework provides a wider methodological structure aimed at ensuring rigour and scalability across diverse contexts.

Implementation models used when implementing PCOMs

One of our new objectives was to identify the implementation models used, which the MRC guidance considers a core element for each phase. “ Frameworks provide a base set of concepts , terms , and definitions by which to articulate dynamic complex contexts and develop much needed measures of context .” [ 146 , 147 , 148 ]. Clinical teams need to recognise the ongoing iterative nature of implementation, using theory to structure the main actions and changes that need to take place when implementing PCOMs. This aligns with newer work drawing on Normalisation Process Theory to understand how PCOMs are operationalised within home care teams and the factors influencing sustained use [ 142 ].

Implementation outcomes measured, and how, when implementing PCOMs

Although most included studies mention implementation outcomes, the majority only mention one or two out of the eight developed by Proctor et al. (acceptability, fidelity, feasibility, adoption, appropriateness, penetration, sustainability, and cost) [ 149 ]. Future studies need to take into consideration a greater number of implementation outcomes. Appendix 9 provides a quick overview for clinical teams regarding objectives three to seven’s results.

Financial costs of implementing PCOMs

Many healthcare systems focus more on organizational efficiency and cost containment than promoting person-centred care, ascribing value to “bureaucratic models” of task-based care [ 79 ]. However, “the rationale for implementing pain assessment systems in palliative care should be based on quality of care rather than reduction of visits” [ 82 ]. Stiel et al. (2012) [ 125 ] list eight outcome assessments related to the economy of the healthcare system in relation to palliative care: costs, length of stay, reasons for admission, quality of care, discharge disposition, number of admissions, funding of palliative care, and facility size. Clinicians and researchers could usefully consider include all of these to provide clearer and in-depth information on costs.

Updated recommendations for PCOMs implementation

The main clinical and research implications of our findings highlight the central importance of staff engagement and training staff in PCOM tools, communication strategies, and cultural competence. The literature suggests that there is better continuity and coordination of care, when PCOMs are used longitudinally, improving shared decision making by sharing PCOMs results between patients, families and clinical teams. Simple cross-sectional studies using one measure do not test sustainability or equity, since they do not allow for comparisons at patient, team or policy maker levels. Future research needs to focus on implementation outcomes because understanding how interventions perform in real-world settings is essential for their success, as is ensuring that innovations like PCOMs are effectively integrated and lead to meaningful improvements in patient care. Costs and longitudinal study approaches also need to be considered.

Finally, proxy-rated PCOMs remain essential in palliative care, particularly when patients are unable to self-report. While tools such as the IPOS have undergone robust validation in proxy-report formats, the development of novel proxy-specific methodologies remains limited, with recent research largely focused on validation rather than advancing implementation strategies.

Strengths and limitations

A major strength of this updated and expanded review is the addition of more objectives to those of our previous review, including examination of frameworks and models of implementation, which provide a base set of concepts, terms, and definitions. Another strength lies in its rigorous and transparent methodology, which was developed and reported in strict accordance with established international guidelines, enabling full replicability. A potential limitation of this study is the heterogeneity of the included studies. However, we feel it was appropriately addressed through the use of a rigorous narrative synthesis, which allowed for systematic comparison, contextual interpretation, and transparent reporting of patterns across diverse study designs and settings. h [ 10 , 134 – 142 ].

Conclusion

This updated systematic review synthesises contemporary evidence on the implementation of patient-centred outcome measures (PCOMs) in palliative care clinical practice. The findings confirm that the POS and ESAS families of measures remain the most commonly implemented PCOMs, while a wide range of other measures are used inconsistently across settings. Despite a substantial expansion of the evidence base since the previous review, the core facilitators and barriers to implementation remain largely unchanged. Successful implementation continues to depend on organisational support, staff engagement and training, and perceived clinical relevance, whereas time pressures, workload, and clinicians’ beliefs persist as key barriers. The integration of electronic PCOMs represents an important recent facilitator but also introduces new challenges related to workflow, data governance, and privacy.

Implementation of PCOMs is consistently characterised as a complex, iterative process. Although a growing number of studies draw on implementation models and frameworks, their application remains uneven and often implicit. Assessment of implementation outcomes is limited, with most studies focusing narrowly on feasibility and acceptability, and there is a complete absence of empirical evidence on the costs of implementation.

Future research should prioritise theory-informed, longitudinal implementation studies that systematically assess a broader range of implementation outcomes, incorporate robust economic evaluations, and examine sustainability, equity, and scale-up across diverse palliative care contexts. Addressing these gaps is essential to support the routine and sustainable use of PCOMs to improve patient- and family-centred palliative care.

Supplementary Information

Supplementary Material 1.

Supplementary Material 2.

Supplementary Material 3.

Supplementary Material 4.

Supplementary Material 5.

Supplementary Material 6.

Supplementary Material 7.

Supplementary Material 8.

Supplementary Material 9.

Abbreviations

British Nursing Index

Cumulative Index to Nursing and Allied Health Literature

Consolidated Framework for Implementation Research

Excerpta Medica dataBASE

Excerpta Medica database - Nursing and Allied Health

Edmonton Symptom Assessment Scale

Intensive Care Unit

Integrated Palliative Care Outcome Scale

Information Technology

Medical Literature Analysis and Retrieval System Online

Medical Research Council

Promoting Action on Research Implementation in Health Services Framework

patient-centred outcome measures

Plan-Do-Study-Act

The Palliative Care Outcome Scale

Preferred Reporting Items for Systematic Reviews and Meta-Analyses

Psychological Abstracts Information Services

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Acknowledgements

Not applicable.

Protocol registration:

CRD42023398653 (13/02/2023): https://www.crd.york.ac.uk/PROSPERO/view/CRD42023398653 .

Authors’ contributions

All authors contributed to the conception and design of the study. BA, SB, FS conducted most of the analysis. BA, SB, FS, SE and BB conducted most of the interpretation of data. All authors drafted the work and substantively revised it. All authors approved the submitted version. All authors have agreed both to be personally accountable for the author’s own contributions and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature.

Funding

Marie Curie (Grant reference MC-21-809). The funder is not involved in designing or conducting this study. FM is a UK National Institute for Health and Care Research (NIHR) Senior Investigator. The views expressed in this article are those of the author(s) and not necessarily those of the NIHR, or the Department of Health and Social Care.

Data availability

all data generated or analysed during this study are included in this published article [and its supplementary information files].

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

References

1. Antunes B Harding R Higginson IJ Implementing patient-reported outcome measures in palliative care clinical practice: a systematic review of facilitators and barriers Palliat Med 2014 28 158 75 10.1177/0269216313491619 23801463 Antunes B, Harding R, Higginson IJ. Implementing patient-reported outcome measures in palliative care clinical practice: a systematic review of facilitators and barriers. Palliat Med. 2014;28:158–75. 10.1177/0269216313491619. 2013/06/27. 23801463 10.1177/0269216313491619

2. Bausewein C Daveson BA Currow DC EAPC white paper on outcome measurement in palliative care: improving practice, attaining outcomes and delivering quality services - Recommendations from the European association for palliative care (EAPC) task force on outcome measurement Palliat Med 2016 30 6 22 10.1177/0269216315589898 26068193 Bausewein C, Daveson BA, Currow DC, et al. EAPC white paper on outcome measurement in palliative care: improving practice, attaining outcomes and delivering quality services - Recommendations from the European association for palliative care (EAPC) task force on outcome measurement. Palliat Med. 2016;30:6–22. 10.1177/0269216315589898. 2015/06/13. 26068193 10.1177/0269216315589898

3. de Wolf-Linder S Dawkins M Wicks F Which outcome domains are important in palliative care and when? An international expert consensus workshop, using the nominal group technique Palliat Med 2019 33 1058 68 10.1177/0269216319854154 31185812 PMC6691595 de Wolf-Linder S, Dawkins M, Wicks F, et al. Which outcome domains are important in palliative care and when? An international expert consensus workshop, using the nominal group technique. Palliat Med. 2019;33:1058–68. 10.1177/0269216319854154. 2019/06/13. 31185812 10.1177/0269216319854154 PMC6691595

4. Eagar K Watters P Currow DC The Australian palliative care outcomes collaboration (PCOC)- -measuring the quality and outcomes of palliative care on a routine basis Aust Health Rev 2010 34 186 92 10.1071/AH08718 20497731 Eagar K, Watters P, Currow DC, et al. The Australian palliative care outcomes collaboration (PCOC)--measuring the quality and outcomes of palliative care on a routine basis. Aust Health Rev. 2010;34:186–92. 2010/05/26. 20497731 10.1071/AH08718

5. Eagar K The Palliative Care Outcome Centre (PCOC) - a national benchmarking system 2014 The Royal College of Surgeons of England Eagar K. The Palliative Care Outcome Centre (PCOC) - a national benchmarking system. The Royal College of Surgeons of England; 2014.

6. Aworinde J Ellis-Smith C Gillam J How do person-centered outcome measures enable shared decision-making for people with dementia and family carers?-A systematic review Alzheimers Dement (N Y) 2022 8 e12304 10.1002/trc2.12304 35676942 PMC9169867 Aworinde J, Ellis-Smith C, Gillam J, et al. How do person-centered outcome measures enable shared decision-making for people with dementia and family carers?-A systematic review. Alzheimers Dement (N Y). 2022;8:e12304. 2022/06/10. 35676942 10.1002/trc2.12304 PMC9169867

7. Etkind SN Daveson BA Kwok W Capture, transfer, and feedback of patient-centered outcomes data in palliative care populations: does it make a difference? A systematic review J Pain Symptom Manage 2015 49 611 24 10.1016/j.jpainsymman.2014.07.010 25135657 Etkind SN, Daveson BA, Kwok W, et al. Capture, transfer, and feedback of patient-centered outcomes data in palliative care populations: does it make a difference? A systematic review. J Pain Symptom Manage. 2015;49:611–24. 2014/08/20. 25135657 10.1016/j.jpainsymman.2014.07.010

8. Evans JM Glazer A Lum R Implementing a Patient-Reported outcome measure for Hemodialysis patients in routine clinical care: perspectives of patients and providers on ESAS-r:Renal Clin J Am Soc Nephrol 2020 15 1299 309 10.2215/CJN.01840220 32843371 PMC7480546 Evans JM, Glazer A, Lum R, et al. Implementing a Patient-Reported outcome measure for Hemodialysis patients in routine clinical care: perspectives of patients and providers on ESAS-r:Renal. Clin J Am Soc Nephrol. 2020;15:1299–309. 2020/08/28. 32843371 10.2215/CJN.01840220 PMC7480546

9. Daveson BA Allingham SF Clapham S The PCOC symptom assessment scale (SAS): A valid measure for daily use at point of care and in palliative care programs PLoS ONE 2021 16 e0247250 10.1371/journal.pone.0247250 33765077 PMC7993777 Daveson BA, Allingham SF, Clapham S, et al. The PCOC symptom assessment scale (SAS): A valid measure for daily use at point of care and in palliative care programs. PLoS ONE. 2021;16:e0247250. 2021/03/26. 33765077 10.1371/journal.pone.0247250 PMC7993777

10. Davis EL Mullan J Johnson CE The experience of Australian aged care workers during a trial implementation of a palliative care outcomes programme Int J Health Plann Manage 2024 39 380 96 10.1002/hpm.3731 37943734 Davis EL, Mullan J, Johnson CE, et al. The experience of Australian aged care workers during a trial implementation of a palliative care outcomes programme. Int J Health Plann Manage. 2024;39:380–96. 2023/11/09. 37943734 10.1002/hpm.3731

11. Dudgeon D The impact of measuring Patient-Reported outcome measures on quality of and access to palliative care J Palliat Med 2018 21 S76 80 10.1089/jpm.2017.0447 29283866 PMC5733646 Dudgeon D. The impact of measuring Patient-Reported outcome measures on quality of and access to palliative care. J Palliat Med. 2018;21:S76–80. 2017/12/29. 29283866 10.1089/jpm.2017.0447 PMC5733646

12. Bradshaw A, Santarelli M, Khamis AM et al. Implementing person-centred outcome measures (PCOMs) into routine palliative care: A protocol for a mixed-methods process evaluation of The RESOLVE PCOM Implementation Strategy. BMJ Open 2021; 11: e051904. 2021/09/05. 10.1136/bmjopen-2021-051904 10.1136/bmjopen-2021-051904 PMC8420722 34479939

13. Pinto C Bristowe K Witt J Perspectives of patients, family caregivers and health professionals on the use of outcome measures in palliative care and lessons for implementation: a multi-method qualitative study Ann Palliat Med 2018 7 S137 50 10.21037/apm.2018.09.02 30339764 Pinto C, Bristowe K, Witt J, et al. Perspectives of patients, family caregivers and health professionals on the use of outcome measures in palliative care and lessons for implementation: a multi-method qualitative study. Ann Palliat Med. 2018;7:S137–50. 2018/10/20. 30339764 10.21037/apm.2018.09.02

14. Page MJ, McKenzie JE, Bossuyt PM et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj 2021; 372: n71. 2021/03/31. DOI: 10.1136/bmj.n71. 10.1136/bmj.n71 PMC8005924 33782057

15. Rethlefsen ML Kirtley S Waffenschmidt S PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews Syst Rev 2021 10 39 10.1186/s13643-020-01542-z 33499930 PMC7839230 Rethlefsen ML, Kirtley S, Waffenschmidt S, et al. PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews. Syst Rev. 2021;10:39. 2021/01/28. 33499930 10.1186/s13643-020-01542-z PMC7839230

16. Antunes B, Barclay S, Kuhn I, et al. Implementing patient-centred outcome measures in palliative care clinical practice for adults (IMPCOM): protocol for an update systematic review of facilitators and barriers. F1000Res. 2023;12(224). 10.12688/f1000research.131479.2. 2023/11/09. 10.12688/f1000research.131479.2 PMC10628357 37942019

17. Aali G, Shokraneh F. No limitations to language, date, publication type, and publication status in search step of systematic reviews. J Clin Epidemiol. 2021;133:165–7. 10.1016/j.jclinepi.2021.02.002. 10.1016/j.jclinepi.2021.02.002 33571633

18. Gough D. Weight of evidence: a framework for the appraisal of the quality and relevance of evidence. Furlong J, Oancea A, editors. Applied and Practice-based Research. Special Edition of Research Papers in Education. 2007; 22(2): 213–228.

19. Popay J, Roberts H, Sowden A et al. Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme version. 2006; 1(1): b92.

20. Skivington K, Matthews L, Simpson SA et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. Bmj. 2021; 374: n2061. 2021/10/02. 10.1136/bmj.n2061. 10.1136/bmj.n2061 PMC8482308 34593508

21. Appleyard SE Larkin MJW Stewart EM Digital medicine in men with advanced prostate Cancer - A feasibility study of electronic Patient-reported outcomes in patients on systemic treatment Clin Oncol (R Coll Radiol) 2021 33 751 60 10.1016/j.clon.2021.04.008 33966948 Appleyard SE, Larkin MJW, Stewart EM, et al. Digital medicine in men with advanced prostate Cancer - A feasibility study of electronic Patient-reported outcomes in patients on systemic treatment. Clin Oncol (R Coll Radiol). 2021;33:751–60. 2021/05/11. 33966948 10.1016/j.clon.2021.04.008

22. Bausewein C Schildmann E Rosenbruch J Starting from scratch: implementing outcome measurement in clinical practice Annals Palliat Med 2018 7 S253 61 10.21037/apm.2018.06.08 30180734 Bausewein C, Schildmann E, Rosenbruch J, et al. Starting from scratch: implementing outcome measurement in clinical practice. Annals Palliat Med. 2018;7:S253–61. 10.21037/apm.2018.06.08. 10.21037/apm.2018.06.08 30180734

23. Bausewein C Simon ST Benalia H Implementing patient reported outcome measures (PROMs) in palliative care–users’ cry for help Health Qual Life Outcomes 2011 9 27 10.1186/1477-7525-9-27 21507232 PMC3112059 Bausewein C, Simon ST, Benalia H, et al. Implementing patient reported outcome measures (PROMs) in palliative care–users’ cry for help. Health Qual Life Outcomes. 2011;9:27. 10.1186/1477-7525-9-27. 21507232 10.1186/1477-7525-9-27 PMC3112059

24. Beddard-Huber E Jayaraman J White L Evaluation of the utility of the Edmonton symptom assessment system (revised) scale on a tertiary palliative care unit J Palliat Care 2015 31 44 50 10.1177/082585971503100107 26399090 Beddard-Huber E, Jayaraman J, White L, et al. Evaluation of the utility of the Edmonton symptom assessment system (revised) scale on a tertiary palliative care unit. J Palliat Care. 2015;31:44–50. DOI: doi:. 26399090 10.1177/082585971503100107

25. Bennett AV Jensen RE Basch E Electronic patient-reported outcome systems in oncology clinical practice Cancer J Clin 2012 62 337 47 10.3322/caac.21150 22811342 Bennett AV, Jensen RE, Basch E. Electronic patient-reported outcome systems in oncology clinical practice. Cancer J Clin. 2012;62:337–47. 10.3322/caac.21150. 10.3322/caac.21150 22811342

26. Bookbinder M Coyle N Kiss M Implementing National standards for cancer pain management: program model and evaluation J Pain Symptom Manage 1996 12 334 47 10.1016/S0885-3924(96)00204-7 8973043 Bookbinder M, Coyle N, Kiss M, et al. Implementing National standards for cancer pain management: program model and evaluation. J Pain Symptom Manage. 1996;12:334–47. doi:. discussion 331–333. 8973043 10.1016/s0885-3924(96)00204-7

27. Bourbonnais FF Perreault A Bouvette M Introduction of a pain and symptom assessment tool in the clinical setting - - lessons learned J Nurs Manage (Wiley-Blackwell) 2004 12 194 200 10.1046/j.1365-2834.2003.00429.x 15089957 Bourbonnais FF, Perreault A, Bouvette M. Introduction of a pain and symptom assessment tool in the clinical setting -- lessons learned. J Nurs Manage (Wiley-Blackwell). 2004;12:194–200. 10.1046/j.1365-2834.2003.00429.x. 10.1046/j.1365-2834.2003.00429.x 15089957

28. Bouvette M, Fothergill-Bourbonnais F, Perreault A. Implementation of the pain and symptom assessment record (PSAR). J Adv Nurs. 2002;40:685–700. 10.1046/j.1365-2648.2002.02428.x. 10.1046/j.1365-2648.2002.02428.x 12473049

29. Bradshaw A Santarelli M Mulderrig M Implementing person-centred outcome measures in palliative care: an exploratory qualitative study using normalisation process theory to understand processes and context Palliat Med 2021 35 397 407 10.1177/0269216320972049 33249996 PMC7897789 Bradshaw A, Santarelli M, Mulderrig M, et al. Implementing person-centred outcome measures in palliative care: an exploratory qualitative study using normalisation process theory to understand processes and context. Palliat Med. 2021;35:397–407. 10.1177/0269216320972049. 33249996 10.1177/0269216320972049 PMC7897789

30. Bush RA Pérez A Baum T A systematic review of the use of the electronic health record for patient identification, communication, and clinical support in palliative care JAMIA Open 2018 1 294 303 10.1093/jamiaopen/ooy028 30842998 PMC6398614 Bush RA, Pérez A, Baum T, et al. A systematic review of the use of the electronic health record for patient identification, communication, and clinical support in palliative care. JAMIA Open. 2018;1:294–303. 2019/03/08. 30842998 10.1093/jamiaopen/ooy028 PMC6398614

31. Campbell GB Belcher SM Lee YJ Intensive daily symptom and function monitoring is feasible and acceptable to women undergoing First-Line chemotherapy for gynecologic cancer Cancer Nurs 2022 45 369 77 10.1097/NCC.0000000000001042 35025773 Campbell GB, Belcher SM, Lee YJ, et al. Intensive daily symptom and function monitoring is feasible and acceptable to women undergoing First-Line chemotherapy for gynecologic cancer. Cancer Nurs. 2022;45:369–77. 10.1097/NCC.0000000000001042. 35025773 10.1097/NCC.0000000000001042

32. Carli Buttenschoen D Stephan J Watanabe S Health care providers’ use and knowledge of the Edmonton symptom assessment system (ESAS): is there a need to improve information and training? Support Care Cancer 2014 22 201 8 10.1007/s00520-013-1955-8 24026980 Carli Buttenschoen D, Stephan J, Watanabe S, et al. Health care providers’ use and knowledge of the Edmonton symptom assessment system (ESAS): is there a need to improve information and training? Support Care Cancer. 2014;22:201–8. 10.1007/s00520-013-1955-8. 24026980 10.1007/s00520-013-1955-8

33. Coast J Bailey C Orlando R Adaptation, acceptance and adaptive preferences in health and capability Well-Being measurement amongst those approaching end of life Patient: Patient-Centered Outcomes Res 2018 11 539 46 10.1007/s40271-018-0310-z 29744765 Coast J, Bailey C, Orlando R, et al. Adaptation, acceptance and adaptive preferences in health and capability Well-Being measurement amongst those approaching end of life. Patient: Patient-Centered Outcomes Res. 2018;11:539–46. 10.1007/s40271-018-0310-z. 10.1007/s40271-018-0310-z 29744765

34. Collins ES Witt J Bausewein C A systematic review of the use of the palliative care outcome scale and the support team assessment schedule in palliative care J Pain Symptom Manage 2015 50 842 e853819 10.1016/j.jpainsymman.2015.07.015 26335764 Collins ES, Witt J, Bausewein C, et al. A systematic review of the use of the palliative care outcome scale and the support team assessment schedule in palliative care. J Pain Symptom Manage. 2015;50:842–e853819. 10.1016/j.jpainsymman.2015.07.015. 26335764 10.1016/j.jpainsymman.2015.07.015

35. Consolo L Castellini G Cilluffo S Electronic patient-reported outcomes (e-PROMs) in palliative cancer care: a scoping review J Patientreported Outcomes 2022 6 102 10.1186/s41687-022-00509-z PMC9500127 36138279 Consolo L, Castellini G, Cilluffo S, et al. Electronic patient-reported outcomes (e-PROMs) in palliative cancer care: a scoping review. J Patientreported Outcomes. 2022;6:102. 10.1186/s41687-022-00509-z. 10.1186/s41687-022-00509-z PMC9500127 36138279

36. Currow DC Allingham S Yates P Improving National hospice/palliative care service symptom outcomes systematically through point-of-care data collection, structured feedback and benchmarking Support Care Cancer 2015 23 307 15 10.1007/s00520-014-2351-8 25063272 PMC4289012 Currow DC, Allingham S, Yates P, et al. Improving National hospice/palliative care service symptom outcomes systematically through point-of-care data collection, structured feedback and benchmarking. Support Care Cancer. 2015;23:307–15. 10.1007/s00520-014-2351-8. 25063272 10.1007/s00520-014-2351-8 PMC4289012

37. Daveson BA Simon ST Benalia H Are we heading in the same direction? European and African doctors’ and nurses’ views and experiences regarding outcome measurement in palliative care Palliat Med 2012 26 242 9 10.1177/0269216311409614 21697267 Daveson BA, Simon ST, Benalia H, et al. Are we heading in the same direction? European and African doctors’ and nurses’ views and experiences regarding outcome measurement in palliative care. Palliat Med. 2012;26:242–9. 10.1177/0269216311409614. 21697267 10.1177/0269216311409614

38. Diffin J Ewing G Harvey G The influence of context and practitioner attitudes on implementation of Person-Centered assessment and support for family carers within palliative care Worldviews Evidence-Based Nurs 2018 15 377 85 10.1111/wvn.12323 30152150 Diffin J, Ewing G, Harvey G, et al. The influence of context and practitioner attitudes on implementation of Person-Centered assessment and support for family carers within palliative care. Worldviews Evidence-Based Nurs. 2018;15:377–85. 10.1111/wvn.12323. 10.1111/wvn.12323 30152150

39. Diplock BD McGarragle KMC Mueller WA The impact of automated screening with Edmonton symptom assessment system (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients Support Care Cancer 2019 27 209 18 10.1007/s00520-018-4304-0 29931490 Diplock BD, McGarragle KMC, Mueller WA, et al. The impact of automated screening with Edmonton symptom assessment system (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients. Support Care Cancer. 2019;27:209–18. 10.1007/s00520-018-4304-0. 29931490 10.1007/s00520-018-4304-0

40. Dobrina R Tenze M Palese A Transforming End-of-Life care by implementing a Patient-Centered care model: findings from an action research project J Hospice Palliat Nurs 2018 20 531 41 10.1097/NJH.0000000000000468 30260814 Dobrina R, Tenze M, Palese A. Transforming End-of-Life care by implementing a Patient-Centered care model: findings from an action research project. J Hospice Palliat Nurs. 2018;20:531–41. 10.1097/NJH.0000000000000468. 10.1097/NJH.0000000000000468 30260814

41. Donaldson MS. Taking stock of health-related quality-of-life measurement in oncology practice in the united States. JNCI Monogr 2004: 155–67. DOI: doi. 10.1093/jncimonographs/lgh017 15504926

42. Downing J Simon ST Mwangi-Powell FN Outcomes ‘out of africa’: the selection and implementation of outcome measures for palliative care in Africa BMC Palliat Care 2012 11 1 10.1186/1472-684X-11-1 22221932 PMC3280153 Downing J, Simon ST, Mwangi-Powell FN, et al. Outcomes ‘out of africa’: the selection and implementation of outcome measures for palliative care in Africa. BMC Palliat Care. 2012;11:1. 10.1186/1472-684X-11-1. 22221932 10.1186/1472-684X-11-1 PMC3280153

43. Dunckley M Aspinal F Addington-Hall JM A research study to identify facilitators and barriers to outcome measure implementation Int J Palliat Nurs 2005 11 218 25 10.12968/ijpn.2005.11.5.218 15944495 Dunckley M, Aspinal F, Addington-Hall JM, et al. A research study to identify facilitators and barriers to outcome measure implementation. Int J Palliat Nurs. 2005;11:218–25. 15944495 10.12968/ijpn.2005.11.5.218

44. Eijsink JFH, Fabian AM, Vervoort JPM et al. Value-based health care in Western countries: a scoping review on the implementation of patient-reported-outcomes sets for hospital-based interventions. Expert Rev PharmacoEcon Outcomes Res 2022: 1–13. DOI: 10.1080/14737167.2023.2136168 10.1080/14737167.2023.2136168 36300427

45. Ellis-Smith C Higginson IJ Daveson BA How can a measure improve assessment and management of symptoms and concerns for people with dementia in care homes? A mixed-methods feasibility and process evaluation of IPOS-Dem PLoS ONE [Electronic Resource] 2018 13 e0200240 10.1371/journal.pone.0200240 29995932 PMC6040756 Ellis-Smith C, Higginson IJ, Daveson BA, et al. How can a measure improve assessment and management of symptoms and concerns for people with dementia in care homes? A mixed-methods feasibility and process evaluation of IPOS-Dem. PLoS ONE [Electronic Resource]. 2018;13:e0200240. 10.1371/journal.pone.0200240. 29995932 10.1371/journal.pone.0200240 PMC6040756

46. Fabian A Domschikowski J Hoffmann M Patient-Reported outcomes assessing the impact of palliative radiotherapy on quality of life and symptom burden in head and neck cancer patients: A systematic review Front Oncol 2021 11 683042 10.3389/fonc.2021.683042 34150646 PMC8213366 Fabian A, Domschikowski J, Hoffmann M, et al. Patient-Reported outcomes assessing the impact of palliative radiotherapy on quality of life and symptom burden in head and neck cancer patients: A systematic review. Front Oncol. 2021;11:683042. 10.3389/fonc.2021.683042. 34150646 10.3389/fonc.2021.683042 PMC8213366

47. Fetz K Vogt H Ostermann T Evaluation of the palliative symptom burden score (PSBS) in a specialised palliative care unit of a university medical centre - a longitudinal study BMC Palliat Care 2018 17 92 10.1186/s12904-018-0342-0 29981577 PMC6035799 Fetz K, Vogt H, Ostermann T, et al. Evaluation of the palliative symptom burden score (PSBS) in a specialised palliative care unit of a university medical centre - a longitudinal study. BMC Palliat Care. 2018;17:92. 10.1186/s12904-018-0342-0. 29981577 10.1186/s12904-018-0342-0 PMC6035799

48. Friedman DR Patil V Li C Integration of Patient-Reported outcome measures in the electronic health record: the veterans affairs experience JCO Clin Cancer Inf 2022 6 e2100086 10.1200/CCI.21.00086 PMC8932492 35290072 Friedman DR, Patil V, Li C, et al. Integration of Patient-Reported outcome measures in the electronic health record: the veterans affairs experience. JCO Clin Cancer Inf. 2022;6:e2100086. 10.1200/CCI.21.00086. 10.1200/CCI.21.00086 PMC8932492 35290072

49. Friis RB Hjollund NH Pappot H Patient-Reported outcome measures used in routine care predict for survival at disease progression in patients with advanced lung cancer Clin Lung Cancer 2021 22 e169 79 10.1016/j.cllc.2020.09.014 33160899 Friis RB, Hjollund NH, Pappot H, et al. Patient-Reported outcome measures used in routine care predict for survival at disease progression in patients with advanced lung cancer. Clin Lung Cancer. 2021;22:e169–79. 10.1016/j.cllc.2020.09.014. 33160899 10.1016/j.cllc.2020.09.014

50. Gabbard J McLouth CJ Brenes G Rapid electronic capturing of Patient-Reported outcome measures in older adults with End-Stage renal disease: A feasibility study Am J Hospice Palliat Med 2021 38 432 40 10.1177/1049909120954805 PMC8216503 32935548 Gabbard J, McLouth CJ, Brenes G, et al. Rapid electronic capturing of Patient-Reported outcome measures in older adults with End-Stage renal disease: A feasibility study. Am J Hospice Palliat Med. 2021;38:432–40. 10.1177/1049909120954805. 10.1177/1049909120954805 PMC8216503 32935548

51. Garcia SF Wortman K Cella D Implementing electronic health record–integrated screening of patient‐reported symptoms and supportive care needs in a comprehensive cancer center Cancer 2019 125 4059 4068 10.1002/cncr.32172 31373682 PMC11345862 Garcia SF, Wortman K, Cella D, et al. Implementing electronic health record–integrated screening of patient‐reported symptoms and supportive care needs in a comprehensive cancer center. Cancer. 2019;125:4059–68. 10.1002/cncr.32172. 31373682 10.1002/cncr.32172 PMC11345862

52. Goyal UD Riegert K Davuluri R Prospective Study of Use of Edmonton Symptom Assessment Scale Versus Routine Symptom Management During Weekly Radiation Treatment Visits JCO Oncology Practice 2020 16 e1029 e1035 10.1200/JOP.19.00465 32384015 Goyal UD, Riegert K, Davuluri R, et al. Prospective Study of Use of Edmonton Symptom Assessment Scale Versus Routine Symptom Management During Weekly Radiation Treatment Visits. JCO Oncology Practice. 2020;16:e1029–35. 10.1200/JOP.19.00465. 32384015 10.1200/JOP.19.00465

53. Graf J Sickenberger N Brusniak K Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial J Med Internet Res 2022 24 e16128 10.2196/16128 35133288 PMC8864528 Graf J, Sickenberger N, Brusniak K, et al. Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial. J Med Internet Res. 2022;24:e16128. 10.2196/16128. 35133288 10.2196/16128 PMC8864528

54. Greenhalgh J Dalkin S Gooding K NIHR Journals Libr Health Serv Delivery Res 2017 1 01 10.3310/hsdr05020 Greenhalgh J, Dalkin S, Gooding K, et al. NIHR Journals Libr Health Serv Delivery Res. 2017;1:01. 10.3310/hsdr05020. 28121094

55. Gressel GM Dioun SM Richley M Utilizing the Patient Reported Outcomes Measurement Information System (PROMIS R) to increase referral to ancillary support services for severely symptomatic patients with gynecologic cancer Gynecol Oncol 2019 152 509 513 10.1016/j.ygyno.2018.10.042 30876496 Gressel GM, Dioun SM, Richley M, et al. Utilizing the Patient Reported Outcomes Measurement Information System (PROMIS R) to increase referral to ancillary support services for severely symptomatic patients with gynecologic cancer. Gynecol Oncol. 2019;152:509–13. 10.1016/j.ygyno.2018.10.042. 30876496 10.1016/j.ygyno.2018.10.042

56. Guo P Gao W Higginson IJ Implementing Outcome Measures in Palliative Care J Palliat Med 2018 21 414 10.1089/jpm.2017.0674 29596041 Guo P, Gao W, Higginson IJ, et al. Implementing Outcome Measures in Palliative Care. J Palliat Med. 2018;21:414. 10.1089/jpm.2017.0674. 29596041 10.1089/jpm.2017.0674

57. Hall A Ewing G Rowland C A drive for structure: A longitudinal qualitative study of the implementation of the Carer Support Needs Assessment Tool (CSNAT) intervention during hospital discharge at end of life Palliat Med 2020 34 1088 1096 10.1177/0269216320930935 32491967 PMC7388143 Hall A, Ewing G, Rowland C, et al. A drive for structure: A longitudinal qualitative study of the implementation of the Carer Support Needs Assessment Tool (CSNAT) intervention during hospital discharge at end of life. Palliat Med. 2020;34:1088–96. 10.1177/0269216320930935. 32491967 10.1177/0269216320930935 PMC7388143

58. Harding R Dinat N Sebuyira LM Measuring and improving palliative care in South Africa: multiprofessional clinical perspectives on development and application of appropriate outcome tools Prog Palliat Care 2007 15 55 9 10.1179/096992607X177845 Harding R, Dinat N, Sebuyira LM. Measuring and improving palliative care in South Africa: multiprofessional clinical perspectives on development and application of appropriate outcome tools. Prog Palliat Care. 2007;15:55–9. 10.1179/096992607X177845.

59. Harding R Simon ST Benalia H The PRISMA symposium 1: outcome tool use. Disharmony in European outcomes research for palliative and advanced disease care: too many tools in practice J Pain Symptom Manage 2011 42 493 500 10.1016/j.jpainsymman.2011.06.008 21963118 Harding R, Simon ST, Benalia H, et al. The PRISMA symposium 1: outcome tool use. Disharmony in European outcomes research for palliative and advanced disease care: too many tools in practice. J Pain Symptom Manage. 2011;42:493–500. 10.1016/j.jpainsymman.2011.06.008. 21963118 10.1016/j.jpainsymman.2011.06.008

60. Hardy JR Edmonds P Turner R The use of the Rotterdam symptom checklist in palliative care J Pain Symptom Manage 1999 18 79 84 10.1016/S0885-3924(99)00050-0 10484854 Hardy JR, Edmonds P, Turner R, et al. The use of the Rotterdam symptom checklist in palliative care. J Pain Symptom Manage. 1999;18:79–84. 10484854 10.1016/s0885-3924(99)00050-0

61. Hawley P Barwich D Kirk L Implementation of the Victoria bowel performance scale J Pain Symptom Manage 2011 42 946 53 10.1016/j.jpainsymman.2011.02.021 21620645 Hawley P, Barwich D, Kirk L. Implementation of the Victoria bowel performance scale. J Pain Symptom Manage. 2011;42:946–53. 10.1016/j.jpainsymman.2011.02.021. 21620645 10.1016/j.jpainsymman.2011.02.021

62. Hill N Use of quality-of-life scores in care planning in a hospice setting: the theme of revelation Int J Palliat Nurs 2002 8 591 3 10.12968/ijpn.2002.8.12.10976 12560801 Hill N. Use of quality-of-life scores in care planning in a hospice setting: the theme of revelation. Int J Palliat Nurs. 2002;8:591–3. 12560801 10.12968/ijpn.2002.8.12.10976

63. Hogberg C Alvariza A Beck I Patients' experiences of using the integrated palliative care outcome scale for a person-centered care: a qualitative study in the specialized palliative home-care context Nurs Inq 2019 26 e12297 10.1111/nin.12297 31132806 Hogberg C, Alvariza A, Beck I. Patients’ experiences of using the integrated palliative care outcome scale for a person-centered care: a qualitative study in the specialized palliative home-care context. Nurs Inq. 2019;26:e12297. 10.1111/nin.12297. 31132806 10.1111/nin.12297

64. Howell D Li M Sutradhar R Integration of patient-reported outcomes (PROs) for personalized symptom management in "real-world" oncology practices: a population-based cohort comparison study of impact on healthcare utilization Support Care Cancer 2020 28 4933 4942 10.1007/s00520-020-05313-3 32020357 Howell D, Li M, Sutradhar R, et al. Integration of patient-reported outcomes (PROs) for personalized symptom management in “real-world” oncology practices: a population-based cohort comparison study of impact on healthcare utilization. Support Care Cancer. 2020;28:4933–42. 10.1007/s00520-020-05313-3. 32020357 10.1007/s00520-020-05313-3

65. Hughes R Aspinal F Addington-Hall J Professionals' views and experiences of using outcome measures in palliative care Int J Palliat Nurs 2003 9 234 238 10.12968/ijpn.2003.9.6.11511 12897694 Hughes R, Aspinal F, Addington-Hall J, et al. Professionals’ views and experiences of using outcome measures in palliative care. Int J Palliat Nurs. 2003;9:234–8. 12897694 10.12968/ijpn.2003.9.6.11511

66. Hughes RA Sinha A Aspinal F What is the potential for the use of clinical outcome measures to be computerised? Findings from a qualitative research study Int J Health Care Qual Assur Inc Leadersh Health Serv 2004 17 47 52 10.1108/09526860410515936 15046473 Hughes RA, Sinha A, Aspinal F, et al. What is the potential for the use of clinical outcome measures to be computerised? Findings from a qualitative research study. Int J Health Care Qual Assur Inc Leadersh Health Serv. 2004;17:47–52. 15046473 10.1108/09526860410515936

67. Hui D Bruera E The Edmonton symptom assessment system 25 years later: past, present, and future developments J Pain Symptom Manage 2017 53 630 43 10.1016/j.jpainsymman.2016.10.370 28042071 PMC5337174 Hui D, Bruera E. The Edmonton symptom assessment system 25 years later: past, present, and future developments. J Pain Symptom Manage. 2017;53:630–43. 10.1016/j.jpainsymman.2016.10.370. 28042071 10.1016/j.jpainsymman.2016.10.370 PMC5337174

68. Hui D Titus A Curtis T Implementation of the Edmonton symptom assessment system for symptom distress screening at a community cancer center: a pilot program Oncologist 2017 22 995 1001 10.1634/theoncologist.2016-0500 28476945 PMC5553963 Hui D, Titus A, Curtis T, et al. Implementation of the Edmonton symptom assessment system for symptom distress screening at a community cancer center: a pilot program. Oncologist. 2017;22:995–1001. 10.1634/theoncologist.2016-0500. 28476945 10.1634/theoncologist.2016-0500 PMC5553963

69. Ihler EM, Sæteren B. Registered nurses’ experiences of using ESAS to map cancer patients’ symptoms. Nor J Clin Nurs / Sykepleien Forskning 2020: 1–16. DOI: 10.4220/Sykepleienf.2019.79585

70. Lee JR Liaw K Chin SM Improving breakthrough pain assessment in a residential hospice Singap Nurs J 2016 43 11 5 Lee JR, Liaw K, Chin SM, et al. Improving breakthrough pain assessment in a residential hospice. Singap Nurs J. 2016;43:11–5. DOI: doi:.

71. Jordhoy MS Inger Ringdal G Helbostad JL Assessing physical functioning: a systematic review of quality of life measures developed for use in palliative care Palliat Med 2007 21 673 82 10.1177/0269216307083386 18073253 Jordhoy MS, Inger Ringdal G, Helbostad JL, et al. Assessing physical functioning: a systematic review of quality of life measures developed for use in palliative care. Palliat Med. 2007;21:673–82. 18073253 10.1177/0269216307083386

72. Kamal AH Bull J Ritchie CS Adherence to measuring what matters measures using Point-of-Care data collection across diverse clinical settings J Pain Symptom Manage 2016 51 497 503 10.1016/j.jpainsymman.2015.12.313 26854995 Kamal AH, Bull J, Ritchie CS, et al. Adherence to measuring what matters measures using Point-of-Care data collection across diverse clinical settings. J Pain Symptom Manage. 2016;51:497–503. 10.1016/j.jpainsymman.2015.12.313. 26854995 10.1016/j.jpainsymman.2015.12.313

73. Kane PM Daveson BA Ryan K Feasibility and acceptability of a patient-reported outcome intervention in chronic heart failure BMJ Support Palliat Care 2017 7 470 9 10.1136/bmjspcare-2017-001355 28864449 Kane PM, Daveson BA, Ryan K, et al. Feasibility and acceptability of a patient-reported outcome intervention in chronic heart failure. BMJ Support Palliat Care. 2017;7:470–9. 2017/09/03. 28864449 10.1136/bmjspcare-2017-001355

74. Kane PM Ellis-Smith CI Daveson BA Understanding how a palliative-specific patient-reported outcome intervention works to facilitate patient-centred care in advanced heart failure: A qualitative study Palliat Med 2018 32 143 55 10.1177/0269216317738161 29154724 Kane PM, Ellis-Smith CI, Daveson BA, et al. Understanding how a palliative-specific patient-reported outcome intervention works to facilitate patient-centred care in advanced heart failure: A qualitative study. Palliat Med. 2018;32:143–55. 10.1177/0269216317738161. 29154724 10.1177/0269216317738161

75. Karamanidou C Natsiavas P Koumakis L Electronic Patient-Reported Outcome-Based interventions for palliative cancer care: A systematic and mapping review JCO Clin Cancer Inf 2020 4 647 56 10.1200/CCI.20.00015 PMC7397776 32697604 Karamanidou C, Natsiavas P, Koumakis L, et al. Electronic Patient-Reported Outcome-Based interventions for palliative cancer care: A systematic and mapping review. JCO Clin Cancer Inf. 2020;4:647–56. 10.1200/CCI.20.00015. 10.1200/CCI.20.00015 PMC7397776 32697604

76. Kilonzo I Lucey M Twomey F Implementing outcome measures within an enhanced palliative care day care model J Pain Symptom Manage 2015 50 419 23 10.1016/j.jpainsymman.2015.04.006 25912276 Kilonzo I, Lucey M, Twomey F. Implementing outcome measures within an enhanced palliative care day care model. J Pain Symptom Manage. 2015;50:419–23. 10.1016/j.jpainsymman.2015.04.006. 25912276 10.1016/j.jpainsymman.2015.04.006

77. Kotronoulas G O’Brien F Simpson MF Feasibility and acceptability of the use of Patient-Reported outcome measures in the delivery of Nurse-Led, supportive care to women with cervical cancer Clin Nurse Specialist: J Adv Nurs Pract 2017 31 E1 10 10.1097/NUR.0000000000000306 28594675 Kotronoulas G, O’Brien F, Simpson MF, et al. Feasibility and acceptability of the use of Patient-Reported outcome measures in the delivery of Nurse-Led, supportive care to women with cervical cancer. Clin Nurse Specialist: J Adv Nurs Pract. 2017;31:E1–10. 10.1097/NUR.0000000000000306. 10.1097/NUR.0000000000000306 28594675

78. Krawczyk M Sawatzky R Relational use of an electronic quality of life and practice support system in hospital palliative consult care: A pilot study Palliat Support Care 2019 17 208 13 10.1017/S1478951518000020 29516852 Krawczyk M, Sawatzky R. Relational use of an electronic quality of life and practice support system in hospital palliative consult care: A pilot study. Palliat Support Care. 2019;17:208–13. 10.1017/S1478951518000020. 29516852 10.1017/S1478951518000020

79. Krawczyk M Sawatzky R Schick-Makaroff K Micro-Meso-Macro practice tensions in using Patient-Reported outcome and experience measures in hospital palliative care Qual Health Res 2019 29 510 21 10.1177/1049732318761366 29542400 Krawczyk M, Sawatzky R, Schick-Makaroff K, et al. Micro-Meso-Macro practice tensions in using Patient-Reported outcome and experience measures in hospital palliative care. Qual Health Res. 2019;29:510–21. 10.1177/1049732318761366. 29542400 10.1177/1049732318761366

80. Krulewitch H London MR Skakel VJ Assessment of pain in cognitively impaired older adults: a comparison of pain assessment tools and their use by nonprofessional caregivers J Am Geriatr Soc 2000 48 1607 11 10.1111/j.1532-5415.2000.tb03871.x 11129750 Krulewitch H, London MR, Skakel VJ, et al. Assessment of pain in cognitively impaired older adults: a comparison of pain assessment tools and their use by nonprofessional caregivers. J Am Geriatr Soc. 2000;48:1607–11. 11129750 10.1111/j.1532-5415.2000.tb03871.x

81. Krumm N Larkin P Connolly M Improving dementia care in nursing homes: experiences with a palliative care symptom-assessment tool (MIDOS) Int J Palliat Nurs 2014 20 187 92 10.12968/ijpn.2014.20.4.187 24763327 Krumm N, Larkin P, Connolly M, et al. Improving dementia care in nursing homes: experiences with a palliative care symptom-assessment tool (MIDOS). Int J Palliat Nurs. 2014;20:187–92. DOI: doi:. 24763327 10.12968/ijpn.2014.20.4.187

82. Lind L Karlsson D A system for symptom assessment in advanced palliative home healthcare using digital pens Med Inf Internet Med 2004 29 199 210 10.1080/14639230400005966 15742987 Lind L, Karlsson D. A system for symptom assessment in advanced palliative home healthcare using digital pens. Med Inf Internet Med. 2004;29:199–210. 10.1080/14639230400005966 15742987

83. Lind L Karlsson D Fridlund B Patients’ use of digital pens for pain assessment in advanced palliative home healthcare Int J Med Informatics 2008 77 129 36 10.1016/j.ijmedinf.2007.01.013 17363323 Lind L, Karlsson D, Fridlund B. Patients’ use of digital pens for pain assessment in advanced palliative home healthcare. Int J Med Informatics. 2008;77:129–36. 10.1016/j.ijmedinf.2007.01.013 17363323

84. Lind S Implementation of knowledge-based palliative care in acute care settings: Obstacles, opportunities and experiences 2022 ProQuest Information & Learning Lind S. Implementation of knowledge-based palliative care in acute care settings: Obstacles, opportunities and experiences. ProQuest Information & Learning; 2022.

85. Lind S Sandberg J Brytting T Implementation of the integrated palliative care outcome scale in acute care settings - a feasibility study Palliat Support Care 2018 16 698 705 10.1017/S1478951517001158 29352836 Lind S, Sandberg J, Brytting T, et al. Implementation of the integrated palliative care outcome scale in acute care settings - a feasibility study. Palliat Support Care. 2018;16:698–705. 2018/01/22. 29352836 10.1017/S1478951517001158

86. Lind S Wallin L Furst CJ The integrated palliative care outcome scale for patients with palliative care needs: factors related to and experiences of the use in acute care settings Palliat Support Care 2019 17 561 8 10.1017/S1478951518001104 30841947 Lind S, Wallin L, Furst CJ, et al. The integrated palliative care outcome scale for patients with palliative care needs: factors related to and experiences of the use in acute care settings. Palliat Support Care. 2019;17:561–8. 10.1017/S1478951518001104. 30841947 10.1017/S1478951518001104

87. Mahmoudi R Moitie T Dorent R Implementation of patient-reported outcome measures in a heart transplant recipient registry: first step toward a patient-centered approach Clin Transplant 2022 36 e14708 10.1111/ctr.14708 35644026 Mahmoudi R, Moitie T, Dorent R, et al. Implementation of patient-reported outcome measures in a heart transplant recipient registry: first step toward a patient-centered approach. Clin Transplant. 2022;36:e14708. 10.1111/ctr.14708. 35644026 10.1111/ctr.14708

88. Mai SS Gerlach C Schmidtmann I Are repeated Self-Reports of psychological variables feasible for patients near the end of life at a palliative care unit? J Palliat Med 2018 21 1005 10 10.1089/jpm.2017.0537 29437545 Mai SS, Gerlach C, Schmidtmann I, et al. Are repeated Self-Reports of psychological variables feasible for patients near the end of life at a palliative care unit? J Palliat Med. 2018;21:1005–10. 10.1089/jpm.2017.0537. 29437545 10.1089/jpm.2017.0537

89. Martins Pereira S Hernandez-Marrero P Ethical challenges of outcome measurement in palliative care clinical practice: a systematic review of systematic reviews Annals Palliat Med 2018 7 S207 18 10.21037/apm.2018.06.05 30180733 Martins Pereira S, Hernandez-Marrero P. Ethical challenges of outcome measurement in palliative care clinical practice: a systematic review of systematic reviews. Annals Palliat Med. 2018;7:S207–18. 10.21037/apm.2018.06.05. 10.21037/apm.2018.06.05 30180733

90. Mayahara M Wilbur J Fogg L Feasibility of e-Pain reporter: A digital pain management tool for informal caregivers in home hospice J Hospice Palliat Nurs 2019 21 193 9 10.1097/NJH.0000000000000548 31045994 Mayahara M, Wilbur J, Fogg L, et al. Feasibility of e-Pain reporter: A digital pain management tool for informal caregivers in home hospice. J Hospice Palliat Nurs. 2019;21:193–9. 10.1097/NJH.0000000000000548. 10.1097/NJH.0000000000000548 31045994

91. Mills ME Murray LJ Johnston BT Feasibility of a standardised quality of life questionnaire in a weekly diary format for inoperable lung cancer patients Eur J Oncol Nurs 2008 12 457 63 10.1016/j.ejon.2008.06.003 18842455 Mills ME, Murray LJ, Johnston BT, et al. Feasibility of a standardised quality of life questionnaire in a weekly diary format for inoperable lung cancer patients. Eur J Oncol Nurs. 2008;12:457–63. 10.1016/j.ejon.2008.06.003. 18842455 10.1016/j.ejon.2008.06.003

92. Muir JCMDFHMDC Davis MSMSNMBA Fine PGMD A systematic assessment and monitoring intervention to improve pain management and quality reporting among home hospice patients J Pain Symptom Manag 2018 56 957 10.1016/j.jpainsymman.2018.08.014 30165124 Muir JCMDFHMDC, Davis MSMSNMBA, Fine PGMD, et al. A systematic assessment and monitoring intervention to improve pain management and quality reporting among home hospice patients. J Pain Symptom Manag. 2018;56:957. 10.1016/j.jpainsymman.2018.08.014. 10.1016/j.jpainsymman.2018.08.014 30165124

93. Nair D Wilson FP Patient-Reported outcome measures for adults with kidney disease: current measures, ongoing Initiatives, and future opportunities for incorporation into Patient-Centered kidney care Am J Kidney Dis 2019 74 791 802 10.1053/j.ajkd.2019.05.025 31492487 PMC6875620 Nair D, Wilson FP. Patient-Reported outcome measures for adults with kidney disease: current measures, ongoing Initiatives, and future opportunities for incorporation into Patient-Centered kidney care. Am J Kidney Dis. 2019;74:791–802. 10.1053/j.ajkd.2019.05.025. 31492487 10.1053/j.ajkd.2019.05.025 PMC6875620

94. O’Reilly M Larkin P Conroy M The impact of a novel tool for comprehensive assessment of palliative care (MPCAT) on assessment outcome at 6- and 12-Month Follow-Up J Pain Symptom Manage 2016 52 107 16 10.1016/j.jpainsymman.2015.12.343 27233135 O’Reilly M, Larkin P, Conroy M, et al. The impact of a novel tool for comprehensive assessment of palliative care (MPCAT) on assessment outcome at 6- and 12-Month Follow-Up. J Pain Symptom Manage. 2016;52:107–16. 10.1016/j.jpainsymman.2015.12.343. 27233135 10.1016/j.jpainsymman.2015.12.343

95. Oldenburger E Oldenburger F Coolbrandt A The use of patient reported outcome measures (PROMs) in palliative radiotherapy: A topical review Radiotherapy Oncol 2020 149 94 103 10.1016/j.radonc.2020.04.045 32360828 Oldenburger E, Oldenburger F, Coolbrandt A, et al. The use of patient reported outcome measures (PROMs) in palliative radiotherapy: A topical review. Radiotherapy Oncol. 2020;149:94–103. 10.1016/j.radonc.2020.04.045. 10.1016/j.radonc.2020.04.045 32360828

96. Parker D Hodgkinson B A comparison of palliative care outcome measures used to assess the quality of palliative care provided in residential aged care facilities: a systematic review JBI Libr Syst Reviewis 2010 8 90 120 10.11124/01938924-201008030-00001 27820164 Parker D, Hodgkinson B. A comparison of palliative care outcome measures used to assess the quality of palliative care provided in residential aged care facilities: a systematic review. JBI Libr Syst Reviewis. 2010;8:90–120. 10.11124/01938924-201008030-00001 27820164

97. Parker D Hodgkinson B A comparison of palliative care outcome measures used to assess the quality of palliative care provided in long-term care facilities: a systematic review Palliat Med 2011 25 5 20 10.1177/0269216310378786 20817748 Parker D, Hodgkinson B. A comparison of palliative care outcome measures used to assess the quality of palliative care provided in long-term care facilities: a systematic review. Palliat Med. 2011;25:5–20. 10.1177/0269216310378786. 20817748 10.1177/0269216310378786

98. Patel M. Piloting a self-reported symptom assessment tool in three outpatient oncology palliative care clinics. ProQuest Information & Learning. 2021;

99. Patel M Bryant AL Mayer DK Using the PDSA framework to improve rates of clinical tool use in outpatient oncology palliative care clinics Clin J Oncol Nurs 2022 26 483 6 10.1188/22.CJON.483-486 36108216 Patel M, Bryant AL, Mayer DK, et al. Using the PDSA framework to improve rates of clinical tool use in outpatient oncology palliative care clinics. Clin J Oncol Nurs. 2022;26:483–6. 10.1188/22.CJON.483-486. 36108216 10.1188/22.CJON.483-486

100. Pearson EJ Todd JG Futcher JM How can occupational therapists measure outcomes in palliative care? Palliat Med 2007 21 477 85 10.1177/0269216307081941 17846087 Pearson EJ, Todd JG, Futcher JM. How can occupational therapists measure outcomes in palliative care? Palliat Med. 2007;21:477–85. 17846087 10.1177/0269216307081941

101. Pezold LA Implementation of the Integrated Palliative Outcome Scale (IPOS) into palliative care practice 2020 ProQuest Information & Learning Pezold LA. Implementation of the Integrated Palliative Outcome Scale (IPOS) into palliative care practice. ProQuest Information & Learning; 2020.

102. Potts MP Cartmell KBPMPH Nemeth LPRNF A systematic review of palliative care intervention outcomes and outcome measures in Low-Resource countries J Pain Symptom Manag 2018 55 1382 10.1016/j.jpainsymman.2017.12.487 29305322 Potts MP, Cartmell KBPMPH, Nemeth LPRNF, et al. A systematic review of palliative care intervention outcomes and outcome measures in Low-Resource countries. J Pain Symptom Manag. 2018;55:1382. 10.1016/j.jpainsymman.2017.12.487 29305322

103. Radionova N Becker G Mayer-Steinacker R The views of physicians and nurses on the potentials of an electronic assessment system for recognizing the needs of patients in palliative care BMC Palliat Care 2020 19 45 10.1186/s12904-020-00554-9 32247316 PMC7129326 Radionova N, Becker G, Mayer-Steinacker R, et al. The views of physicians and nurses on the potentials of an electronic assessment system for recognizing the needs of patients in palliative care. BMC Palliat Care. 2020;19:45. 10.1186/s12904-020-00554-9. 32247316 10.1186/s12904-020-00554-9 PMC7129326

104. Rauenzahn SL Schmidt S Aduba IO Integrating palliative care services in ambulatory oncology: an application of the Edmonton symptom assessment system J Oncol practice/American Soc Clin Oncol 2017 13 e401 7 10.1200/JOP.2016.019372 PMC5455154 28301279 Rauenzahn SL, Schmidt S, Aduba IO, et al. Integrating palliative care services in ambulatory oncology: an application of the Edmonton symptom assessment system. J Oncol practice/American Soc Clin Oncol. 2017;13:e401–7. 10.1200/JOP.2016.019372. 10.1200/JOP.2016.019372 PMC5455154 28301279

105. Rawlings D Hendry K Mylne S Using palliative care assessment tools to influence and enhance clinical practice Home Healthc Nurse 2011 29 139 45 10.1097/NHH.0b013e31820ba808 21368625 Rawlings D, Hendry K, Mylne S, et al. Using palliative care assessment tools to influence and enhance clinical practice. Home Healthc Nurse. 2011;29:139–45. 10.1097/NHH.0b013e31820ba808. quiz 146 – 137. 21368625 10.1097/NHH.0b013e31820ba808

106. Reynolds S Bannigan K Promoting the use of outcome measures across disciplines through action research with practitioners in a palliative care setting Int J Therapy Rehabilitation 2019 26 1 16 10.12968/ijtr.2017.0104 Reynolds S, Bannigan K. Promoting the use of outcome measures across disciplines through action research with practitioners in a palliative care setting. Int J Therapy Rehabilitation. 2019;26:1–16. 10.12968/ijtr.2017.0104.

107. Ruder S 7 tools to assist hospice and home care clinicians in pain management at end of life Home Healthc Nurse 2010 28 458 68 10.1097/NHH.0b013e3181ed7504 20811180 Ruder S. 7 tools to assist hospice and home care clinicians in pain management at end of life. Home Healthc Nurse. 2010;28:458–68. 10.1097/NHH.0b013e3181ed7504. quiz 469–470. 20811180 10.1097/NHH.0b013e3181ed7504

108. Rugno FC Carlo MM The palliative outcome scale (POS) applied to clinical practice and research: an integrative review Rev Latinoam Enferm 2016 24 e2764 10.1590/1518-8345.0993.2764 PMC4996092 27533273 Rugno FC, Carlo MM. The palliative outcome scale (POS) applied to clinical practice and research: an integrative review. Rev Latinoam Enferm. 2016;24:e2764. 10.1590/1518-8345.0993.2764. 10.1590/1518-8345.0993.2764 PMC4996092 27533273

109. Sandham MH Hedgecock E Hocaoglu M Strengthening community End-of-Life care through implementing Measurement-Based palliative care Int J Environ Res Public Health [Electronic Resource] 2022 19 24 10.3390/ijerph19137747 PMC9265763 35805407 Sandham MH, Hedgecock E, Hocaoglu M, et al. Strengthening community End-of-Life care through implementing Measurement-Based palliative care. Int J Environ Res Public Health [Electronic Resource]. 2022;19:24. 10.3390/ijerph19137747. 10.3390/ijerph19137747 PMC9265763 35805407

110. Sawatzky R Laforest E Schick-Makaroff K Design and introduction of a quality of life assessment and practice support system: perspectives from palliative care settings J Patientreported Outcomes 2017 2 36 10.1186/s41687-018-0065-2 PMC6104521 30175318 Sawatzky R, Laforest E, Schick-Makaroff K, et al. Design and introduction of a quality of life assessment and practice support system: perspectives from palliative care settings. J Patientreported Outcomes. 2017;2:36. 10.1186/s41687-018-0065-2. 10.1186/s41687-018-0065-2 PMC6104521 30175318

111. Schick-Makaroff K Sawatzky R Team QR Divergent perspectives on the use of the Edmonton symptom assessment system (Revised) in palliative care J Hospice Palliat Nurs 2020 22 75 81 10.1097/NJH.0000000000000617 31842176 Schick-Makaroff K, Sawatzky R, Team QR. Divergent perspectives on the use of the Edmonton symptom assessment system (Revised) in palliative care. J Hospice Palliat Nurs. 2020;22:75–81. 10.1097/NJH.0000000000000617. 10.1097/NJH.0000000000000617 31842176

112. Schlichter E Lopez O Scott R Feasibility of Nurse-Led multidimensional outcome assessments in the neuroscience intensive care unit Crit Care Nurse 2020 40 e1 8 10.4037/ccn2020681 32476030 Schlichter E, Lopez O, Scott R, et al. Feasibility of Nurse-Led multidimensional outcome assessments in the neuroscience intensive care unit. Crit Care Nurse. 2020;40:e1–8. 10.4037/ccn2020681. 32476030 10.4037/ccn2020681

113. Schuler T Back M Hruby G Introducing computed tomography Simulation-Free and electronic Patient-Reported outcomes-Monitored palliative radiation therapy into routine care: clinical outcomes and implementation experience Adv Radiation Oncol 2021 6 100632 10.1016/j.adro.2020.100632 PMC8039552 33851063 Schuler T, Back M, Hruby G, et al. Introducing computed tomography Simulation-Free and electronic Patient-Reported outcomes-Monitored palliative radiation therapy into routine care: clinical outcomes and implementation experience. Adv Radiation Oncol. 2021;6:100632. 10.1016/j.adro.2020.100632. 10.1016/j.adro.2020.100632 PMC8039552 33851063

114. Schulman-Green D Bradley EH Pace KB Testing a standardized symptom assessment tool: experiences from the NAHC QAPI collaborative Caring 2008 27 14 8 19068871 Schulman-Green D, Bradley EH, Pace KB, et al. Testing a standardized symptom assessment tool: experiences from the NAHC QAPI collaborative. Caring. 2008;27:14–8. DOI: doi:. 19068871

115. Schulman-Green D Cherlin EJ McCorkle R Benefits and challenges in use of a standardized symptom assessment instrument in hospice J Palliat Med 2010 13 155 9 10.1089/jpm.2009.0245 19827961 PMC2883490 Schulman-Green D, Cherlin EJ, McCorkle R, et al. Benefits and challenges in use of a standardized symptom assessment instrument in hospice. J Palliat Med. 2010;13:155–9. 10.1089/jpm.2009.0245. 19827961 10.1089/jpm.2009.0245 PMC2883490

116. Schwartz CE Merriman MP Reed G Evaluation of the Missoula-VITAS quality of life Index–revised: research tool or clinical tool? J Palliat Med 2005 8 121 35 10.1089/jpm.2005.8.121 15662181 Schwartz CE, Merriman MP, Reed G, et al. Evaluation of the Missoula-VITAS quality of life Index–revised: research tool or clinical tool? J Palliat Med. 2005;8:121–35. 15662181 10.1089/jpm.2005.8.121

117. Seipp H Haasenritter J Hach M Integrating patient- and caregiver-reported outcome measures into the daily care routines of specialised outpatient palliative care: a qualitative study (ELSAH) on feasibility, acceptability and appropriateness BMC Palliat Care 2022 21 60 10.1186/s12904-022-00944-1 35501844 PMC9063228 Seipp H, Haasenritter J, Hach M, et al. Integrating patient- and caregiver-reported outcome measures into the daily care routines of specialised outpatient palliative care: a qualitative study (ELSAH) on feasibility, acceptability and appropriateness. BMC Palliat Care. 2022;21:60. 2022/05/04. 35501844 10.1186/s12904-022-00944-1 PMC9063228

118. Slater A Freeman E Patients’ views of using an outcome measure in palliative day care: a focus group study Int J Palliat Nurs 2004 10 343 51 10.12968/ijpn.2004.10.7.14576 15365487 Slater A, Freeman E. Patients’ views of using an outcome measure in palliative day care: a focus group study. Int J Palliat Nurs. 2004;10:343–51. 15365487 10.12968/ijpn.2004.10.7.14576

119. Slater A Freeman E Is the palliative care outcome scale useful to staff in a day hospice unit? Int J Palliat Nurs 2005 11 346 54 10.12968/ijpn.2005.11.7.18487 16116391 Slater A, Freeman E. Is the palliative care outcome scale useful to staff in a day hospice unit? Int J Palliat Nurs. 2005;11:346–54. DOI: doi:. 16116391 10.12968/ijpn.2005.11.7.18487

120. Smith V Wise K Evaluating nurses’ action outcomes and exploring their perspectives of implementing the POS-S (Renal) assessment tool for haemodialysis patients Ren Soc Australasia J 2017 13 14 21 Smith V, Wise K. Evaluating nurses’ action outcomes and exploring their perspectives of implementing the POS-S (Renal) assessment tool for haemodialysis patients. Ren Soc Australasia J. 2017;13:14–21. DOI: doi:.

121. Sommerbakk R Haugen DF Tjora A Barriers to and facilitators for implementing quality improvements in palliative care - results from a qualitative interview study in Norway BMC Palliat Care 2016 15 61 10.1186/s12904-016-0132-5 27422410 PMC4947264 Sommerbakk R, Haugen DF, Tjora A, et al. Barriers to and facilitators for implementing quality improvements in palliative care - results from a qualitative interview study in Norway. BMC Palliat Care. 2016;15:61. 10.1186/s12904-016-0132-5. 27422410 10.1186/s12904-016-0132-5 PMC4947264

122. Spaner D Caraiscos VB Muystra C Use of standardized assessment tools to improve the effectiveness of palliative care rounds: A quality improvement initiative J Palliat Care 2017 32 134 40 10.1177/0825859717740051 29096574 Spaner D, Caraiscos VB, Muystra C, et al. Use of standardized assessment tools to improve the effectiveness of palliative care rounds: A quality improvement initiative. J Palliat Care. 2017;32:134–40. 10.1177/0825859717740051. 29096574 10.1177/0825859717740051

123. Stevens AM Gwilliam B A’Hern R Experience in the use of the palliative care outcome scale Support Care Cancer 2005 13 1027 34 15846523 10.1007/s00520-005-0815-6 Stevens AM, Gwilliam B, A’Hern R, et al. Experience in the use of the palliative care outcome scale. Support Care Cancer. 2005;13:1027–34. 15846523 10.1007/s00520-005-0815-6

124. Stewart E Tavabie S White N A short report examining the introduction of routine use of Patient-Reported outcome measures in a mixed oncology population Clin Oncol (R Coll Radiol) 2022 34 241 6 10.1016/j.clon.2021.11.016 34876332 Stewart E, Tavabie S, White N, et al. A short report examining the introduction of routine use of Patient-Reported outcome measures in a mixed oncology population. Clin Oncol (R Coll Radiol). 2022;34:241–6. 10.1016/j.clon.2021.11.016. 34876332 10.1016/j.clon.2021.11.016

125. Stiel S Pastrana T Balzer C Outcome assessment instruments in palliative and hospice care–a review of the literature Support Care Cancer 2012 20 2879 93 10.1007/s00520-012-1415-x 22410859 Stiel S, Pastrana T, Balzer C, et al. Outcome assessment instruments in palliative and hospice care–a review of the literature. Support Care Cancer. 2012;20:2879–93. 10.1007/s00520-012-1415-x. 22410859 10.1007/s00520-012-1415-x

126. Suri S Yoong D Short D Feasibility of implementing a same-day electronic screening tool for clinical assessment to measure patient-reported outcomes for eliciting actionable information on adherence to HIV medication and related factors in a busy Canadian urban HIV clinic Int J STD AIDS 2022 33 247 56 10.1177/09564624211032796 34293990 Suri S, Yoong D, Short D, et al. Feasibility of implementing a same-day electronic screening tool for clinical assessment to measure patient-reported outcomes for eliciting actionable information on adherence to HIV medication and related factors in a busy Canadian urban HIV clinic. Int J STD AIDS. 2022;33:247–56. 10.1177/09564624211032796. 34293990 10.1177/09564624211032796

127. Swart NC Zhang A Lazenby M The acceptability and feasibility of routine use of validated cancer symptom assessment instruments among patients and nurses in the oncology ward at Princess Marina Hospital, in Gaborone, Botswana J Hospice Palliat Nurs 2022 24 E109 16 10.1097/NJH.0000000000000874 35438657 Swart NC, Zhang A, Lazenby M. The acceptability and feasibility of routine use of validated cancer symptom assessment instruments among patients and nurses in the oncology ward at Princess Marina Hospital, in Gaborone, Botswana. J Hospice Palliat Nurs. 2022;24:E109–16. 10.1097/NJH.0000000000000874. 10.1097/NJH.0000000000000874 35438657

128. Tavares AP Paparelli C Kishimoto CS Implementing a patient-centred outcome measure in daily routine in a specialist palliative care inpatient hospital unit: an observational study Palliat Med 2017 31 275 82 10.1177/0269216316655349 27383636 Tavares AP, Paparelli C, Kishimoto CS, et al. Implementing a patient-centred outcome measure in daily routine in a specialist palliative care inpatient hospital unit: an observational study. Palliat Med. 2017;31:275–82. 10.1177/0269216316655349. 27383636 10.1177/0269216316655349

129. Van Cutsem E De Gramont A Henning G Improving outcomes in patients with CRC: the role of patient reported outcomes–An ESDO report Cancers 2017 9 59 10.3390/cancers9060059 28587143 PMC5483878 Van Cutsem E, De Gramont A, Henning G, et al. Improving outcomes in patients with CRC: the role of patient reported outcomes–An ESDO report. Cancers. 2017;9:59. 10.3390/cancers9060059. 28587143 10.3390/cancers9060059 PMC5483878

130. van den Hurk CJG Mols F Eicher M A narrative review on the collection and use of electronic Patient-Reported outcomes in cancer survivorship care with emphasis on symptom monitoring Curr Oncol 2022 29 4370 85 10.3390/curroncol29060349 35735458 PMC9222072 van den Hurk CJG, Mols F, Eicher M, et al. A narrative review on the collection and use of electronic Patient-Reported outcomes in cancer survivorship care with emphasis on symptom monitoring. Curr Oncol. 2022;29:4370–85. 10.3390/curroncol29060349. 35735458 10.3390/curroncol29060349 PMC9222072

131. Viecelli AK Duncanson E Bennett PN Perspectives of Patients, Nurses, and nephrologists about electronic symptom monitoring with feedback in Hemodialysis care Am J Kidney Dis 2022 80 215 e226211 10.1053/j.ajkd.2021.12.007 35085687 Viecelli AK, Duncanson E, Bennett PN, et al. Perspectives of Patients, Nurses, and nephrologists about electronic symptom monitoring with feedback in Hemodialysis care. Am J Kidney Dis. 2022;80:215–e226211. 10.1053/j.ajkd.2021.12.007. 35085687 10.1053/j.ajkd.2021.12.007

132. Voorend CGN Berkhout-Byrne NC Meuleman Y Perspectives and experiences of patients and healthcare professionals with geriatric assessment in chronic kidney disease: a qualitative study BMC Nephrol 2021 22 9 10.1186/s12882-020-02206-9 33407240 PMC7789317 Voorend CGN, Berkhout-Byrne NC, Meuleman Y, et al. Perspectives and experiences of patients and healthcare professionals with geriatric assessment in chronic kidney disease: a qualitative study. BMC Nephrol. 2021;22:9. 10.1186/s12882-020-02206-9. 33407240 10.1186/s12882-020-02206-9 PMC7789317

133. Wu G McBride K Loudon J Improving the use of patient-reported outcomes among patients receiving radiation therapy during the COVID-19 pandemic J Med Imaging Radiation Sci 2022 53 328 33 10.1016/j.jmir.2022.05.007 PMC9130713 35725807 Wu G, McBride K, Loudon J. Improving the use of patient-reported outcomes among patients receiving radiation therapy during the COVID-19 pandemic. J Med Imaging Radiation Sci. 2022;53:328–33. 10.1016/j.jmir.2022.05.007. 10.1016/j.jmir.2022.05.007 PMC9130713 35725807

134. Consolo L Colombo S Basile I Barriers and facilitators of electronic patient-reported outcome measures (e-PROMs) for patients in home palliative cancer care: a qualitative study of healthcare professionals’ perceptions BMC Palliat Care 2023 22 111 10.1186/s12904-023-01234-0 37542264 PMC10401773 Consolo L, Colombo S, Basile I, et al. Barriers and facilitators of electronic patient-reported outcome measures (e-PROMs) for patients in home palliative cancer care: a qualitative study of healthcare professionals’ perceptions. BMC Palliat Care. 2023;22:111. 2023/08/05. 37542264 10.1186/s12904-023-01234-0 PMC10401773

135. Hui D Mastroleo GS De Rozman A Implementation of patient reported outcomes in outpatient palliative care: from paper to computer J Pain Symptom Manage 2023 66 e197 203 10.1016/j.jpainsymman.2023.04.012 37080480 PMC11875839 Hui D, Mastroleo GS, De Rozman A, et al. Implementation of patient reported outcomes in outpatient palliative care: from paper to computer. J Pain Symptom Manage. 2023;66:e197–203. 2023/04/21. 37080480 10.1016/j.jpainsymman.2023.04.012 PMC11875839

136. Ito N Sato A Takeuchi K Development and validation of clinical implementation methods for patient-reported outcomes in Japanese multi-center palliative care units J Patient Rep Outcomes 2024 8 49 10.1186/s41687-024-00730-y 38743180 PMC11093964 Ito N, Sato A, Takeuchi K, et al. Development and validation of clinical implementation methods for patient-reported outcomes in Japanese multi-center palliative care units. J Patient Rep Outcomes. 2024;8:49. 2024/05/15. 38743180 10.1186/s41687-024-00730-y PMC11093964

137. Müller E Mayer-Steinacker R Gencer D Feasibility, use and benefits of patient-reported outcome measures in palliative care units: a multicentre observational study BMC Palliat Care 2023 22 6 10.1186/s12904-022-01123-y 36641450 PMC9839955 Müller E, Mayer-Steinacker R, Gencer D, et al. Feasibility, use and benefits of patient-reported outcome measures in palliative care units: a multicentre observational study. BMC Palliat Care. 2023;22:6. 2023/01/15. 36641450 10.1186/s12904-022-01123-y PMC9839955

138. Ratzel E Pretzell IM Kindler T Patient reported outcome measurement (PROM) under real-life conditions of non-curable cancer outpatients with the integrated palliative outcome scale (IPOS) and NCCN-Distress Thermometer - A mixed methods study PEC Innov 2024 4 100264 10.1016/j.pecinn.2024.100264 38404931 PMC10883829 Ratzel E, Pretzell IM, Kindler T, et al. Patient reported outcome measurement (PROM) under real-life conditions of non-curable cancer outpatients with the integrated palliative outcome scale (IPOS) and NCCN-Distress Thermometer - A mixed methods study. PEC Innov. 2024;4:100264. 2024/02/26. 38404931 10.1016/j.pecinn.2024.100264 PMC10883829

139. Seipp H Haasenritter J Hach M State-wide implementation of patient-reported outcome measures (PROMs) in specialized outpatient palliative care teams (ELSAH): A mixed-methods evaluation and implications for their sustainable ໿use BMC Palliat Care 2022 21 216 10.1186/s12904-022-01109-w 36461081 PMC9716659 Seipp H, Haasenritter J, Hach M, et al. State-wide implementation of patient-reported outcome measures (PROMs) in specialized outpatient palliative care teams (ELSAH): A mixed-methods evaluation and implications for their sustainable ໿use. BMC Palliat Care. 2022;21:216. 2022/12/03. 36461081 10.1186/s12904-022-01109-w PMC9716659

140. Burner-Fritsch I Bolzani A Hriskova K Kolmhuber S Bausewein C Hodiamont F Challenges developing an electronic patient-reported outcome measurement for palliative home care: A qualitative interview and focus group study Palliat Med 2023 37 2 265 74 10.1177/02692163221141487 36600402 Burner-Fritsch I, Bolzani A, Hriskova K, Kolmhuber S, Bausewein C, Hodiamont F. Challenges developing an electronic patient-reported outcome measurement for palliative home care: A qualitative interview and focus group study. Palliat Med. 2023;37(2):265–74. 10.1177/02692163221141487. 36600402 10.1177/02692163221141487

141. Burner-Fritsch I, Kolmhuber S, Hodiamont F, Bausewein C, Hriskova K. Implementing ePROM in specialist palliative home care: the professionals’ perspective – a mixed-methods study. Palliat Care Social Pract. 2023;17. 10.1177/26323524231186827. 10.1177/26323524231186827 PMC10408331 37560175

142. Lehmann-Emele E Jansky M Clapham S Using normalization process theory to evaluate the use of patient-centred outcome measures in specialist palliative home care—a qualitative interview study BMC Palliat Care 2024 23 1 10.1186/s12904-023-01329-8 38166973 PMC10763078 Lehmann-Emele E, Jansky M, Clapham S, et al. Using normalization process theory to evaluate the use of patient-centred outcome measures in specialist palliative home care—a qualitative interview study. BMC Palliat Care. 2024;23:1. 10.1186/s12904-023-01329-8. 38166973 10.1186/s12904-023-01329-8 PMC10763078

143. Deming WE Out of the crisis 1982 Cambridge, Massachusetts The MIT Press Deming WE. Out of the crisis. Cambridge, Massachusetts: The MIT Press; 1982.

144. Kitson A Harvey G McCormack B Enabling the implementation of evidence based practice: a conceptual framework Qual Health Care 1998 7 149 58 10.1136/qshc.7.3.149 10185141 PMC2483604 Kitson A, Harvey G, McCormack B. Enabling the implementation of evidence based practice: a conceptual framework. Qual Health Care. 1998;7:149–58. 10.1136/qshc.7.3.149. 1998/08/05. 10185141 10.1136/qshc.7.3.149 PMC2483604

145. Rycroft-Malone J Kitson A Harvey G Ingredients for change: revisiting a conceptual framework Qual Saf Health Care 2002 11 174 80 10.1136/qhc.11.2.174 12448812 PMC1743587 Rycroft-Malone J, Kitson A, Harvey G, et al. Ingredients for change: revisiting a conceptual framework. Qual Saf Health Care. 2002;11:174–80. 10.1136/qhc.11.2.174. 2002/11/27. 12448812 10.1136/qhc.11.2.174 PMC1743587

146. Damschroder LJ, Reardon CM, Widerquist MAO et al. The updated Consolidated Framework for Implementation Research based on user feedback. Implement Sci 2022; 17: 75. 2022/10/31. 10.1186/s13012-022-01245-0 10.1186/s13012-022-01245-0 PMC9617234 36309746

147. Stover AM Haverman L van Oers HA Using an implementation science approach to implement and evaluate patient-reported outcome measures (PROM) initiatives in routine care settings Qual Life Res 2021 30 3015 33 10.1007/s11136-020-02564-9 32651805 PMC8528754 Stover AM, Haverman L, van Oers HA, et al. Using an implementation science approach to implement and evaluate patient-reported outcome measures (PROM) initiatives in routine care settings. Qual Life Res. 2021;30:3015–33. 2020/07/12. 32651805 10.1007/s11136-020-02564-9 PMC8528754

148. Damschroder LJ Aron DC Keith RE Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science Implement Sci 2009 4 50 10.1186/1748-5908-4-50 19664226 PMC2736161 Damschroder LJ, Aron DC, Keith RE, et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50. 2009/08/12. 19664226 10.1186/1748-5908-4-50 PMC2736161

149. Proctor E Silmere H Raghavan R Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda Adm Policy Ment Health 2011 38 65 76 10.1007/s10488-010-0319-7 20957426 PMC3068522 Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38:65–76. 2010/10/20. 20957426 10.1007/s10488-010-0319-7 PMC3068522

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты